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Within the mammalian nucleus, many major cellular functions are performed 
including transcription,  pre-mRNA splicing and ribosome assembly,  ail of which 
are important for successful gene expression, and, to achieve this, the nucleus 
has evolved as a highly organised, dynamic structure (Dundr and Misteli, 2001). 
In  this  study  a  complete  ultrastructural  and  molecular  investigation  of  the 
neuronal  nucleus  has  been  undertaken,  characterising  three  subdomains  in 
detail: speckles, the nucleolus, and the Cajal body.
It  has  recently  been  established  that  several  human  neurodegenerative 
diseases  are  associated  with  changes  in  the  organisation  of the  neuronal 
nucleus,  and  this  is  believed  to  be the  principle  cause  of cellular dysfunction 
and  resulting clinical symptoms.  Many of these diseases and their associated 
nuclear  pathology  have  successfully  been  reproduced  in  transgenic  mouse 
models.
In  this  study  I  have  determined  the  detailed  ultrastructural  and  molecular 
organisation  of the  nucleus of neurons within the striatum  of the mouse brain 
and compared this to nuclei of striatal neurons in a transgenic mouse model of 
Huntington’s disease and  in  a  mutant mouse lacking  the gene for the  protein 
p80 coilin.  In the HD mouse there is a dramatic reorganisation of the nucleus 
accompanied  by  the  formation  of  a  novel  nuclear  subdomain,  the  neuronal 
intranuclear inclusion (Nil), which is associated with the movement of the Cajal 
body from the nucleolus to the Nil.  This occurs with a change in the molecular 
composition  of the speckles and a  major reorganisation  in the structure of the 
nucleolus.  In  contrast,  the  p80  mutant  mouse  is  characterised  by  major 
alterations  in  the  distribution  and  molecular  composition  of the  Cajal  body. 
However,  this  is  not  similarly  associated  with  dramatic changes  in  either the 
speckles or the nucleolus.
These  studies  clearly  establish  novel  and  important  changes  in  the 
organisation of the neuronal nucleus associated with the formation of the Nil  in 
Huntington’s disease.
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14 INTRODUCTIONIntroduction
CHAPTER 1
The  mammalian  nucleus  is  a  highly  organised,  dynamic  structure within 
which  many  of the  cell’s  major functions  occur  including  transcription,  pre- 
mRNA  splicing  and  ribosome  assembly,  all  of which  are  vital  for successful 
gene  expression  (Dundr and  Misteli,  2001).  Individual  chromosomes  in  the 
interphase  nuclei  occupy  discrete  domains,  which  are  called  chromosome 
territories  (Hebert  and  Matera,  2000).  Numerous,  morphologically  distinct, 
membraneless  domains  including  Cajal  Bodies,  the  nucleolus,  PML domains 
and speckles occupy the interchromatin spaces and are shown in figure1.1.  It 
has  now  been  suggested  that  the  individual  domains  have  defined  spatial 
relationships with each other and with the surrounding genomic DNA (Schul et 
al.,  1998a).  Using immunofluorescence microscopy, many nuclear factors often 
show a punctate staining pattern and localise to distinct bodies.
SAM68
Nuclear Pore 
Complex
Heterochromatin
Cleavage Body
PcG Body Cajal Body (red) 
GEM (green)
OPT domain
RNA polymerase
Chromosome Territory
PML Body
Nucleoli (red) 
Peripheral nuclear 
lamina (green)
Speckles
Perinucleolar Compartment (PNC)
Figure 1.1
A  schematic  illustration  summarising  the  various  nuclear  domains  that  constitute  the 
mammalian cell nucleus (Adapted from Spector, 2003).
15 INTRODUCTION1.1  Nucleolus
The  most  prominent  of  all  the  subcompartments  in  the  nucleus  is  the 
nucleolus and  is one of the most extensively studied (Monneron and Bernhard, 
1969;  Dundr and  Misteli, 2002).  Most mammalian nuclei contain between one 
and  four  nucleoli.  The  main  function  of the  nucleolus  is  the  biogenesis  of 
ribosomes  (Shaw  and  Jordan,  1995),  which  involves  transcribing  rDNA, 
processing  transcripts  and  assembling  rRNA  with  ribosomal  proteins.  The 
average  nucleolus  of a  mammalian cell can  produce up to  10,000  ribosomes 
per minute (Huang, 2002).
1.1.1  Ribosomal Biogenesis
The nucleolus is assembled around repeats of ribosomal genes (rDNA) and 
they  cluster at  chromosomal  loci  called  nucleolar organising  regions  (NORs) 
(Ghosh,  1976;  Derenzini, 2000).  Eukaryotic somatic cells can contain hundreds 
of  ribosomal  genes  (Raska  et  al.,  2004).  RNA  polymerase  I  drives  the 
transcription  of  ribosomal  genes  and  about 40,000  copies  per cell  exist  and 
synthesise  pre-rRNA  (Gerbi  et  al.,  2003).  This  many  RNA  polymerase  I 
molecules  are  needed  because  as  many  as  50  polymerase  molecules  are 
thought to transcribe each rRNA gene simultaneously (Mosgoeller et al.,  2000). 
The  pre-rRNA consists of  18S,  5.8S  and  28S  rRNA sequences together with 
internal and  external transcribed spacer sequences.  Upstream binding factor, 
(UBF), forms part of the transcriptional complex together with RNA polymerase 
I,  Tata  binding  protein  (TBP),  three  transcription  activity  factors  (TAFs), 
transcription initiation factors, TIF-1A and TIF-1C, and other factors.
Mature ribosomal  RNA biogenesis  is a complicated  process that is carried 
out by many factors; non-ribosomal proteins and ribonucleoproteins (RNPs) and 
small  nucleolar  RNAs  (snoRNAs).  RNA  helicases  and  RNA  chaperones 
mediate  RNP  folding  and  remodelling.  5S  rRNA  is  synthesised  in  the 
nucleoplasm and then, together with ribosomal proteins that are synthesised in 
the cytoplasm,  become recruited to the nucleolus and  become  integrated  into 
pre-ribosomal  particles  (Tschochner and  Hurt,  2003).  With  help from  special 
adaptor  molecules,  the  almost  completed  ribosomal  subunits  move  to  the 
cytoplasm.
16 INTRODUCTION1.1.2 Nucleolar Morphology
Nucleoli  vary  a  great  deal  in  appearance  depending  on  the  cell  type. 
However,  most  nucleoli  are  composed  of  three  morphologically  distinct 
components: the fibrillar centres, the dense fibrillar component and the granular 
component (Shaw and Jordan,  1995) (figure 1.2).  Different nucleolar proteins 
localise to the different regions of the nucleolus.  There is a gradual transition 
from the fibrillar centres through the dense fibrillar component to the granular 
component.  The fibrillar centres  (FCs) are each found to accommodate four 
genes and a typical  HeLa cell has about 30 FCs.  Only approximately 120-150 
of the total number of rDNA genes (approximately 540) are active in HeLa cells 
(Dundr  and  Misteli,  2001).  FCs  resemble  NORs  and  are  thought to  be  the 
interphasic counterparts of mitotic NORs (Goessens,  1984).  Each gene  has 
between  100-120  engaged  RNA  polymerase  I  molecules.  The  molecular 
organisation  of  an  active  ribosomal  gene  is  a  structure  that  resembles  a 
Christmas tree  and  was first  seen  in  spreads  of amphibian  oocytes  (Raska, 
2003). The dense fibrillar component (DFC) contains no rDNA but does contain 
an accumulation of elongating and full length  primary transcripts together with 
fibrillarin  and  nuclear  proteins  involved  in  pre-mRNA  cleavage.  Cleavage 
events  start  in  the  DFC  (GC).  Late  processing  and  rRNA  assembly  into 
ribosomal subunits occur in the (GC) (Carmo-Fonseca et al., 2000).
Figure 1.2
Ultrastructural  characteristics 
of nucleoli from HeLa cells,  (a) 
A  reticulate  nucleolus  that  is 
transcriptionally  active. 
Fibrillar  centres  (F),  dense 
fibrillar  component  (D)  and 
granular  component  (G)  can 
be  seen,  (b)  This  nucleolus 
has large  FCs (F),  surrounded 
by DCF (D).  It is also possible 
to  see  a  Cajal  body 
(arrowheads).  Scale  bars  = 
200  A n a (taken  from  Olson  et 
al., 2000).
17 INTRODUCTION1.1.3 Sites of rRNA Transcription
The site of actual  pre-rRNA transcription is controversial.  One study using 
electron microscopy to visualise the sites of labelled nucleotide incorporation in 
the  nucleolus  of  HeLa  cells  (Koberna  et al.,  2002)  showed  that  the  newly 
synthesised RNA was found in the DFC or bordering the DFC and FC but not in 
the FCs alone.  Other studies support this notion (Hozak et al.,  1994; Cmarko et 
al., 2000; Biggiogera et al., 2001).  However, results from other research groups 
contrast this idea.  Mais and Scheer (2001), for example, visualised Br-U,  UBF 
and  RNA polymerase I  in Xenopus oocytes surrounded  by fibrillarin  labelling. 
This suggests that transcription is occurring in the FCs and not the DFC.  These 
contrasting findings have led  to several possible models of the sites of rRNA 
transcription and these are illustrated in figure 1.3 (Huang, 2002).
At DFC  At FC  At FC/DFC
Figure 1.3
Schematic  representation  of the  possible  sites  of  rRNA transcription within  the  nucleolus  (taken 
from Huang, 2002).
1.1.4  Proteins of the Nucleolus
It has been suggested that the nucleolus may have additional functions as 
well as those involved  in ribosome subunit synthesis (Pederson,  1998; Scheer 
and Hock,  1999).  Some of the proteins that constitute the nucleolus have also 
been shown to  be engaged  in  a  shuttling  cycle between the nucleus and the 
cytoplasm  and  may play a key role  in the transport of other proteins (Melese 
and  Xue,  1995).  Andersen  et al.  (2002)  identified  hundreds  of  protein 
components of the nucleolus using mass spectrometry.  A complete list can be 
seen at:
www.dundee.ac.uk/lifesciences/lamonddatabase/flash.htm.
18 INTRODUCTIONThe list of proteins found to localise in the nucleolus highlight the fact that 
many  biological  processes  and  pathways  function  within  the  nucleolus; 
ribosome biogenesis,  mRNA metabolism, translation, cell cycle regulation and 
signal  recognition  particles  biogenesis.  Experiments  have  shown  that  the 
nucleolus also appears to have other functions which include roles in  nuclear 
export,  modifying small RNAs, forming  RNPs and controlling ageing (Olson et 
al.,  2000).  Carmo-Fonseca  et al.  (2000)  now  suggests  that  molecular 
sequestration  of  proteins  within  the  nucleolus  is  a  mechanism  to  regulate 
cellular functions.
Fibrillarin
Fibrillarin  is  a  component  of  the  nucleolar  U3  snoRNP  complex  that 
functions with other box C/D snoRNPs in site-specific 2’-0-methylation of pre- 
rRNA  (Snaar  et  al.,  2000).  Fibrillarin  is  also  directly  involved  in  post- 
translational  processes e.g.  pre-rRNA processing,  pre-rRNA methylation  and 
ribosome assembly.  Fibrillarin is localised to the DFC of the nucleolus and  is 
also found in Cajal bodies (figure 1.4) (Reimer et al.,  1987).  It has been shown 
to be highly mobile in nucleoli and Cajal bodies (Snaar et al., 2000).
Coilin Fibrillarin Merge
Figure 1.4
Confocal  microscopy  image  showing  trigeminal  ganglion  neurons  double  stained  with 
p80 coilin and fibrillarin.  Scale bar = 5 p^(taken from Pena et al., 2001).
GAR1
GAR1  is found in the DFC of the nucleolus and is associated with a subset 
of snoRNAs  (Girard  et al.,  1994).  GAR1  is  believed  to  be  involved  in  the 
processing  of 35S  primary transcripts of pre-rRNA and  the  synthesis  of  18S 
rRNA (Shaw and Jordon, 1995).
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Nopp140 interacts with largest subunit of RNA polymerase I and functions in 
the transcription of rRNA genes (Snaar et al.,  2000).  It is found  in a  complex 
with  NAP57  and  also moves  between cytoplasm and  nucleolus,  and  between 
Cajal  body  and  nucleolus.  Nopp140  interacts  with  p80  coilin  (Isaac  et al.,
1998)  and is found in Cajal bodies (Meier and  Blobel,  1994) as well as the DFC 
of the nucleolus (Shaw and Jordon,  1995).
NAP57
NAP57  (Nopp140  -associated  protein  of  57  kDeJ  interacts  with  H/ACA 
snoRNPs and functions  in  pseudouridylation of rRNA (Snaar et a,  2000).  It is 
found  in  the  DFC  of  the  nucleolus  and  exist  in  a  complex  with  Nopp140. 
NAP57 is suggested to function in the chaperoning of ribosomal proteins and/or 
pre-ribosome  assembly.  NAP57  is  also  found  in  Cajal  bodies  (Meier  and 
Blobel,  1994)
C23 (nucleolin)
C23  is  found  in  the  GC  of  the  nucleolus  and  is  involved  in  pre-rRNA 
processing  (Sirri et al.,  2002).  It is a nucleolar phosphoprotein that is involved 
in transcriptional control and also plays a role in the development of RNA in pre­
ribosome formation (Shaw and Jordon,  1995).  C23 has also been suggested to 
have a chaperone-like role in mediating interactions of proteins and rRNA (Xue 
and Melese,  1994).
B23 (nucleophosim)
B23  is  found  in  the  GC  of  the  nucleolus  and  is  involved  in  pre-rRNA 
processing  (Sirri  et al.,  2002).  B23  is  a  highly  conserved  phosphoprotein 
protein  and  suggested  to  be  play a  role  in the  intermediate or later stages of 
ribosome biogenesis (Shaw and Jordon,  1995).  It binds NLS sequences and is 
thought to shuttle between the nucleolus and the cytoplasm.
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UBF  (upstream  binding  factor)  is  found  in  the  FCs  and  the  DFC  of the 
nucleolus (Shaw and Jordon,  1995).  It is a transcription factor that forms part of 
RNA polymerase I transcription machinery (Flernandez-Verdun et al., 2002).
RNA polymerase I
RNA  polymerase  I  is found  in  FCs  of the  nucleolus.  It forms  part of the 
polymerase  I  transcription  machinery  (Flernandez-Verdun  et al.,  2002) and  is 
involved in transcribing only rDNA (Shaw and Jordon,  1995)
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Figure 1.5
A  schematic  diagram  showing  the  different  functional  pathways  in  the  nucleolus.  Pre-rRNAs  are  co- 
transcriptionally pseudouridinylated, 2’-0-methylated  and cleaved.  This  is  mediated  by  snoRNAs  and 
rRNA  is  then  assembled  into  large  and  small  pre-ribosomal  subunits.  They  are  then  exported  to  the 
cytoplasm.  The  nucleolus  also  functions  in  pre-tRNA  maturation  and modification  of spliceosomal  U6 
snRNA (taken from Dundr and Misteli, 2001).
21 INTRODUCTION1.1.5 Nucleolar Dynamics
Fully active nucleoli are large with extensive intermingling of FCs,  DFC and 
GC,  whereas  inactive  nucleoli  are  often  small  and  compact  and  the  three 
morphological  components  frequently  segregate  (Shaw  and  Jordan,  1995). 
Despite the  morphological  differences,  nucleoli  are  a  permanent  membrane- 
less structure seen in  nearly all eukaryotic cells.  Transcription driven by RNA 
polymerase  I  was  originally  suggested  to  be  sufficient  and  necessary  to 
organise and maintain this steady-state architecture (Weisenberger and Scheer, 
1995).  Several  studies  support  this  view  and  show  that  when  rRNA 
transcription is inhibited with Actinomycin  D, the nucleolus begins to segregate 
(Busch and Smetana,  1970; Granick,  1975).  Also the introduction of ribosomal 
genes on minichromosomes results in the formation of ‘mini-nucleoli’ (Oakes et 
al.,  1998).
However,  recent  studies  have  suggested  that  there  might  be  additional 
levels  of regulation  in  the  maintenance  of nucleolar  morphology.  One  study 
shows  that  the  re-assembly  of  the  nucleolus  during  cell  cycle  and 
embryogenesis occurs before the resumption of rRNA transcription (Hernandez- 
Verdun et al.,  1998;  Hernandez-Verdun et al.,  2002) and CDK2 inhibitors have 
been shown to slow down the processing of rRNA but do not affect the rate of 
rRNA transcription (Sirri et al.,  2002).  Two RNA-binding proteins,  FRGYa and 
b, have been identified as factors that mediate the disassembly of the nucleolus 
in  Xenopus  oocytes  (Gonda  et al.,  2003)  and  this  provides  evidence  that 
nucleolar  structure  can  be  uncoupled  from  RNA  polymerase  I  driven 
transcription (Misteli, 2003).  The role of FRGYa and b in the disassembly of the 
nucleolus  may  be  via  their  non-sequence  specific  rRNA  binding  that  could 
prevent the  interaction  of rRNA with  other  binding  partners.  This  implicates 
rRNA itself in the maintenance of nucleolar morphology (Raska et al., 2004).
All the research points towards a steady-state morphology for the nucleolus 
that  is  very  dynamic  and  complicated.  The  maintenance  of  the  nucleolar 
architecture involves an influx of components, transcription and RNA processing 
together with ribosome assembly and export (Snaar et al.,  1999;  Misteli, 2001). 
There  is  evidence  to  suggest  that  no  diffusion  barrier  exists  between  the 
nucleolus  and  the  nucleoplasm  (Melese  and  Xue,  1995)  and  there  is  a
22 INTRODUCTIONcontinuous exchange of nucleolar components (Misteli,  2001).  Therefore,  the 
picture of a  nucleolus  must be a very dynamic image,  with different molecules 
associating  and  disassociating  at  any  given  time.  It  is,  however,  an  open 
system with the nucleolar structure being directly linked to its functional activity 
(Raska et ai, 2004).
1.1.6 The Nucleolus and Other Domains
Several  sub-nuclear  compartments  are  often  associated  with  nucleoli 
including,  the  perinucleolar compartment  (PNC)  and  the  Cajal  body  (chapter 
1.2.9).  The PNC is an irregularly shaped structure ranging  in size from 0.25 to 
1   pm  in  diameter.  It was first described  by the  localisation  of hnRNP  1/PTB 
(polypyrimidine tract binding) protein (Ghetti et ai,  1992).  Electron microscopy 
studies  show  that  multiple,  thick,  electron-dense  strands  comprise the  PNC, 
each 80-180 nm in diameter (Huang etal.,  1997).  Huang (1998a) suggests that 
PNC are mainly seen  in transformed cells and  rarely seen  in  non-transformed 
primary cells in culture.
Several  molecular  components  have  been  localised  to  the  PNC.  They 
include snRNAs transcribed  by  RNA polymerase  III  (Matera  et ai,  1995)  and 
three RNA binding  proteins:  PTB/hnRNP  1,  CUG binding  protein and  KH-type 
splicing  regulatory  protein  (KSRP)  (Huang,  1998a).  The  presence  of these 
factors  in  the  PNC  suggests  that  the  PNC  is  involved  in  RNA  metabolism 
(Huang  et  ai,  1998a).  It  has  recently  been  shown  that  two  small  RNAs 
transcribed by RNA polymerase III are present in the PNC (Wang et ai, 2003) 
and that the presence of the PNC is dependent on continuous RNA polymerase 
III transcription.
23 INTRODUCTION1.2  The Cajal Body
Ramon  Y  Cajal  (figure  1.6)  first  described  the  Cajal  body  in  1903  as  a 
‘nucleolar accessory body’ (reviewed by Gall, 2003).  The small round structure
CBs  are  highly  conserved  in  evolution  (Bohmann  et ai,  1995b)  and  are 
thought  to  play  a  role  in  snRNP  transport  and  maturation  (Sleeman  and 
Lamond,  1999).  CBs disassemble during mitosis and reforms during G1  phase 
after transcription is reinitiated (Andrade et ai,  1993;  Ferreira et ai,  1994) and 
have  been  shown  to  be  highly  mobile  structures  that  move  throughout  the 
nucleoplasm (Platani et ai, 2000) but are not found in cells of every tissue type.
1.2.1  Cajal Body Structure
Monneron and  Bernhard used electron microscopy (EM) to investigate and 
describe the fine ultrastructure of mouse,  rat and human nuclei.  A “regressive 
EDTA method” was used to provide contrast between structures that contained 
RNA and those that do not.  Many nuclei contained a spherical structure that 
was  0.3-0.5  pm  in  diameter and  composed  of what  Monneron  and  Bernhard 
described  as  coiled  threads.  Similar  images  were  seen  in  rat  trigeminal 
neurons of ‘nucleolar accessory body’  (Hardin  et al.,  1969) at EM.  It was not 
until later that it was established that the coiled bodies described by Monneron 
and  Bernhard,  and,  the  accessory  bodies  seen  in  neurons,  were  in  fact the 
same  structure  (Lafarga  et ai,  1983).  A  combination  of  light  and  electron 
microscopy experiments showing the morphology and  staining  patterns of the
was located within the nucleus and, together 
with  the  nucleolus,  stained  heavily  when 
using silver staining techniques that Cajal had 
developed to stain  neurons.  The Cajal  body 
did not attract much attention  until it was first 
seen  in  non-neuronal  cells  many years  later 
(Monneron and  Bernhard,  1969)  and termed 
the  coiled  body.  It  has  more  recently  been 
suggested  (Gall  et  ai,  2000)  that  this 
subdomain be renamed the Cajal body (CB).
Figure 1.6
Photograph of Ramon Y Cajal.
24 INTRODUCTION‘coiled’ body and ‘accessory body’ of Cajal in neurons revealed these structures 
were indeed the same nuclear body.  Cajal bodies have now been reported  in 
many different cell types and are seen with identical morphology in the nuclei of 
both  plants  and  animal  cells  (Moreno  Diaz de  la  Espina,  1980;  Lamond  and 
Carmo-Fonseca,  1993).
The  ultrastructural appearance of the  Cajal  body  is found  to  be  a  roughly 
spherical structure that is not bound by a membrane (Kinderman and  LaVelle, 
1976).  The average diameter ranges from 0.1-1.0 ^depending on the cell type 
(Lamond and  Carmo-Fonseca,  1993).  CBs appear to be composed  of coiled 
threads that have diameters of approximately 40-50  r\m  and are arranged as an 
accumulation of granules.  The granules are embedded in low-density material 
(Lafarga etal.,  1983).
1.2.2  p80 coilin: the Cajal body marker protein
Human autoimmune sera was identified that stained Cajal bodies in cultured 
cells (Andrade et ai,  1991).  From one of the sera, a cloned cDNA was isolated 
and found to encode a  CB-protein.  When  run on  a Western  Blot,  the protein 
was found  to  be  80  kDa  in  size and was  named  p80 coilin.  Antibodies were 
affinity purified from the 80 kDa band  and  using  immuno-electron  microscopy 
the antigen was shown to localise predominantly to CBs (Raska et ai,  1991).
When  p80 coilin was first sequenced  it showed  no  clear homology to any 
other known protein motifs (Lamond and Carmo-Fonseca,  1993) until a similar 
protein  was  identified  in  the  oocyte  of Xenopus  laevis  (Tuma  et ai,  1993). 
SPH-1, as the protein was called, was localised to the sphere organelles in the 
Xenopus  oocytes.  Sphere  organelle were  first  seen  as  ‘knobs’  attached  to 
lampbrush  chromosomes from  amphibian  oocytes  (Gall,  1954)  and  evidence 
now  supports  the  notion  that these  are  amphibian  Cajal  bodies  (Gall  et ai, 
1995;  Roth,  1995).  It  has  since  become  evident that  human  p80  coilin  and 
Xenopus  SPH-1  are  orthologous  proteins  (Bauer  and  Gall,  1997).  The 
discovery of p80 coilin  has also been  used to show that Cajal  bodies exist in 
plant cells (Beven et ai,  1995) and that they also contain U2B”, U1,  U2 and U6 
snRNAs.
25 INTRODUCTION1.2.3  p80 coilin: structure
Full length p80 coilin is 576 amino acids in length and has a predicted mass 
of 62.6 kDajbut it runs on a SDS-PAGE at approximately 20 kDa greater (Chan 
et al.,  1994; Wu et at.,  1994).  This discrepancy cannot be  accounted for by 
post-translational modifications.  p80 coilin does exhibit multiple phosphorylated 
serine  residues  in  interphase  nuclei  and  is  hyperphosphorylated  at  mitosis 
(Carmo-Fonseca  et at.,  1993).  However,  phosphorylation  only  has  minor 
effects on the SDS-PAGE motility.  The phosphorylation state of p80 coilin  is 
probably more important for the proper localisation of p80 coilin and therefore 
Cajal body function (Hebert and Matera, 2000) (chapter 1.4).
Figure 1.7
Schematic  diagram  showing  the 
alignment of mouse,  human and frog 
p80  coilin  (taken  from  Tucker et at., 
2000).
The N-terminus and the C-terminus of amphibian and mammalian p80 coilin 
show more than 50% identical residues but only 33% of residues in the middle 
region and this is shown in figure 1.7.  Therefore, the conserved protein motifs 
or domains  are  likely to  be found  in  the  highly  homologous  regions.  When 
mouse and  human  sequences are aligned,  together with the sequence from 
frog p80 coilin the homology can be clearly seen.
The  first  100  amino  acids  of  the  N-terminus  have  several  interesting 
properties.  Deletion constructs of human p80 coilin revealed that the first 102 
amino acids (18% of the molecule) targeted it to Cajal bodies within germinal 
vesicle of amphibians (Wu et al.,  1994).  Bellini and Gall (1998) found that the 
same first 100 residues of the amino terminus of p80 coilin were both necessary 
and sufficient to bind single stranded  nucleic acids and poly r(G) and poly (U) 
RNA  homopolymers  in  vitro.  The  amino  terminus  has  also  been  shown  to 
interact with the nucleolar protein, Nopp140 (Isaac et al.,  1998).
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2  6 INTRODUCTIONThe N-terminus also has a self-interacting domain and this has been shown 
to be necessary and sufficient to localise p80 coilin to Cajal bodies in HeLa cells 
(Hebert and  Matera, 2000).  However,  hyperphosphorylation of p80 coilin was 
seen to cause a reduction in self-association.  Two simple and bipartite nuclear 
localisation signals (NLSs) have also been  identified  in p80 coilin (Almeida et 
al.,  1998) together with  a cryptic nucleolar localisation signal  (NoSL)  (Hebert 
and Matera, 2000).
Less is known about the C-terminus of p80 coilin but a stretch of arginine 
and glycine dipeptide residues, known as the RG box domain, has been located 
there and it has been shown by Hebert et al. (2001) that this motif binds to the 
survival of motor neurons protein, SMN, and is also essential for the proper CB 
formation.  Without the RG motif no SMN or the macromolecular complex it is 
part of,  Sm proteins or snRNPs are found to localise to CBs.  The deletion of 
the  RG  box  also  results  in  an  increase  in  the  nucleoplasmic fraction  of p80 
coilin.  The binding domains of p80 coilin are shown in figure 1.8.
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Figure 1.8
A diagram highlighting all the identified domains of p80 coilin.
1.2.4  p80 coilin: function
The actual function of p80 coilin is still unclear and it was thought that it was 
an  important  structural  component  of  Cajal  bodies.  However,  it  has  been 
shown that this  is  in fact not true as  Bauer and  Gall demonstrated that Cajal 
body-like structures could form  in a  nuclear extract that had  been depleted of 
p80 coilin.  Also,  p80 coilin  knock-out mice that have  been  created that lack 
85% of the protein and are still viable and fertile (Tucker et al., 2001).  Exons 2
27 INTRODUCTIONto  7  are  deleted  in  the  knockout  mouse  and  using  immunocytochemistry, 
‘residual’ CBs can be identified that do not contain exon  1  of p80 coilin.  These 
CBs fail to recruit snRNPs, Sm proteins and the SMN complex but the nucleolar 
proteins, fibrillarin and  Nopp140,  do accumulate in the ‘residual’  CBs (chapter 
1.4.3).  Thus,either  the  structural  function  of  p80  coilin  is  not  essential  or 
another protein can take on  its role in the nuclei lacking p80 coilin.  It has also 
been shown that after microinjection of antibodies raised against p80 coilin  in 
HeLa  cells,  CBs  are  seen  to  disappear  (Almeida  et al.,  1998)?but  no  major 
cellular  abnormalities  were  detected  during  this  period.  This  suggests  that 
whatever  the  function  of  p80  coilin,  it  can  still  be  carried  out  by  the 
nucleoplasmic pool.
Evidence has suggested a  relationship between snRNPs and  Cajal  bodies 
since the discovery that snRNPs accumulate in CBs.  A link between p80 coilin 
and  snRNPs  has  also  been  shown  with  transient  expression  of  p80  coilin 
mutants,  some  of  which  cause  altered  distribution  of  splicing  snRNPs 
(Bohmann et al.,  1995a).  Another connection between snRNPs and p80 coilin 
was shown  by  Bauer et al.  (1994).  Their studies  showed that CBs  could  be 
found  in  pronuclei  assembled  in  vitro in Xenopus egg extract^but if p80 coilin 
was removed from the egg extract before pronuclei formation, splicing snRNPs 
would not accumulate in CBs and vice versa, supporting a link between the two 
factors.
1.2.5  Cajal Body Components
Numerous molecular components have been detected  in Cajal  bodies and 
many  of these  molecules  are  involved  in  processing  of  all  RNA  types  and 
transcription.  Their identification was made easier with the identification of the 
CB marker,  p80 coilin,  as double-labelling experiments could  be performed to 
discover additional CB components. As mentioned  previously,  splicing factors 
were among the first to be identified (Brasch and Ochs,  1992; Carmo-Fonseca 
et al.,  1992).  Anti-Sm and anti-trimethylguanosine (TMG) staining showed both 
antigens localised to CBs as well as the well-known speckled pattern (Fakan et 
al.,  1984, Carmo-Fonseca et al.,  1991b).  The presence of Sm and TMG in the 
CBs strongly supported the idea that snRNAs and snRNPs were also localised
28 INTRODUCTIONin CBs.  Since then all five of the major splicing snRNPs (U1,  U2,  U4,  U5 and 
U6)  have  been  localised  to  the  Cajal  body  and  all  are  subunits  of  the 
spliceosome  (Carmo-Fonseca  et al.,  1991a;  Carmo-Fonseca  et al.,  1991b; 
Huang  and  Spector et al.,  1992;  Carmo-Fonseca et al.,  1992).  However,  the 
non-snRNP splicing factor, SC35, does not localise to CBs as immunoreactivity 
for anti-SC35 only reveals a speckled pattern of staining (Spector,  1991).  Basal 
transcription factors TFIIF and TFIIH, Tata binding protein (TBP) and  proximal 
element  sequence-binding  transcription  factor (PTF)  (Schul  et al.,  1998b)  as 
well  as  nucleolar components  fibrillarin,  Nopp140  and  NAP57  have  all  been 
localised to CBs (Raska et al.,  1991;  Meier and Blobel,  1992; Meier and Blobel, 
1994). All of the CB components were also found elsewhere in the nucleus at 
equal or greater concentrations, and,  even p80 coilin  is not localised  solely to 
the CBs, as it also exhibits a diffuse nucleoplasmic distribution.  It has also been 
shown  that  there  is  heterogeneity  among  the  components  seen  in  different 
Cajal bodies within individual cells (Alliegro and Alliegro,  1998).
1.2.6  SMN: the SMA-determining gene
Survival  of motor  neuron  protein  (SMN)  is  the  protein  that  is  affected  in 
spinal  muscular  atrophy  (SMA).  Detailed  characterisation  of  the  smallest 
deletions found  in SMA patients allowed the identification and characterisation 
of  the  SMN  gene  (Lefebvre  et al.,  1995).  SMA  is  a  recessive  autosomal 
disorder that is  characterised  by degeneration  of motor neurons  in  the spinal 
cord  resulting  in  muscle weakness  and  often  death  in  childhood  and  affects 
about  1   in  6000  births  (Dubowitz,  1995;  Lefebvre et al.,  1998;  Meister et al., 
2002).  Due  to  this,  SMA  is  one  of the  leading  hereditary  causes  of  infant 
mortality.
The  positional  cloning  strategy  revealed  that  SMN  gene  is  located  on 
Chromosome 5 and exists in duplicate (Melki eta!.,  1990;  Burghes et al.,  1994). 
One copy  is  referred to as the telomeric copy,  SMNt/SMN1,  and  one  copy  is 
called the centromeric copy,  SMNc/SMN2.  In 98% of SMA patients,  SMN1  is 
lacking and SMN2 is a highly homologous copy (Lefebvre et al.,  1995).  There 
are  only  5  nucleotide  differences  between  SMN1  and  SMN2  (Lorson  et al.,
1999)  (figure  1.9).  One  of  the  differences  is  located  in  exon  7.  It  is  a
29 INTRODUCTIONtranslationally silent varian^  but causes alternative splicing  of exon 7 that is 
specific for SMN2 transcripts.
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Figure 1.9
Schematic diagram showing  the 5  nucleotide differences  between  SMN1  and  SMN2  (taken from  Lorson, 
1999).
SMA patients show an increase in RNA transcripts lacking exon 7 compared 
to control individuals (Lorson et al.,  1999). The truncated transcripts represent 
the major form derived from SMN2.  However, the presence of SMN2 gene in 
SMA patients and SMA mouse models is not sufficient to compensate for SMN1 
defects (Monani et al., 2000).  In many cases of SMA, an increased number of 
SMN2 copies correlates with  milder disease phenotypes,  implying that SMN2 
can sometimes be translated into a functional protein and could be a target as a 
modifying gene in SMA (Monani et al., 2000).
The SMN gene encodes a protein that is 294 amino acids with a molecular 
weight of 38 kDa and shows no homology to any other proteins.  It has 9 exons 
and they are numbered as shown in figure  1.10.  In humans,  SMN  is a highly 
alternatively spliced protein (Jong et al., 2000).  Most SMN1  transcripts (90%) 
are full length but  10% are missing exon  5 or exon 7 and a small fraction are 
missing  exon  3  or  exon  3  and  exon  7,  whereas,  only  20-30%  of  SMN2 
transcripts are full  length.  The remaining transcripts have been shown to lack 
exon 3, exon 5 or exon 7 or a combination of all 3 exons.  Murine SMN, on the 
other hand,  is  not alternatively  spliced  and  shows  82%  homology to  human 
SMN at the amino acid level (Bergin et al.,  1997) but the mouse genome only 
has one copy.
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Figure 1.10
A diagram illustrating differential splicing of exon 7 in SMN1  and SMN2 transcripts.
In HeLa cells, SMN is found in both the cytoplasm and the nucleus (Liu and 
Dreyfuss,  1996).  In some cell types,  SMN localises in gems (chapter 1.2.10)^ 
but  in  many  cell  types,  for  example  neurons,  gems  are  not  seen  and  SMN 
colocalises with p80 coilin in Cajal bodies (figure  1.11)  (Carvalho et al.,  1999;
Young et al., 2000; Young et al., 2001).
Figure 1.11
Double-immunolabelling of p80 coilin  and  SMN  in  neurons showing that p80 and 
SMN colocalise (taken from Pena et al., 2001).
Immunocytochemical analysis of SMA patient fibroblasts shows a significant 
decrease  in the  number of gems  in  SMA type  I  (Coovert et al.,  1997) and  a 
correlation  between the  number of gems and  disease severity was  reported. 
Immunofluorescence microscopy carried out on liver and spinal cord cells from
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al.,  1997).  This  study  analysed  SMA type  I  and  type  III  motor  neurons  and 
demonstrated  that  SMN-positive  gems  were  not  seen^but  p80  coilin-positive 
CBs were present in the fetal neurons.
SMN2 gene has a variable copy number and it is suggested that SMA type II 
patients  have a greater copy  number of SMN2  and  this  reduces the disease 
severity.  In SMA type II only a small reduction in the number of gems was seen 
in  patient fibroblasts supporting the  idea that larger numbers of SMN2 genes 
can  lead  to  increased  expression  of full  length  SMN  protein  (Coovert  et al., 
1997).  Therefore SMA type II patients have more SMN protein from the greater 
number  of  SMN2  genes  and  in  sufficient  amounts  is  able  to  assemble  into 
gems.  Frugier et al.  (2000) also showed a reduction in the number of gems in 
nuclei from  a  mouse model  of SMA that had  a conditional  deletion  of murine 
SMN exon 7.
1.2.7  SMN Interacting Partners
When Liu and Dreyfuss (1996) screened a HeLa cDNA library using SMN as 
bait  in  the  yeast two-hybrid  system,  SMN  protein  was  found  to  interact with 
itself, fibrillarin and heterogeneous nuclear RNPs (hnRNPs).  It was shown that 
SMN  protein  could  interact with  both full  length  SMN  and the  protein  lacking 
exon  7  corresponding  to  the  product  of  the  alternatively  spliced  SMN2 
transcript.  Two novel proteins were also shown to interact with SMN.  One of 
these  novel  proteins  is  Gemin2  (formerly known  as  SIP1  for SMN-interacting 
protein).  Since then a large number of other proteins  have been identified as 
interacting partners of SMN.  This is summarised in figure 1.12 (Charroux et al., 
1999;  Campbell  et al.,  2000;  Friesen  and  Dreyfuss,  2000;  Jong  et al.,  2000; 
Young et al.,  2000;  Hebert et al.,  2001; Jones et al., 2001;  Matera and  Hebert, 
2001; Mourelatos et al., 2001;  Pellizzoni et al., 2001b; Voss et al., 2001; Wang 
and Dreyfuss, 2001).
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Figure 1.12
Diagram highlighting all the known binding domains of SMN protein.
1.2.8  SMN Complex
It has since been discovered that SMN protein is part of a macromolecular 
complex that has a molecular weight of 300  kDa with  Gemin2  and  up to five 
additional Gemin proteins (figure 1.13) (Campbell, et al., 2000; Charroux et al., 
2000;  Baccon  et al.,  2002;  Gubitz  et al.,  2002;  Pellizzoni  et al.,  2002).  In 
somatic cells, SMN and the Gemins colocalise in the cytoplasm and the nucleus 
(Charroux  et al.,  1999).  The  cytoplasmic complex  containing  SMN  and  the 
other  Gemins  also  contains  Sm  proteins  that  are  components  of  the 
spliceosomal snRNPs (Liu et al.,  1997).  Transfection studies with a deletion of 
the  N-terminal  of SMN  (SMNAN27)  show that SMN  has  a  critical  role  in the 
cytoplasmic association of snRNPs (Pellizzoni et al.,  1998).  A reorganisation of 
snRNPs  is  seen  when  SMNAN27  is  overexpressed  in  the  nucleus.  Large 
CBs/gems are formed that contain  mutated  SMN, together with  snRNPs and 
other nuclear proteins.  The SMNAN27 mutation also inhibits pre-mRNA splicing 
in vitro (Pellizzoni et al.,  1998) suggesting that SMN also plays a role in splicing. 
In the cytoplasm, SMN complex has a role in snRNA binding to Sm proteins and 
so it is implicated in the metabolism of snRNPs.  The association of SMN and 
Gemin2  in  the  cytoplasm  of Xenopus oocytes shows this.  When antibodies 
directed  against  the  SMN-Gemin2  complex  were  injected  into  oocytes  the 
assembly of snRNP proteins and snRNAs were interfered with (Fischer et al., 
1997).  A similar study has also been performed in HeLa cells and, in this case, 
pre-mRNA splicing was also inhibited (Meister et al., 2000).
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A schematic representation of the SMN complex (adapted from Charroux 
etai, 2000).
The same study by Fischer et al. (1997) also showed that the SMN complex 
is thought to accompany the snRNPs into the nucleus to Cajal bodies.  In CBs 
or gems, the SMN complex may have a role in the assembly of small nucleolar 
RNPs  (snoRNPs)  and  metabolism  for  pre-rRNA  splicing  (Pellizzoni  et  al., 
2001a; Jones et al., 2001; Whitehead et al., 2002) due to the ability of SMN to 
interact with fibrillarin and GAR1 and their colocalisation in CBs.  SMN may also 
play  a  role  in  the  assembly  of transcriptosomes which  are  large  complexes 
containing  RNA polymerase I,  II or III, transcription factors and spliceosomes, 
for the coordinated synthesis and processing of mRNA and rRNA (Pellizzoni et 
al.,  2001b).  The possible functions of the SMN  complex are shown  in figure 
1.14.  Any  one  of these  interactions  may  be  altered  in  SMA  and  therefore 
represent a defective pathway contributing to the pathology seen in SMA.  An 
example of this has already been  identified as SMA-causing  mutations in the 
Tudor domain and SMN oligormerisation domain affect the binding of SMN to 
Sm  proteins  (Meister  et al.,  2002)  and  implicates  defects  in  spliceosomal 
snRNP assembly as part of the underlying the development of SMA (Carvalho 
etai, 1999).
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Figure 1.14
A diagram showing how the SMN  complex is implicated in a number 
of cellular complexes.  The  SMN  complex  is  suggested  to  mediate 
the  assembly in  Cajal  bodies via  its interactions with target  proteins 
(taken from Terns and Terns, 2001).
1.2.9  Cajal Bodies and the Nucleolus
As first implicated by Cajal’s original ‘accessory’ term for CBs, there appears 
to  be an  intimate  relationship  between the  nucleolus and the Cajal  body.  A 
physical  connection  between  the two  structures  can  be  seen  using  electron 
microscopy  studies  revealing  fibres  connecting  CBs  to  the  periphery  of the 
nucleolus (Kinderman and  LaVelle,  1976;  Raska et al.,  1990).  It is not only a 
spatial relationship that can be seen between these two subdomains, as there 
is also a molecular relationship as well.  Cajal bodies contain several nucleolar 
proteins:  fibrillarin,  Nopp140,  NAP57 and  ribosomal  protein  S6 (Raska et al., 
1990; Raska etai.,  1991; Jimenez-Garcia etai.,  1994; Meier and Blobel, 1994). 
A  number  of  these  nucleolar  factors  have  functions  related  to  pre-rRNA 
processing.  Fibrillarin is involved in pre-rRNA processing  in yeast and is also 
associated  with  the  C/D  box  snoRNAs that  play  a  role  in  site-specific 2’-0- 
methylation and processing of rRNA (Weinstein and Steitz,  1999).  Meier and 
Blobel  have shown,  using  co-immunoprecipitation, that  Nopp140 and  NAP57 
form a stoichiometric complex together in the  nucleolus.  It is suggested that 
they function in the chaperoning of ribosomal proteins and/or the assembly of 
pre-ribosomes.  Phosphorylation is thought to regulate the interaction between 
the  two  compartments  (Lyon  et al.,  1997)  and  this  will  be  discussed  later 
(chapter 1.4).
35 INTRODUCTION1.2.10 Cajal Bodies and the Other Nuclear Domains
The nucleolus is not the only domain that is reported to be associated with 
the  CB.  The  cleavage  body  was  first  seen  using  transmission  electron 
microscopy and appeared as a structure juxtaposed to the CB.  It was seen to 
be composed of a more homogenous,  paler material than the CB (Schul et al., 
1996; Lafarga et al.,  1998). The cleavage body was found to contain two factors 
involved  in the cleavage and  polyadenylation of pre-mRNA transcripts: the 64 
kDa  cleavage  stimulation  factor  (CstF64)  and  the  100  kDa  cleavage  and 
polyadenylation  specificity  factor  (CPSF)  (Schul  et al.,  1996).  Transcription 
factors,  including  TFIIE  and  TFIIF  (RAP74)  have  also  been  localised  to 
cleavage bodies in HeLa cells (Gall et al.,  1999).
Gems were first described  on the basis of immunostaining with antibodies 
against the survival of motor neuron  (SMN)  protein  (Liu  and  Dreyfuss,  1996). 
Gems have been frequently seen near or associated with CBs that have been 
identified using staining with an antibody to p80 coilin.  It was later discovered 
that gems  do  not occur in  every cell type and  that the  original  HeLa  cell  line 
(PV)  used  by Dreyfuss was actually highly unusual  in this regard.  Recently a 
study  of a  variety  of tissue  types  indicated  that  many  adult  mammalian  cell 
types  lack  gems  (Young  et al.,  2000),  and,  SMN  and  other  members  of the 
SMN complex are seen to colocalise with p80 coilin at a single focus (Matera 
and Frey,  1998).
1.2.11 Cajal Body Function
Cajal  bodies  have  been  implicated  in  a  number of key  cellular processes 
mainly due to  the  components that  have  been  show to  localise within  them. 
This led  to the idea that CBs were storage sites for many different factors but 
further  evidence  has  identified  a  more  dynamic  role  as  several  studies 
demonstrated  that  particular  molecules  are  actually  targeted  to  CBs.  Three 
main areas of function for CBs  have come to  light:  histone  pre-mRNA 3’-end 
processing, pre-mRNA splicing and transcription.
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The function of Cajal bodies is still not known but it has been suggested that 
CBs play a role in histone pre-mRNA 3’-end processing.  This is because CBs 
in amphibian oocytes were seen firmly attached to specific gene loci (Gall et al., 
1981)  and  in situ hybridisation  showed that the  sites  of CB  attachment were 
located at or very near to histone genes.  The localisation of U7 snRNP to CBs 
supports the association between CBs and histone genes further as U7 snRNP 
cleaves the  3’-terminus of histone  pre-mRNA (Frey  and  Matera,  1995).  It  is 
possible th^t the presence of U7 snRNP,  in the attached CB,  is a mechanism 
assuring  its  recruitment to the sites of histone pre-mRNA transcription.  Frey 
and  Matera  (1995) also demonstrated the association of CBs with a subset of 
histone gene loci in HeLa cells.  This was only seen for a small number of Cajal 
bodies as most CBs were found to be free in the nucleoplasm.  However, the 
association  between  the  Cajal  body  and  gene  loci  does  not  have  to  be 
sustained for their expression (Shopland et al., 2001).
The histone gene cluster is not the only gene cluster that is often seen to be 
associated with the Cajal body.  It has also been shown that CBs can also be 
found juxtaposed to the snRNA genes (Jacobs et al.,  1999;  Smith and  Bentley 
Lawrence,  2000;  Frey and  Matera,  2001) as well as snoRNA host genes; the 
hsc70 gene  hosting the  U14 snoRNA,  the S3 gene  hosting the  U15 snoRNA 
and  the  UHG  gene  hosting  the  U22  snoRNA  (Schul  et al.,  1999).  These 
snoRNAs do not have their own genes but are encoded in the introns of other 
genes (the snoRNA hosting genes).
1.2.13  Cajal Bodies and Splicing or Processing of pre-mRNA
The  presence  of Sm  epitope  and  the  TMG  cap  together with  the  all  the 
major and minor splicing snRNAs -  U1,  U2, U4,  U5, U6,  U11  and U12 -  in CBs 
has  le<l  to  speculation  that  CBs  may  function  in  splicing  or  in  the  general 
processing  of pre-mRNA.  However,  as Cajal  Bodies do not contain  DNA and 
lack vital splicing factors such as SC35 or U2AF, nascent pre-mRNA or poly(A) 
mRNA  (Matera,  1999),  it  is  unlikely  that they  are  actual  sites  of pre-mRNA 
transcription or splicing.
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involved in the biogenesis of snRNPs.  It has been shown that nascent snRNPs 
do  not  accumulate  in  Cajal  bodies but  maturing  or  mature  snRNPs  can  be 
found in CBs in high concentrations.  The first evidence to support this is pulse- 
chase  experiments  with  titrated  UTP  that  show  a  lag-time  before  CBs  are 
labelled  (Fakan  and  Bernhard,  1971).  Secondly,  pulses  of Br-UTP  revealed 
that CBs are separate from  but adjacent to sites of transcription  (Schul et al., 
1998b).  Thirdly,  the  localisation  of trimethylguanosine  (TMG)  cap  and  Sm 
protein  epitopes to  CBs  shows that snRNPs  concentrated within  CBs  are  at 
least partially mature.  This is because splicing snRNAs are synthesised in the 
nucleus  but  exported  to  the  cytoplasm,  where  they  are  assembled  into  Sm 
particles, acquire the TMG cap and then return to the nucleus (Liu et al.,  1997). 
The presence of the Sm and TMG epitopes in CBs suggests that snRNAs have 
completed the cytoplasmic part of their life cycle.
This idea is further supported  by the research  of Dreyfuss and co-workers 
on  SMN  (Liu  et  al.,  1997).  They  showed  that  SMN  is  found  in  both  the 
cytoplasm and the nucleus.  In the nucleus,  SMN  is localised to CBs or gems 
and in the cytoplasm,  it plays an important role in the cytoplasmic assembly of 
snRNPs (Fischer et al.,  1997).  Antibodies directed against SMN and one of it 
binding partners,  Gemin2, were shown to interfere with the proper assembly of 
Sm  proteins  and  spliceosomal  snRNAs  when  microinjected  into  HeLa  cells. 
Mutational analysis of SMN in cultured cells has shown that over expression of 
an  N-terminal  deletion,  called  SMNAN27,  inhibits  pre-mRNA  splicing  and 
causes  a  redistribution  of  splicing  snRNPs  into  large  CB-like  structures 
(Pellizzoni et al.,  1998).  This evidence suggests that SMN and  its associated 
proteins may play a role within the nucleus that involves the recycling of splicing 
components and /or maintaining the active form of splicing machinery (Charroux 
etai.,  1999; Pellizzoni etai.,  1999).
Another connection between CBs and splicing was shown when amphibian 
oocytes where microinjected with radiolabelled U7 snRNA and the endogenous 
U7 snRNA within CBs was replaced by the injected constructs (Wu et al.,  1996). 
Narayanan  et al.  (1999)  also  used  amphibian  oocytes  to  demonstrate  that 
microinjected fluorescently labelled  C/D box small  nucleolar RNAs (snoRNAs) 
associated  with  CBs  transiently  before  accumulating  in  the  nucleolus  and
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targeting region) resulted in the retention of the mutated snoRNAs in CBs.
When  mammalian  cells  are  microinjected  with  plasmids  encoding  the  Sm 
proteins  B,  D1  and  E,  tagged  with  either green  fluorescent  protein  (GFP)  or 
yellow-shifted  GFP  (YFP)  and  then  pulse expressed  (Sleeman  and  Lamond, 
1999), the newly synthesised fluorescently tagged snRNPs accumulate first in 
CBs,  then the nucleolus and  afterwards in speckles.  This data suggests that 
transition  of snRNPs through CBs and  nucleoli  is only part of their maturation 
pathway.
1.2.14  Cajal Bodies and Transcription
Recent studies have shown that CBs also contain the three eukaryotic RNA 
polymerases and other factors that function in transcription.  From the data from 
these studies, Gall (2001) suggests Cajal bodies could be sites of transcription 
machinery assembly.  It  is thought that RNA polymerases associate with their 
respective transcriptional and  processing factors  in CBs,  from where they are 
transported as pre-assembled complexes to the actual site of transcription. The 
first  evidence  to  support  this  comes  from  staining  of  somatic  CBs  with  a 
monoclonal  antibody,  8WG16,  which  recognises  the  unphosphorylated  C- 
terminal domain (CTD) of the large subunit of RNA polymerase II  (Schul et al., 
1998b).  This antibody also stains CBs in the Xenopus germinal vesicle (Gall et 
al.,  1999).  A further two antibodies against RNA polymerase II also stain CBs: 
ARNA, an antibody that recognises an epitope outside the CTD,  and,  H14, an 
antibody that recognises the CTD when serine-5  is  phosphorylated  (Gall  and 
Murphy,  1998).  The  H14  staining  is  quite  surprising  as  the  CTD  becomes 
phosphorylated after RNA polymerase  II  has  become bound to the chromatin 
template and before elongation.  It therefore recognises an active form of RNA 
polymerase  II.  If  germinal  vesicles  are  exposed  to  5,6-dichloro-1-beta-d- 
ribofuranosylbenzimidazole (DRB), an inhibitor of transcription, the H14 staining 
disappears  over a  period  of time  (two to three  hours).  The  staining  returns 
when  the  inhibitor  is  removed  (Morgan  et al.,  2000).  DRB  inhibits  several 
protein  kinases  and  prevents the  phosphorylation  of the  CTD  In  vitro and  in 
vivo.  Gall  speculated  that this experiment shows that  RNA polymerase  II  is
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phosphorylated form of RNA polymerase II leaves and is replaced with only the 
unphosphorylated form.  A study demonstrating that newly synthesised  RNA 
polymerase II subunits are targeted specifically to CBs supports the notion that 
RNA  polymerase  II  moves  through  Cajal  bodies  (Morgan  et al.,  2000).  An 
epitope-tagged transcript of the RNA polymerase II subunit  were injected into 
the  cytoplasm  of  amphibian  oocytes  and  within  a  few  hours  tagged  RNA 
polymerase II protein was seen in CBs (Morgan et al., 2000).
Nuclear proteins that are involved in transcription and the processing of RNA 
polymerase  II transcripts  have also been  localised to or adjacent to  CBs via 
immunostaining (figure 1.15).  They include Tata binding protein (TBP), snRNA 
gene-specific transcription factor, PTF- and TFIIF (RAP74) (Schul et al.,  1998b) 
as well as TFIIH (Grande et al., 1997).
Figure 1.15
Immunostaining  of Cajal  bodies  in  HeLa  cells 
demonstrating  that  TBP  and  PTF  colocalise 
with  p80  coilin  (taken  from  Schul  et  al., 
1998b).
The  evidence  for  RNA  polymerase  I  and  III  is  based  only  on 
immunostaining.  Antibodies against two large subunits of RNA polymerase  I 
have been  localised to CBs in Xenopus germinal vesicles (Gall et al.,  1999). 
Two  subunits  of  RNA  polymerase  III  and  one  subunit  shared  by  both  RNA 
polymerase I and III have all been found to localise within oocyte CBs (Wang et 
al.,  1997).  TFIIA,  a transcription factor specific for 5S  rRNA,  has also  been 
shown in oocyte CBs (Gall etai., 1999).
4 0 INTRODUCTIONCajal  bodies  contain  a  variety  of  components  that  are  involved  in 
transcription  and  processing  of all three types  of RNA and  include the three 
eukaryotic  RNA polymerases.  Even though  many of these factors are found 
more abundantly elsewhere in the cell, targeting experiments have shown how 
many  of them  rapidly  and  specifically  localise  in  CBs.  These  discoveries 
support the  model  of CB  function  as  a  site  of preassembly  of transcription 
machinery.
Pena  et  al.  (2001)  have  shown  that  there  is  a  relationship  between 
transcription  and  the  number  of  Cajal  bodies  and  their  relationship  to  the 
nucleolus.  Mature trigeminal ganglion  neurons (TGN) were studied and their 
cell body size, which is determined by transcriptional activity in diploid cells, was 
shown to correlate with the  number of CBs seen  per nucleus.  There was a 
significant increase in  CBs from small to large neurons.  Large neurons also 
showed  the  highest  percentage of nucleolar-associated  CBs.  These  results 
suggest that the number of CBs per nucleus and CB localisation is transcription 
dependent.
1.3 Speckles
One nuclear compartment that occupies around 20% of the nuclear volume 
is  commonly  called  ‘speckles’  (Misteli,  2000).  Almost  every  essential  pre-
mRNA splicing factor is concentrated  within 
:  the  20-40  domains  called  speckles  or
!||F -  -  • '  splicing  factor  compartments  (Fu  and
Maniatis,  1990)  as well  as  having  a diffuse 
nucleoplasmic  distribution  (figure  1.16). 
Speckles were  first  described  on  the  basis 
of their distinct morphology,  long before the
Figure 1.16
Immunostaining  of speckles  (from  Misteli,  discovery of pre-mRNA Splicing.
2000).
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Using  transmission  electron  microscopy  (TEM),  speckles  are  to  be 
composed of two separate structures with differing ultrastructures (Puvion and 
Puvion-Dutilleul, 1996).  The first, called interchromatin granule clusters (IGCs), 
have  an  apparent  diameter  of  0.8  to  1.8  and  are  composed  of  dense 
granules about 20-25  r\win diameter (Monneron and  Bernhard,  1969)  (figure 
1.17).  IGCs were first seen by Swift in 1959 and represent the major part of the 
speckle.  They contain numerous factors that are involved in RNA synthesis and 
processing.  The  IGCs  are  interconnected  by  the  second  structure,  the 
perichromatin fibrils (PFs) (Dundr and  Misteli,  2001).  The PFs are tiny fibres 
that  are  variable  in  diameter from  30 to  50  m and  are thought to  represent 
nascent transcripts as they are rapidly labelled with [3H]-uridine (Spector, 1993). 
Both structures can be seen by TEM without the need for antibody labelling and 
have also been visualised in living cells (Misteli and Spector,  1998).  The IGCs 
and PFs compose a large latticework in the nucleus that can be seen to interact 
with  the  surface  of the  nucleolus  and  the  nuclear envelope  (Spector et al.,
1991).
Figure 1.17
A  transmission  electron  micrograph  of 
mouse  liver showing  interchromatin  granule 
clusters  (IGCs).  Scale  bar  = I  pm  (taken 
from Mintz et al.,  1999).
Early  experimental  work  localised  the  small  nuclear  ribonucleoprotein 
particles (snRNPs) to speckles (Spector et al.,  1983) and led  to the belief that 
speckles were  involved  in  snRNP assembly.  When the  splicing factor SC35 
was  seen  to  colocalise  with  antibodies  to  snRNPs  within  speckles  (Fu  and 
Maniatis, 1990; Spector et al.,  1991), it provided the first evidence that speckles
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domain  (RS  domain)  composed  of approximately  120  amino  acids  at the  C- 
terminal was discovered to be sufficient and essential to target proteins into the 
nucleus and specifically to speckles (Li and  Bingham,  1991;  Fu and  Maniatis,
1992).  Several splicing factors have this domain and they are termed the SR 
proteins.  Studies  have  demonstrated  that  there  are  differences  in  the 
localisation  pathways of different SR proteins  (Caceres et al.,  1997;  Dye  and 
Patton,  2001).  A second domain, the RNA-recognition motif (RRM)  has been 
identified in SR proteins that either contains one or two RRMs.  A single RRM 
requires a  RS domain for proper localisation to speckles whereas SR proteins 
with two RRMs do not.
1.3.2  Transcription and Splicing
It was then suggested that these subdomains were more than just sites of 
snRNP assembly or storage and that speckles possibly corresponded to sites of 
spliceosomal  assembly  or  splicing  itself.  More  evidence  was  provided  to 
support this  idea when  it was discovered that polyadenylated  (poly(A)+)  RNA 
colocalised with snRNPs (Carter et al.,  1991).
The idea that speckles corresponded to sites of spliceosomal assembly or 
splicing  itself was  later to  be  proved  incorrect  when  it  was  discovered  that 
transcription and  splicing occur together.  Most RNA polymerase  II transcripts 
are processed before being exported from the nucleus into the cytoplasm where 
they are translated into proteins (Spector,  1993).  For the majority of transcripts, 
this  processing  includes  splicing  out  of  non-coding  intron  regions.  Splicing 
occurs  in  an  RNA-protein  complex called  a  spliceosome that  is composed  of 
many proteins and snRNAs and is shown in figure 1.18.
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Figure 1.18
Diagram  showing  the  spliceosome  assembly 
pathway  (taken from Graveley, 2000).
Experiments  using  adenovirus  2  as  a  model  system  to  study the  spatial 
relationship  of  transcription  and  splicing  showed  that  after  infection,  RNA 
polymerase II, pre-mRNA splicing factors and hnRNP proteins were shuttled to 
sites of Ad2  RNA synthesis and all colocalised  (Jimenez-Garcia and Spector,
1993).
Fluorescence microscopy data supports this  idea and  puts the  position of 
genes at the periphery of or between speckles (Huang and Spector, 1996; Zeng 
et al.,  1997; Smith et al.,  1999) and that the association between nascent RNA 
and splicing factors is intron-dependent (figure 1.19).  Nucleotide incorporation 
experiments and gene mapping studies showed that sites of active transcription 
can  be found throughout the nuclear volume and that the majority of actively 
transcribing genes are found within the PFs and largely excluded from the IGCs 
(Misteli etai.,  1998).
U4/U6-U5 tn-anRNP
44 INTRODUCTIONFurther evidence that suggests transcription and splicing generally occur at 
the periphery of speckles comes from the localisation of acetylated histones, a 
general indicator of transcriptional activity or competent DNA, to the periphery 
of speckles, but very rarely to their interior (Hendzel et al.,  1998).  Cmarko et al. 
(1999)  microinjected  5-bromo-UTP  (BrUTP)  into  living  cells  and  used 
postembedding  immuno-electron  microscopy  to  visualise  various  factors 
involved  in transcription and  splicing.  They demonstrated that PFs were the 
major site of nascent transcripts and pre-mRNA processing.
Figure 1.19
Immunostaining  showing  that  transiently  expressed  RNA  transcript  containing  introns  are 
spatially associated with  splicing  factors.  The  RN/^are  localised  by  FISH  with  biotinylated 
probes (green) and SC35 is detected using a monoclonal antibody (red) and colocalise to the 
same nuclear region (yellow) (taken from Huang and Spector,  1996).
The association of transcription sites with speckles does not simply reflect 
the  amount of splicing  factors  bound  to transcripts  but  it  is  suggested  to  be 
influenced in a locus specific manner.  Neugebauer and Roth (1997) discovered 
that there was a gene specific accumulation of individual splicing factors at sites 
of transcription.  They identified a single member of the SR family of proteins 
that can only be detected at -20% of these sites.
However,  a  different  study  showed  that  the  intranuclear  position  of 
transcriptionally active EVB genes,  as well as nascent transcripts,  revealed  a 
random distribution with  regard  to speckles and therefore argued against the 
locus-specific organisation of mRNA genes and speckles (Melcak et al., 2000). 
IGCs are therefore proposed as storage and/or assembly sites for pre-mRNA 
splicing  factors  and  these  splicing  factors  are  recruited  to  sites  of  active 
transcription (Jimenez-Garcia and Spector, 1993).
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was seen that upon  gene activation,  pre-mRNA splicing  factors are  released 
from  speckles  and  redistribute  to  sites  of  active  transcription  (Misteli  and 
Spector, 1997).
The inhibition of transcription also causes a redistribution of splicing factors. 
When  cells are treated with  either Actinomycin-D or a-amanitin,  inhibition  of 
RNA  polymerases  is  caused  and  splicing  factors  are  seen  to  accumulate 
specifically  in  speckles  and  there  is  a  subsequent enlargement  of speckles 
(Carmo-Fonseca etai.,  1992; Zeng etai.,  1997) (chapter 1.4.4).
These findings have been summarized by Misteli (2000) and are shown  in 
figure 1.20.  The first image represents a transcriptionally active gene (red) that 
is associated with the periphery of a speckle (yellow).  When transcription  is 
inhibited, as in the second image, the gene is usually found some distance from 
the more rounded speckle.  The last images shows that unspliced RNA (green) 
from highly expressed genes, or genes with numerous introns, may be released 
from sites of transcription and move towards speckles.
Figure 1.20
Diagram showing the relative positioning of transcription sites and speckles  (taken from  Misteli, 
2000).
active gene inactive gene highly expressed gene/ 
extensively spliced gene
4 6 INTRODUCTION1.3.3 Screening and Trafficking
Speckles have also been suggested to play a functional role in pre-mRNA 
transcript screening and trafficking (Johnson et al., 2000).  In some cases of the 
disease,  osteogenesis  imperfecta,  there  is  a  mutation  in  the  collagen  type  1  
gene, COL1A1, which results in a shift in the reading frame and the subsequent 
retention  of  intron  26  in  the  mutant  RNA.  The  mutant  transcripts  do  not 
accumulate at nuclear pores but can  be seen to accumulate speckles.  From 
these  results,  it is  suggested that nuclear export of COL1A1  mRNA from the 
nucleus  is a  multi-step process (Johnson  et al.,  2000).  The first event  is the 
movement of the mRNA from the gene into the adjacent speckle, which creates 
a RNA track on one side of the gene.  The (normal) mRNA then moves into the 
nucleoplasm  and,  when  it  reaches  the  nuclear  envelope,  the  mRNA 
translocates through the nuclear pore into the cytoplasm.
The  results  implicate speckles  in  the  screening  and  entrapping  of mutant 
COL1A1  RNA  and  imply  that  the  correct  splicing  of  pre-mRNA  is  not  only 
needed for  RNA maturation  but also  serves  as  a  control  step  as the  mutant 
mRNA is partially spliced but not exported.
1.3.4 Components of Speckles
A  biochemical  nuclear fractionation  protocol  was  used  to  separate  IGCs 
from  chromatin,  nuclear  lamins,  nucleoli  and  other  nuclear  bodies.  A  mass 
spectrometry  technique  was  then  employed  and  results  revealed  that  each 
speckle  compartment  contains  about  75  proteins  (Mintz  et al.,  1999).  The 
proteins identified can be divided into five main categories:
i.  Pre-mRNA splicing factors and snRNPs
ii.  Transcription factors
iii.  3’ processing factors
iv.  SR protein kinases
v.  Ribosomal proteins
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Speckles are spatially dynamic with  regard to movement and  composition. 
The  splicing  factors  within  the  IGCs  are  highly  mobile  and  are  constantly 
associating with  and  dissociating from  the compartment (Misteli  et al.,  1997). 
Although  the  overall  position  of the speckle  is  maintained  (Eils  et at.,  2000), 
each  compartment undergoes continuous  changes  in  shape,  suggesting  that 
there is a high degree of internal dynamics (Misteli, 2001).  When the splicing 
factor,  SF2/ ASF,  was studied  (Phair and  Misteli,  2000)  its  residence time  in 
speckles  was  not  more  than  45  seconds  and  at  least  10,000  molecules  of 
SF2/ASF are lost from the speckle per second per cell.  This means that each 
speckle has a complete turnover of SF2/ASF within two minutes. The half-life of 
most splicing factors is fairly long and only 10-20% of any given splicing factor 
is engaged in the splicing reaction at any time in vivo (Misteli, 2000).
1.3.6 Speckles and RNA 3’ Maturation
If RNA 3’ processing is inhibited by treating cells with Ara-A, which does not 
affect  RNA  synthesis,  a  reversible  disruption  of the  speckles  can  be  seen. 
PABII  is a poly(A) binding protein that is involved in the polyadenylation of pre- 
mRNA transcripts and is usually localised in speckles (Krause et al.,  1994) but 
when  cells  are  treated  with  Ara-A,  the  speckles  become  smaller  and  still 
immunostain for PABII and SC35 and U2 snRNP B” (Schul et al.,  1998c).  This 
points  towards  a  structural  relationship  between  speckles  and  RNA  3’ 
maturation.
1.3.7 Role in Apoptosis
A study by Shav-Tel et al.  (2001) indicates that polypyrimidine tract binding 
protein (PTB)-associated splicing factor (PSF) can be localised  in speckles by 
using  antibody  B92  but this  immunostaining  disappears during  apoptosis.  In 
apoptotic cells, PSF redistributes from speckles into a globular nuclear structure 
and  disassociates from  PTB and  binds to new binding  partners,  including  U1- 
70k and SR proteins.  It is suggested that the new functions acquired  by PSF 
may be due to the protein’s hyperphosphorylation.  It has been reported that the
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apoptosis (Utz et al.,  1998) and it is suggested that splicing factors can regulate 
apoptosis by regulating caspase activity.
1.3.8  Regulation via Phosphorylation
It was suggested that there must be signals generated  in the nucleus that 
regulate the localisation of the factors to where they are temporally required for 
specific functions (Spector,  1993).  With regard to splicing factors and speckles, 
it is believed to be a 2-step process that mainly involves the release of splicing 
factors  from  speckles,  which  is  mediated  by the  RS  domain  found  in  many 
splicing proteins.  The association of splicing factors with the target pre-mRNA 
follows this  and  is  mediated  by their  RNA-recognition  motif (RRM).  It  is the 
phosphorylation of the serine residues in the RS domain by SR protein kinases 
that  displace  the  splicing  factor  from  the  speckle  either  individually  or 
complexed  to  other  components  involved  in  RNA  processing.  The 
phosphorylation  has the  second  effect of making  the  proteins  “active” which 
leads to their incorporation into the spliceosome.  It also allows the subsequent 
binding  of the factors to the  C-terminal  domain  of the  large  subunit of RNA 
polymerase II  (Eils et al.,  2000).  After the reaction, the dephosphorylation of 
the proteins by specific phosphatases allows them to  return to the speckles. 
This is shown in figure 1.21.
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Figure 1.21
Diagram  showing  the  mechanisms  of  splicing  factor  localisation  by 
phosphorylation (taken from Misteli, 2000).
49 INTRODUCTIONEvidence to  support this suggestion was  shown  by the  overexpression  of 
different splicing  factor specific protein  kinases.  This  leads to the  release of 
splicing factors from speckles and some the kinases have been  located  in the 
speckles  (Gui  et al.,  1994;  Colwill  et al.,  1996;  Misteli,  2000).  Time-lapse 
microscopy experiments in  living cells have shown that the release of splicing 
proteins  can  be  blocked  in  the  presence  of a  kinase  inhibitor  (Misteli  et al.,
1997).  Other experiments  have also shown that the accumulation of splicing 
factors  in  speckles  upon  inhibition  of transcription  requires  serine-threonine 
protein  phosphatase activity  (Misteli  and  Spector,  1996).  These experiments 
are discussed  in  chapter  1.4.4  and  strongly  support a  control  mechanism  of 
splicing factor distribution by a cycle of phosphorylation and dephosphorylation 
and  relocalisation  of SR proteins can  occur if there is an  improper balance  in 
the  phosphorylation  state.  This  phosphorylation  could  also  modulate  protein- 
protein interactions within the spliceosome itself, aiding the organisation of the 
spliceosome during splicing (Misteli,  1999).
Due to this finding it is believed that the IGCs are linked to the 
phosphorylation state of the SR proteins with dephosphorylated splicing factors 
favouring  an  association  with  speckles  (Misteli  and  Spector,  1997)  and, 
therefore,  also the ability of the  processing  machinery to  perform  pre-mRNA 
splicing.  It has also been shown if splicing factors cannot interact with the CTD 
of the large subunit of RNA polymerase II, they are not targeted to transcription 
sites and splicing is reduced (Misteli and Spector,  1999).  The phosphorylation 
state  of  the  CTD  of  RNA  polymerase  II  also  affects  splicing:  when 
hyperphosphorylated  (RNA polymerase  llo),  splicing  is  strongly  activated  but 
when  hypophosphorylated  (RNA  polymerase  lla)  splicing  can  be  inhibited 
(Hiros  eetal.,  1999).
1.3.9  Maintenance
The  maintenance  of the  speckle  or  IGC  is  thought  to  be  due to  protein- 
protein interactions including the RS domain that are found in the SR family of 
proteins (Sacco-Bubulya and  Spector,  2002),  rather than  by an attachment to 
an  IGC-specific  framework.  Upon  overexpression  of  Clk/STY  the  stable 
population of poly(A)+ RNA usually found in speckles is seen to redistribute and
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transcription.  It is therefore suggested that the stable population of poly(A) RNA 
may have a role in maintaining the organisation of splicing components in their 
nuclear  domains  and  they  could  represent  the  core  organising  unit  of the 
individual IGCs and the binding site for the pre-mRNA processing proteins.
Another motif thought to act as a protein-protein interaction sequence is the 
zinc  finger  motif  (Dye  and  Patton,  2001).  It  has  been  shown  to  act  as  a 
subnuclear localisation domain and this raises the possibility that the zinc finger 
found  in  many splicing  components  might be  involved  in  their localisation  to 
speckles.  Splicing  proteins  that  have the  zinc finger  domain  are  SF1,  U1- 
snRNP-specific  protein  C  (U1C),  SFa60/SAP61,  SAP62,  SF3a120/SAP114,  and 
hslu7.  Another study showed splicing factors SF3b155/SAP155 did not contain a 
RS  domain  and  was  found  to  localise  to  speckles  (Eilbracht  and  Schmidt- 
Zachmann,  2001).  Mutation  experiments  revealed  a  threonine/proline- 
dlpeptide  domain  (TP  domain)  that  was  required  for  the  accumulation  of 
SF3b15 5 /SAP155 in speckles.
It  has  therefore  been  shown  that  speckles  function  in  the  storage  and 
assembly  of spliceosomal  components with  splicing  factors  moving  towards 
active genes and pre-mRNA transcripts moving towards speckles.  Figure 1.22 
(Misteli,  2000) shows diagrammatically the potential functions of speckles;  a) 
controlling the level of splicing factors in the nucleoplasm to optimise splicing; b) 
recycling splicing factors; c) controlling the relative ratios  of multiple splicing 
factors in the nucleoplasm to regulate splice-site selection; d) site assembly of 
complexes involved in transcription and RNA processing to aid the coupling of 
transcription and RNA processing.
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Figure 1.22
Diagram showing the possible functions of speckles (taken from Misteli, 2000).
5i INTRODUCTIONThe  basic  morphology of speckles  at either  light  microscopy  or TEM  can 
indicate the transcriptional state of the cell.  Cells with  increased transcription 
show a decrease in the overall number and size of speckles whereas cells with 
reduced  or  no transcriptional  activity  have  an  increased  number of speckles 
(Lamond and Earnshaw,  1998).  Examining the different phosphorylation states 
of  RNA  polymerase  II  large  subunit  (LS)  can  also  reveal  the  transcriptional 
activity of the cell.  For example, hyperphosphorylation of RNA polymerase II LS 
CTD is a better indicator of the polymerase’s tight association to speckles rather 
than  its  transcriptional  activity  as  RNA  polymerase  II  and  splicing  factors 
redistribute simultaneously according to the actual transcriptional activity of the 
nucleus  (Bregman  et al.,  1995;  Kim  et al.,  1997).  This  gives  an  image  of a 
dynamic  nucleus  that  reorganises  its  components  through  a  mechanism  of 
phosphorylation depending on the functional requirements of the cell.
1.4 Nuclear Architecture Meets Metabolic Activity
There appears to be a strong relationship between nuclear architecture and 
fundamental nuclear processes such as gene expression.  The organisation of 
the  nuclear  subcompartments  is  thought  to  be  a  mechanism  of  bringing 
together molecules of related functions, thus improving the efficiency of cellular 
processes.  The assembly of the substructures is a response to the metabolic 
requirements  of the  cell.  Changes  in  the  activity within  the  cell  can  cause 
alterations in the relative concentrations and distributions of different proteins in 
different nuclear structures  (Carmo-Fonseca et al.,  1992;  Lafarga et al.,  1994; 
Bregman  et al.,  1995;  Zeng  et al.,  1997;  Sleeman  et al.,  1998;  Pena  et al., 
2001; von Mikecz et al., 2000).  Many studies have been carried out that involve 
drug  treatment  of  cultured  cells  to  alter  various  cellular  processes.  The 
alterations to the structure and molecular composition of the nucleus have been 
well  documented  and  can  be discussed  according  to their effect on  different 
nuclear subdomains.
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Alterations  in  nucleolar  morphology  and  size  have  been  observed  in 
response to changes in the transcriptional rate of the nucleolus.  An example of 
this is osmotic stress, which causes cellular activation and induces the transient 
expression  of  immediate-early  genes  such  as  c-fos  and  c-jun  that  are 
transcription  factors.  Administration  of  hypertonic  NaCI  solution  to  rats  by 
intraperitoneal  injection  results  in  osmotic  stress  and  transcription  of 
neurohormones  is  seen  to  increase  in  supraoptic  nuclei  (SON)  neurons 
(Lafarga  et  al.,  1991).  Nucleoli  from  dehydrated  SON  neurons  have  an 
increased  diameter  and,  when  viewed  using  an  electron  microscope,  it  is 
possible to see that there are  large masses of granular component and small 
fibrillar  centres  (Lafarga  et al.,  1991)  (figure  1.23).  It  is  suggested  that the 
changes  in  size and  arrangement are due to the osmotic induction  of protein 
synthesis and the need for ribosomes.  The changes in nucleolar structure are 
related  to  both  RNA  metabolism  and  protein  synthesis.  The  increase  in 
granular component may represent an increase in the processing of pre-rRNA 
and  the decrease  in the fibrillar centres may  represent splitting  of centres to 
make  increase the  number of transcription  units.  Therefore, the  increase  in 
transcription results in a change to the structure of the nucleolus.
Figure 1.23
Nucleolus  from  an  osmotically 
stimulated SON  neuron.  Large masses 
of  GC  can  be  seen  with  small  FCs 
(arrowheads)  (taken  from  Lafarga  et 
al.,  1991). X29K
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stress actually results in transcription inhibition and this causes changes to the 
morphology of the nucleolus (Lafarga et al.,  1998; Berciano etal., 2002).  There 
is  a  partial  segregation  of the  granular  and  dense  fibrillar  component  and 
disruption to the fibrillar centres.  This suggests that during  a period of down 
regulation of transcription, the nucleolus undergoes morphological changes as 
well.
To support this idea, studies have shown that when all nuclear transcription 
is inhibited  in many cell types with Actinomycin  D,  structural alterations to the 
nucleolus are seen. When cultured liver cells were treated with Actinomycin D, 
a  progressive  decrease  in  nucleolar  size  and  a  redistribution  of  nuclear 
components to form  ‘caps’ was seen (Reynolds et al.,  1964) (figure  1.24).  In 
HeLa cells, these caps have now been shown to immunolabel with a variety of 
different  nuclear  proteins:  p80  coilin,  fibrillarin,  PSF,  U1  snRNP  (Carmo- 
Fonseca  et al.,  1992).  It has also been shown that the treatment of cells with 
Actinomycin D induces the redistribution of some nucleolar proteins.  C23,  B23 
and the nucleolar RNA helicase,  RH-ll/Gu,  all translocate from  the  nucleolus 
into the  nucleoplasm  after drug treatment (Perlaky et al.,  1997).  Therefore,  if 
transcription is inhibited the nucleolus becomes smaller,  caps are formed and 
some nuclear proteins are seen to redistribute to different nuclear localisations.
Figure 1.24
Nucleoli from Actinomycin D treated liver cells.  It is possible to see two types of nucleolar caps; 
dense (DNC) or light (LNC)  (taken from Reynolds et al.,  1964). X11K (A) and X20K (B)
54 INTRODUCTIONOkadaic  acid  is  a  serine-threonine  protein  phosphatase  inhibitor  and 
prevents dephosphorylation.  After HeLa cells were treated with okadaic acid, a 
decrease in the  number of nucleoli  per nucleus was seen  and the  remaining 
nucleoli  became  larger  (Lyon  et al.,  1997).  There w os also  a  change  in  the 
internal structure of the nucleolus.  If dephosphorylation is inhibited there is a 
change  in the  number,  size  and  morphology of nucleoli,  suggesting  that the 
phosphorylation  of  proteins  plays  an  important  role  in  controlling  nucleolar 
organisation.
Cyclohexirride not only inhibits protein synthesis but it also inhibits nucleolar 
rRNA synthesis (Gokal et al.,  1986).  It does not however, affect extranucleolar 
synthesis of pre-mRNA (Lafarga et al.,  1994).  SON neurons from rats treated 
with cycloheximide show changes to the organisation of the nucleolus (Lafarga 
et al.,  1994).  There  is also a decrease  in the size of the  nucleolus with the 
formation of larger and fewer fibrillar centres (figure 1.25).  The fibrillar centres 
are often  located  eccentrically  and  not completely  surrounded  by the dense 
fibrillar component.  These results support the concept that on-going nucleolar 
transcription is needed to maintain normal nucleolar assembly.
Figure 1.25
Nucleolus from cycloheximide treated SON  neuron.  It 
is  possible to see  large  FCs  (★  )  and  FCs  in  direct 
contact  with  the  nucleoplasm  (arrowhead).  GC=g 
(taken from Lafarga etal.,  1994). X23K
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In HeLa cells that express p80 coilin fused to GFP,  it has been shown that 
all Cajal bodies have the ability to move in every interphase nucleus (Platani et 
al.,  2000).  These  movements  can  be visualised  over periods  of one to two 
hours and  involve a  range of different movements;  translocation through the 
nucleoplasm, joining together of individual  CBs,  separation of smaller bodies 
from  larger ones,  moving  to and  from the  nucleolar periphery and within the 
nucleolus (figure 1.26).  This shows that CBs are very mobile structures in the 
nucleus and can be catergorised into two different classes shown in table 1.1.
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Figure 1.26
Images  over  a  period  of time  showing  the  movements  of Cajal  bodies.  The  boxed  area  shows  a  CB 
splitting to form two CBs  (taken from Platani et al., 2000).  Scale bar =f  pm.
CB > 0.4pm small slow restricted
mini CB > 0.2pm large fast unrestricted
Table 1.1
A table summarising the two classes of CBs and the key features of each class (taken from Platani et al 
2000).
The two classes of CBs vary in  size,  molecular composition  and  dynamic 
behaviour.  The  restricted  movement  of  the  larger  CBs  may  reflect 
transcriptional association with specific gene loci (Platani et al., 2000).
*6 INTRODUCTIONAfter osmotic stress, which causes cellular activation and an increase in the 
transcription of neurohormones in rat SON neurons, an increase in the number 
of Cajal  bodies  can  be  seen  (Lafarga  et al.,  1991).  The  formation  of Cajal 
bodies  may  be  closely  related  to  the  metabolic  activity  of  the  neuron,  in 
particular, protein synthesis.  There may be an increase in the number of CBs in 
response to  an  increase  in  transcription.  When  the  initial  phase  of osmotic 
stress  was  examined  more  closely  it  was  discovered  that  transcription  is 
actually  inhibited  initially.  A decrease  in  CBs was  seen  in  this  period  and  a 
peak of p80 coilin  nucleolar cap formation was also observed  (Lafarga et al.,
1998).  The reverse is seen when this phase ends.  The nucleolar caps appear 
to  have  the  same  ultrastructure  as  normal  CBs  suggesting  that  CBs  are 
continually  arising  at  the  periphery  of the  nucleolus.  When  transcription  is 
increased,  the caps  readily grow into mature CBs.  Therefore,the  increase in 
transcription means that there is an increase in the number of CBs per nucleus 
and a decrease in p80 coilin nucleolar caps.  The decrease in transcription may 
represent  a  slowing  down  of the  maturation  of  CBs  so  they  become  more 
prominent at the nucleolar periphery.
When all nuclear transcription is inhibited using Actinomycin D in HeLa cells, 
CBs are seen to disappear completely and the proteins that usually localise in 
CBs  redistribute  (Carmo-Fonseca  et al.,  1992).  p80  coilin  forms  a  distinct 
nucleolar  cap  and  snRNPs  only  accumulate  in  speckles.  This  is  another 
example  of CB  formation  being  dependent  on  cellular activities,  in  particular 
transcription.
Heat  shock  also causes  major changes  in  transcriptional  activity  as  most 
RNA  polymerase  II  transcription  is  inhibited  with  concomitant  induction  of 
specific  “heat  shock”  genes.  It  may  also  affect  pre-mRNA  splicing  (Carmo- 
Fonseca  et al.,  1992).  HeLa  cells were  heat shocked  by a  temperature  shift 
from 37 °C to 45 °C for 15 minutes.  Afterwards, the localisation of p80 coilin is 
unchanged and remains in CBs but snRNPs are no longer seen in CBs.
In  rat  SON  neurons  the  fine  ultrastructure  of  CBs  can  be  altered  by 
cyclohexirride  treatment  (Lafarga  et  a,  1994).  Protein  and  nucleolar  rRNA 
synthesis  are  both  inhibited  by  cycloheximide  but  it  does  not  affect 
extranucleolar  synthesis  of  pre-mRNA  (Gokal  et  al.,  1986).  After  drug 
treatment alterations to  CBs  have  been  seen  and  include  segregation  of the
57 INTRODUCTIONamorphous  matrix,  compactation  of the coiled  threads  and  formation  of CB- 
derived dense bodies of a fibrillar nature (figure 1.27).  This suggests that there 
is an  association  between  the  maintenance  of normal  CB  ultrastructure  and 
protein and rRNA synthesis.
Figure 1.27
Electron  micrograph  of  a  CB  showing  a 
segregated  portion  of amorphous  matrix  (arrow) 
after  cycloheximide  treatment  (taken  from 
Lafarga etal.,  1994). X20K
If dephosphorylation  is  inhibited  by the treatment of  HeLa  cells with  the 
serine-threonine  protein  phosphatase  inhibitor,  okadaic  acid,  Cajal  bodies 
appear inside the nucleolus and are found to stain positively for p80 coilin and 
snRNPs (figure 1.28) (Lyon et al.,  1997; Sleeman et al.,  1998).  This suggests 
that the phosphorylation of certain  CB  proteins  is important for the formation 
and  localisation  of  CBs  within  the  nucleus.  Okadaic  acid  may  disturb  an 
existing  equilibrium  between  the  rate  of  snRNP  entry  and  exit  from  the 
nucleolus.  The overexpression of snRNPs has also been shown to trigger the 
de novo formation of CBs in cells that previously lacked them (Sleeman et al.,
2001)  and this does not happen when p80 coilin is overexpressed.  The results 
suggest  that  the  formation  of  CBs  may  be  linked  to  the  level  of  snRNP 
expression.
58 INTRODUCTIONFigure 1.28
In  Okadaic  acid  treated  HeLa  cells  CBs 
(arrow)  are  seen  in  regions  of the  nucleolus 
(no)  (taken from Lyon et al.,  1997). Scale bar 
=1  Mm -
Another study that shows  snRNPs  no  longer accumulating  in  the  CBs  of 
HeLa  cell  is  after  treatment  with  Leptomycin  B  (Carvalho  et  al.,  1999). 
Leptomycin B inhibits the export of U snRNA to the cytoplasm.  There is also a 
decrease in the number of Cajal bodies per nucleus and a redistribution of p80 
coilin to the nucleolus (Carvalho et al.,  1999).  It is suggested that leptomycin B 
disrupts the flux of p80 coilin from the nucleolus leading to the disappearance of 
CBs.  However,  immunostaining of leptomycin  B treated  cells with antibodies 
against SMN or Gemin2 reveals that both proteins can still be seen in CBs but 
there is also increase in the number of gems (Carvalho et al., 1999).
1.4.3  The p80 coilin Knock-out Mouse
The p80 coilin  null  mutant/knock-out (p80  KO) mouse is another example 
where  alterations to  Cajal  bodies  have  been  reported.  p80  KO  mice  were 
generated that contained a deletion of exons 2 to exon 7 (85%) of the p80 coilin 
gene,  which  corresponds to the  C-terminal 487  amino  acids  (Tucker et al.,
2001).  The p80 KO mice showed reduced viability but were still fertile.
Tissue  from  the  p80  KO  mice  or  cells  derived  from  mutant  embryos 
displayed extranucleolar foci that contained fibrillarin and Nopp140.  These foci 
were  of similar size  and  shape to  CBs  and  so termed  ‘residual’  CBs.  The 
‘residual’ CBs did  not contain splicing snRNPs or any proteins from the SMN 
complex (Tucker et al., 2001).  When sensory ganglion neurons from wild-type 
and knock-out animals were stained using the silver impregnation technique, in 
the knock-out mice only nucleoli showed  a silver deposition,  whereas,  in the
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p80  coilin  was  transiently  expressed  in  knock-out  cells,  this  led  to  the 
formation of CBs that contained fibrillarin, Nopp140, snRNPs and SMN.  These 
results suggest that full length p80 coilin is needed for the correct formation and 
maintenance of CBs and that the C-terminal  of p80  coilin  plays an  important 
role in the recruitment of snRNPs and SMN complex to CBs.
Further studies using p80 KO mouse embryonic fibroblasts (MEF) revealed 
that the depletion of p80 coilin does not disrupt the processing  of Sm snRNAs 
which  is proposed to occur in  CBs (Jady et al.,  2003).  It was shown that Sm 
snRNAs  colocalised  in  CB-sized  nuclear foci  with  small  Cajal-body-specific 
RNAs  (scaRNAs^ but  not with  fibrillarin  or  SMN.  scaRNAs  are  Sm  snRNA 
modification  guide  RNAs  that  play  a  role  in  the  processing  of snRNAs  and 
localise within  CBs  (Jady  et al.,  2003).  These findings show that in  p80  KO 
MEF  cells,  there  are  two  different  types  of  ‘residual’  CBs  neither  of which 
contain the SMN complex. These results also demonstrate that in the absence 
of full length p80 coilin, Sm snRNPs are able to cdlocalise in residual CBs with 
scaRNAs and that the internal modifications of Sm snRNAs are likely to occur in 
these foci.
As  CBs  are  proposed  to  play  a  role  in  the  biogenesis  of small  nucleolar 
RNPs (snoRNPs),  the distribution of U3 snoRNP was  investigated  in the  p80 
KO  MEF  cells  (Jady  et  al.,  2003).  It  was  demonstrated  that  U3  snoRNP 
accumulates in the fibrillarin-positive ‘residual’ CBs.  This finding suggests that 
the two different types of ‘residual’ CBs in the p80 KO cells carry out either the 
biogenesis  of snRNPs  or snoRNPs.  The discovery of two  different types  of 
residual  CBs,  that accumulate either Sm snRNAs or snoRNAs,  suggests that 
p80  coilin  may  play  a  role  in  coupling  the  biogenesis  of  Sm  snRNPs  and 
snoRNPs in one domain (Jady et al., 2003).
1.4.4 Alterations to Speckles
The initial phase of osmotic stress  is associated with a down-regulation of 
transcription  in  rat SON  neurons and speckles are reported to  become  larger 
and fewer in number (figure  1.29) (Lafarga et al.,  1998).  When transcription is 
activated,  in  the  stress  response  phase,  speckles  are  more  numerous  and
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Actinomycin  D or a-amanitin,  speckles are also seen to decrease in  number 
and  become  larger  in  size  (Misteli  et al.,  1997).  The  rounded  up  speckles 
contain U2, U4,  U5 and U6 snRNPs as well as SC35 and hyperphosphorylated 
RNA  polymerase  II  (Bregman  et al.,  1995).  Both  studies  show  that when 
transcription is inhibited speckles become fewer and larger.
Figure 1.29
A  nucleus  from  a  SON  neuron  after  the 
initial period of osmotic stress that has large 
speckles (red  ★  )  (taken from Lafarga et 
al.,  1998). X9K
Heat shock causes major changes in transcriptional activity and most RNA 
polymerase  II  transcription  is  inhibited with  concomitant induction  of specific 
“heat shock” genes.  It may also affect pre-mRNA splicing (Carmo-Fonseca et 
al.,  1992).  HeLa cells that are heat shocked by a temperature raise from 37 °C 
to 45 °C for  15  minutes show a  redistribution  of snRNPs  (figure  1.30).  The 
splicing  snRNPs  no  longer accumulate  in  speckles and  a widespread  rather 
than  a  diffuse  nucleoplasmic staining  pattern  can  be seen.  A change  in the 
transcriptional  activity of a  cell  can  cause alterations to the speckle staining 
pattern.
Figure 1.30
Heat shock affects the distribution of snRNPs.  A widespread nucleoplasmic staining can 
be  seen  instead  of the  characteristic ‘speckled’  pattern  (taken from  Carmo-Fonseca  et 
al.,  1992). Scale bar = 10, pfft.
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short half-life splicing factors  (Berciano et al.,  2002) but has no affect on the 
extranucleolar synthesis  of pre-mRNA (Gokal  et al.,  1986).  When  rats were 
treated with cycloheximide, the characteristic speckle staining pattern was no 
longer seen  in  SON  neurons.  There  is  a  redistribution  of splicing factors to 
large and  infrequent speckles and there is also a decrease  in  nucleoplasmic 
staining  (figure  1.31).  Therefore,  if protein  and  rRNA  synthesis  is  inhibited 
speckles become large and infrequent.
Figure 1.31
Cycloheximide treatment 
causes the  redistribution 
of snRNPs in HeLa cells. 
Large,  infrequent 
speckles  are  seen 
(Berciano  et  al.,  2002). 
Scale bar = 10  pro.
Cycloheximide U2B”&Coili
Okadaic  acid  is  a  serine-threonine  protein  phosphatase  inhibitor  and 
prevents protein dephosphorylation.  After HeLa cells are treated with okadaic 
acid, the speckle staining pattern becomes more diffuse (figure 1.32) (Misteli et 
al.,  1997) suggesting that if dephosphorylation is prevented there is a gradual 
increase in the nucleoplasmic pool of splicing factors.
B
0*
fmm   10'  20*  30  ________
Figure 1.32
Okadaic acid causes a gradual increase in the nucleoplasmic pool of splicing factor, SF2/ASF 
(Misteli eta!.,  1997). Scale bars: A = 5  B = 720  0rr\.
62 INTRODUCTIONIt has also been shown that treatment of HeLa cells with  staurospine,  an 
inhibitor  of  protein  kinases,  causes  a  slight  rounding  up  of some  speckles 
(Misteli  et al.,  1997).  Staurospine  was  shown  to  prevent  all  the  dynamic, 
peripheral movements in speckles.  Therefore,  preventing the phosphorylation 
of splicing factors causes speckles to become less dynamic (figure 1.33).  The 
results from okadaic acid and staurospine treatment support the idea that the 
phosphorylation  of  SR  protein  splicing  factors  leads  to  their  release  from 
speckles.
Figure 1.33
Staurospine  treatment  of  HeLa  cells  prevents the dynamic,  peripheral  movements of speckles 
(Misteli et al.,  1997). Scale bars: f\ = 5 p t b = 500 m .
The overexpression of specific kinases has also been shown to disrupt the 
distribution  and  composition  of  speckles.  The  overexpression  of  kinases, 
Clk/STY and DYRK1A,  both cause the disassembly of speckles (Colwill et al., 
1996; Sacco-Bubulya and Spector, 2002; Alvarez etal., 2003).  The SR protein, 
SC35,  redistributes  to  a  diffuse  nuclear  localisation  when  Clk/STY  is 
overexpressed and  IGCs are not seen via TEM (Sacco-Bubulya and Spector, 
2002).  A similar staining pattern for SC35 is also seen with the overexpression 
of DYRK1A (figure  1.34) (Alvarez et al., 2003).  If a kinase is overexpressed, 
there  is  an  increase  in  the  phosphorylation  of splicing  factors  and  a  loss  of 
speckles.  The  kinases  may  directly  regulate  the  activity  and  localisation  of 
splicing factors.  The phosphorylation state of SR proteins  is highly correlated 
with  the  structural  organisation  of one  of the  ultrastructural  components  of 
speckles, the IGCs.  Phosphorylation of SR proteins may be a key event in their 
recruitment to transcription sites from speckles.
63 INTRODUCTION1.4.5 Formation of Aggregates
Many studies that used drug treatment to alter various cellular processes not 
only  caused  disruption  of specific  nuclear subdomains  but  also  caused  the 
formation of a nuclear aggregate or inclusion.  In SON  neurons, from rats that 
had  been  subjected  to water deprivation  and  also  had  been treated  with the 
protein  synthesis  inhibitor,  cycloheximide,  a  dense  body  that was  round  in 
structure  and  ranges  from  0.2  pm  to  0.8  pm  in  diameter  was  seen  using 
electron  microscopy  (Lafarga  et  al.,  1993).  The  nuclear  inclusion  was 
composed of densely packed fibrillar material and did not stain positively for fos 
immunoreactivity, one of the immediate-early genes activated by osmotic stress 
(figure  1.36A)  (Lafarga  et al.,  1993).  Cycloheximide  not only inhibits  protein 
synthesis  but  has  also  been  shown  to  induce  changes  to  the  nucleolus:  a 
decrease  nucleolar  size  and  the  formation  of fewer,  larger fibrillar  centres. 
Cycloheximide  inhibits  nucleolar rRNA synthesis as well  (Gokal  et al.,  1986) 
and, due to this,  it has been suggested that the inclusion may contain proteins 
destined  for the  nucleolus  and  therefore the  presence  of the  inclusion  may 
represent dysfunction of the  nucleolus.  However,  no nucleolar proteins have 
been shown to localise to this inclusion to date.
The  formation  of a  nuclear  inclusion  can  also  be  seen  when  all  nuclear 
transcription is inhibited using Actinomycin D in cultured liver cells (figure 1.36B) 
(Reynolds  et al.,  1964).  This again shows that if transcription  is  inhibited,  a 
nuclear inclusion may form.
Inclusion  formation  in  cells  after 
cycloheximide  treatment  (A)  or 
Actinomycin D treatment (B) (taken 
from  Lafarga  et  a l,  1993;
Reynolds  et  al.,  1964).  X38K  (A) 
and X5K (B)
Figure 1.36
65 INTRODUCTIONMutation  analysis  of  survival  of  motor  neuron  (SMN)  protein  cause  a 
number of alterations to the distribution of nuclear proteins.  There is a dramatic 
relocalisation  of  many  proteins  to  nuclear  inclusions  when  SMNAN27  is 
expressed.  p80 coilin, snRNPs, fibrillarin, GAR1, U3 snoRNP, RNA polymerase 
lla,  RHA,  TBP,  PSF,  CstF64  and  CPSF160,but  not  RNA  polymerase  No, 
hnRNP or SC35  have been  shown to localise in  large CB/gems (figure  1.37) 
(Pellizzoni et al.,  1998;  Pellizzoni et al.,  2001a;  Pellizzoni et al.,  2001b).  The 
SMNAN27 mutation also inhibits splicing and the inclusion formation could be in 
response to this inhibition.
Figure 1.37
Expression of SMNAN27 causes the redistribution of many nuclear factors 
to large nuclear inclusions that resemble large CBs/gems (Pellizzoni et al., 
1998).
The  above  examples  show  that  the  steady-state  equilibrium  of  nuclear 
subdomains  can  be  altered  in  response  to  experimental  manipulation. 
Understanding why these nuclear changes occur in  response to alterations in 
metabolic activity will  hopefully help our understanding of the basic principles 
underlying nuclear organisation.
6 6 INTRODUCTION1.5 Nuclear Ultrastructure and Human Disease
Nuclear  subcompartments  have  been  implicated  in  a  number  of  human 
diseases.  PML  (promyelocytic  leukemia)  bodies  are  absent  in  patients  with 
promyelocytic  leukemia  (Hodges  et  al.,  1998)  and  the  appearance  of  a 
perinucleolar  cap  (PNC)  has  been  seen  in  transformed  cells  (Huang  et al., 
1997).  Changes  in  the  nucleolus,  Cajal  body and  speckles  have  also  been 
associated with a variety of diseases.
1.5.1  The Nucleolus and Disease
Nucleolar  proteins  are  also  mutated  in  a  number  of  diseases  and  one 
example  is Treacher Collins  syndrome (TCS)  (Marsh  et al.,  1998).  TCS  is  a 
disorder of craniofacial development and  is caused  by a  mutation  in the TCS 
gene  (TCOF1).  Analysis  of the  TCOF1  gene  in  individuals  affected  by  TCS 
revealed most mutations caused a premature stop codon.  The protein encoded 
for  by  TCOF1  has  been  named  treacle  and  is  a  nucleolar  protein. 
Immunocytochemistry using an antibody generated against treacle showed that 
it localised to the nucleolus and the cytoplasm (Marsh et al.,  1998).  The same 
group also demonstrated that in  TCS,  mutated treacle did  not localise to the 
nucleolus.  This  was  demonstrated  by  using  the  technique  of  in  vitro  site- 
directed  mutagenesis  to  introduce  mutations  that  are  commonly  found  in 
individuals  with  TCS  into  the  murine  homologue  of  TCOF1.  The  mutated 
proteins were no longer seen to localise within the nucleolus and it is suggested 
that treacle plays a role in shuttling between the nucleolus and the cytoplasm.
Several  proteins  that  localise  to  the  nucleolus  are  involved  in  cancer 
including both the Werner's syndrome (WRN) and the Bloom's syndrome (BLM) 
gene products.  Werner’s syndrome is a rare autosomal recessive disorder that 
features premature aging and  patients often die of cancer in the fourth or fifth 
decade (Marciniak et al.,  1998).  Bloom’s syndrome is a genetic disorder that is 
characterised  by immunodeficiency,  retarded growth and  a predisposition to a 
wide variety of cancers (Wu et al., 2000).  BLM and WRN proteins are both part 
of the  RecQ  helicase  family  which  are  DNA  helicases  that  affect  genome 
stability  (reviewed  in  Mohaghegh  and  Hickson,  2001).  Cells  derived  from
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manifests  as  an  elevated  frequency  of  homologous  recombination  events 
(Mohaghegh and  Hickson,  2001).  Both  proteins have also been found  in  the 
nucleolus.  Yankiwski  et al.  (2000)  demonstrated  that  BLM  localised  to  the 
nucleolus of human fibroblasts during S phase, however, in early Gi phase BLM 
was absent from the nucleolus.  WRN protein was also shown to be present in 
the  nucleolus  in  a  number of cell  lines,  including  sarcomas  and  carcinomas 
(Marciniak et al.,  1998)  and  this  localisation was  not shown  to  be  cell-cycle 
dependent.
Spinocerebellar  ataxias  (SCAs)  are  neurodegenerative  disorders 
characterised by neuronal loss within the cerebellum and brainstem and part of 
the  CAG  triplet repeat diseases  (chapter  1.7.1).  SCA7  is  caused  by a  CAG 
triplet repeat expansion in the coding region of ataxin-7 (David et al.,  1997).  In 
COS-1 cells, wild-type ataxin-7 has been shown to have nuclear distribution and 
a portion of the protein is localised to the nucleolus (Kaytor et al.,  1999).  This 
raises the possibility that the expansion  of the polyglutamine tract in  ataxin-7 
seen in SCA7 may result in altered nucleolar function.
1.5.2  Cajal bodies/Gems and Disease
Spinal  muscular atrophy  (SMA)  is caused  by loss of function  mutations  in 
the SMN1  gene and results in the degeneration of motor neurons in the spinal 
cord  (chapter 1.2.6).  Defects in spliceosomal snRNP assembly may underlie 
the  development  of  SMN  (Carvalho  et  al.,  1999)  and,  in  SMA  patients,  a 
decrease in the number of gems is seen (Coovert et al.,  1997;  Lefebvre et al.,
1997).
In  tumour  cells,  a  change  in  the  localisation  of  Cajal  bodies  has  been 
reported  (Ochs et al.,  1994).  When a  number of different breast cancer cells 
were  examined,  several  lines  appeared  to  have  Cajal  bodies  within  the 
nucleolus as well as prominent nucleoplasmic CBs.  CBs at both  localisations 
stained  positively for p80  coilin  as well  as fibrillarin  and  Sm  proteins.  Cajal 
bodies are also disrupted  in a form of acute leukemia in which the Cajal body 
component,  eleven-nineteen  lysine-rich  leukemia  protein  (ELL)  is  fused  to 
myeloid-lymphoid  leukemia  protein  (MLL)  to  form  a  chimeric  fusion  protein
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protein  that  has  been  shown  to  localise  in  CBs with  EAF1  (ELL-Associated 
Factor 1|) but in murine MLL-ELL leukemia cells neither p80 coilin or EAF1  are 
seen  in  CBs and  immunocytochemistry with  antibodies  against either protein 
revealed a faint nucleoplasmic distribution (Polak et al., 2003).
In a single study by Yamada et al.  (2001) it as suggested that Cajal bodies 
can be seen juxtaposed to neuronal intranuclear inclusions (chapter 1.6.5) seen 
in neurons from  individuals dentatorubral and  pallidoluysian  atrophy (DRPLA) 
and  spinocerebellar  ataxia  3  (SCA3),  both  of which  are  CAG  triplet  repeat 
diseases that result from polyglutamine expansions (chapter 1.7.1).
1.5.3  Speckles and Disease
Mutation  in  splicing  factors  can  also  give  rise  to  specific  human  genetic 
diseases.  Mutations  in  the  U5  snRNP  protein,  precursor  mRNA  processing 
protein  8  (Prp8)  (McKie  et al.,  2001),  and  the  U4/U6  snRNP  proteins,  Prp3 
(Chakarova  et al.,  2002)  and  Prp31  (Vithana  et  al.,  2001),  all  give  rise  to 
Retinitis Pigmentosa (RP).  RP is characterised by progressive degeneration of 
the photoreceptors and this leads to blindness.  The identification of mutations 
in three  pre-mRNA splicing  factor genes  possibly  highlights  a  mechanism  of 
photoreceptor degeneration due to defects in pre-mRNA splicing (Chakarova et 
al., 2002).
Oculopharyngeal  muscular  dystrophy  (OPMD)  is  caused  by  a  short 
expansion of the GCG triplet repeat encoding a polyalanine tract in the mRNA 
3'  processing  and  polyadenylation  factor,  poly(A)-binding  protein  2  (PABR2). 
PABP2  has  been  shown  to  localise  to  speckles  in  C2  cells  and  research 
suggests that PABP2 plays a  role in the expression of muscle-specific genes 
(Kim et al.,  2001).  In OPMD,  PABP2 is no longer seen to localise in speckles 
but accumulates in a neuronal intranuclear inclusion.  The altered distribution of 
PABP2 may play a role in OPMD pathology.
The  sequestration  of splicing  factors  may  contribute  to  the  pathology  of 
myotonic dystrophy (DM)  (chapter 1.7.5). There are two types of DM;  DM1  is 
caused by either a CTG-repeat expansion in the 3'  untranslated  region  of the 
myotonic  dystrophy  protein  kinase  (DMPK)  gene  and  DM2  is  caused  by  a
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(ZNF9) gene (Fardaei et al., 2002). The RNAs transcribed from these expanded 
loci  accumulate  in  the  nuclear  foci,  and  RNA-binding  proteins  from  the 
muscleblind  protein  family,  such  as  MBNL,  MBLL  and  MBXL,  adhere  to  the 
transcripts and are suggested to be sequestered into the nuclear inclusion.This 
results  in  a trans-dominant dysregulation  of pre-mRNA alternative splicing  in 
muscle for several genes,  including that of the  insulin-receptor (Savkur et al., 
2004).
1.6 Huntington’s Disease
Each of the fore mentioned nuclear subdomains (nucleolus, Cajal body and 
speckles)  have  been  implicated  in  triplet  repeat  diseases.  This  family  of 
diseases is characterized  by an expanded CAG  repeat tract and  include  nine 
such  diseases;  the  spinocerebellar  ataxias,  (SCAs),  dentatorubral  and 
pallidoluysian  atrophy  (DRPLA)  and  spinal  and  bulbar  muscular  atrophy 
(SBMA)  as  well  as  Huntington’s  disease  (HD).  The  most  common  CAG 
expansion disease is Huntington’s disease and is associated with documented 
nuclear changes (Roizin et al.,  1979; DiFiglia et al.,  1997).  HD is an autosomal 
dominantly inherited progressive neurodegenerative disease.  Onset is usually 
in adult life, with a mean of around 40 years.  The neuropathologic hallmark of 
the  disease  is  neuronal  loss  and  gliosis  in  the  caudate  nucleus  and  the 
putamen  (the  striatum)  resulting  in  atrophy (figure  1.38).  The  medium-sized 
striatal  neurons  that contain  gamma-aminobutyric  acid  and  substance  P,  as 
neurotransmitters, are selectively depleted.  Clinical symptoms include gradual 
involuntary  movements,  progressive  dementia  and  psychiatric  disturbances, 
especially mood disorder and personality changes (for a comprehensive review 
of the clinical profile of HD, see Harper,  1996).
7 0 INTRODUCTIONFigure 1.38
Photograph  showing  coronal  brain  sections.  Severe  atrophy  in  the 
brain of a patient with HD (left) compared with a control (right).
1.6.1  The Huntington’s Disease Gene
The gene responsible for HD was identified in  1993 (Huntington’s Disease 
Collaborative  Research  Group,  1993)  and  localised  to  human  chromosome 
four.  The affected gene,  IT15 (Interesting Transcript 15), spans approximately 
210 K b within the 4p16.3 locus and has 67 exons.  The mutation underlying HD 
is an expansion of a CAG/polyglutamine tract in the first exon.  The CAG repeat 
length is highly polymorphic in the population (Kremer et al.,  1994).  The CAG 
repeat size in the normal range is (CAG)6 to (CAG>39, whereas in the expanded 
range is (CAG>35 to (CAG)iso (Bates et al., 1997).  Individuals with repeat sizes 
between  35  and  39  do  not always develop  symptoms.  Adult onset patients 
account for  90%  cases  and  typically  have  expansions  from  40-55  repeats, 
whereas juvenile onset cases only account for 10% of cases and are caused by 
expansions of greater than 70 repeats.
There is a well-established inverse correlation between CAG repeat length 
and  age  of  onset  (Stine  et al.,  1993;  Brinkman  et al.,  1997)  (figure  1.39). 
However, patients with identical repeat lengths can differ in their ages at onset 
and therefore genetic factors are  likely to affect the age of onset,  as  can  be 
seen  by varying  age  of onset  in  family  members with  similar CAG  sizes.  It 
appears that there are a number of genetic modifiers, which can either, delay or
71 INTRODUCTIONpromote onset of the disease.  One study discovered that the presence of a 
glutamic acid polymorphism, A2642, adjacent to the CAG repeat influenced the 
age at onset in patients with HD (Vuillaume et al.  1998).  The number of CAG 
repeats in the upper allele accounts for up to 70% of the variation in the age of 
onset (Andrew et al.,  1993).  The polyglutamine tract is very unstable and has 
been  shown  to  increase  in  size when  paternally  inherited.  HD  also shows 
‘anticipation’  which  is  increasing  severity  or the  earlier  onset  of disease  in 
subsequent generations  (Gusella et al.  1993, Telenius et al.,  1993, Zuhlke et 
al.  1993).
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Figure 1.39
A  graph  showing  the  inverse  correlation  between  CAG  repeat  length  and  age  of 
onset for all the polyglutamine diseases (taken from Gusella and MacDonald, 2000).
A study  recently showed  that there are  high  levels of CAG  repeat  length 
variation in many tissues of a mouse model of HD (Kennedy and  Shelbourne,
2000).  The  mice  were  generated  by  inserting  72-80  CAG  repeats  into  the 
mouse  HD  gene  and  therefore full  length  mutant  huntingtin  was  expressed. 
The mice demonstrate behavioural and pathological features that are indicative 
of early HD.  Analysis of the repeat sizes of individual mutant alleles in tissues
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and prone to expansion in the striatum of these mice.  The expansion was also 
shown to increase with age and some striatal cells from old HD mice contained 
mutations that had  tripled  in size.  This suggests that repeat expansions can 
occur by a mechanism that is not based on replication.
1.6.2  Huntingtin mRNA and Protein
Northern blot and in situ hybridisation studies have shown that 10.3 and  13.6 
kb  transcripts  are  synthesised  from  the  HD  gene  and  are  expressed  in 
peripheral tissues as well as the brain (Lin et al.,  1993; Ambrose et al.  1994). 
There are high levels of expression in neurons, testes, ovaries and lung and low 
levels  in  pancreas,  smooth  muscle  and  liver.  The two  isoforms  result from 
differential  3’  polyadenylation  and  this  may  be  a  mechanism  to  regulate the 
expression  (Lin et al.  1993) The  larger,  13.7  kb fragment is the predominant 
transcript in the human  brain as well as in the mouse brain  (Casanova et al., 
1996).
The gene product is a 348 kDa protein named huntingtin (htt) that consists 
of 3144 amino acids.  No proteins homologous to huntingtin have been found 
yet.  The  CAG  repeat  begins  at  residue  18  and  is  then  followed  by  29 
consecutive  prolines.  Huntingtin  also  contains  a  basic  peptide  region 
PIRRKGKEK  (amino  acid  1182-1190)  and  one study  showed  that when  this 
peptide was fused to|3-galactosidase it was sufficient to  localize the protein  in 
the  nucleus  of  human  293  cells  (Bessert et al.,  1995).  Huntingtin  protein  is 
ubiquitously expressed and  seen in  many tissue types.  Despite this fact, the 
neuronal pathology of HD is selective and largely restricted to specific areas of 
the brain, the striatum and the cortex (Landwehrmeyer et al.,  1995).
Studies  investigating  the  localisation  of the  huntingtin  protein  have  also 
shown that it is expressed at higher levels in the brain (Strong et al.,  1993).  The 
protein  has been shown to have both cytoplasmic and  nuclear localisations in 
cultured  human  and  murine  cells  (De  Rooij  et al.,  1996;  Hoogeveen  et al., 
1993).  Immunostaining by DiFiglia et al. (1995) of human and rat brain reveals 
huntingtin  to  be  localized  in  neurons,  particularly  cell  bodies  and  dendrites. 
Immuno-electron  microscopy  showed  huntingtin  to  be  in  the  matrix  of  the
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that htt may have a function in vesicle trafficking (DiFiglia et al.  1995;  Sapp et 
al.  1997; Velieretal.  1998).
A  more  recent  study  suggests  that  huntingtin  is  found  in  the  nucleus  of 
human  cells.  Kegel  et al.  (2000)  investigated the distribution  of huntingtin  in 
normal and  HD  patient fibroblasts using a variety of different antibodies.  The 
results  showed  full  length  wild-type  huntingtin  in  the  nucleus  and  that  both 
normal  and  mutant  huntingtin  were  present  diffusely  throughout  the 
nucleoplasm as well as being associated with the nucleolus, speckles and PML 
bodies.  The  same  study discovered  that  both  mutant and  normal  huntingtin 
repressed transcription when targeted to DNA.  These findings have led  to the 
suggestion that  huntingtin  may function  in  the  regulation  of transcription  and 
mutant huntingtin may disrupt this.  Tao and Tartakoff (2001) have also shown a 
nuclear pool of an N-terminal 70 kDa huntingtin in the nucleus of HeLa cells.  It 
has also been suggested that huntingtin plays a role in the normal function of 
some  nuclear  and  perinuclear  organelles  and  helps  to  maintain  their 
morphology  (Hilditch-Maguire  et al.,  2000).  The  nuclear organelles  are the 
nucleolus  and  the  speckles  and  therefore  implicate  huntingtin  in  RNA 
biogenesis and trafficking.
The mouse, rat and pufferfish homologues of the huntingtin gene have been 
identified  and  cloned  (Lin  et al.,  1994;  Schmitt et al.,  1995;  Baxendale et al., 
1993).  The  human  and  mouse genes share  90%  homology and  the  highest 
degree  of sequence  identity  is within  the  first  5  exons  where  identical  exon 
boundaries  are  seen  but with  different  sized  introns  (Lin  et al.,  1995).  The 
pufferfish  gene  is  also  highly  conserved  and  shares  69%  homology  to  the 
human  gene.  The  murine  CAG  repeat  encodes  only  7  glutamines  and  is 
interrupted by a CAA.  The pufferfish glutamine repeat is only 4 CAGs long and 
is encoded for by 2 CAGs and 2 CAAs.
The function  of normal  huntingtin  remains  unclear.  Several  groups  have 
generated Hdh (the mouse homologue of huntingtin) knockout mice and these 
mice have all been shown to be embryonic lethal (Nasir et al.  1995; Duyao et al. 
1995).  Heterozygous  knockout  has  no  distinguishable  effect.  Likewise,  in 
humans  the  loss  of  one  htt  allele  does  not  produce  HD  pathology.  This 
information  supports the  hypothesis that HD  is caused  by a  ‘gain  of function’
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evidence to  support this  idea  because  in  the  disorder there  is  a  loss  of the 
telomeric region of chromosome four (including the HD gene), yet suffers show 
no related symptoms of HD (Gottfried et al.  1981).
1.6.3  Interacting Partners of Huntingtin
Huntingtin has been shown to interact with a large number of other proteins 
(Faber et al.,  1998; Jones, 1999; Steffan et al., 2000; Dunah et al., 2002; Harjes 
and Wanker,  2003;  Holbert e al,  2003).  It is  possible that mutant htt interacts 
abnormally with cellular proteins.  Interacting partners of huntingtin include:
Glyceraldehyde-3-phosphate dehyrogenase (GAPDH)
Calmodulin
Huntingtin-interacting protein 1  (HIP1)
Huntingtin-interacting protein 2 (HIP2)
Huntingtin-associated protein 1   (HAP1)
Huntingtin-associated protein 40 (HAP40)
WW domain proteins (HYPA, HYPB, HYPC)
Cystathionine -synthase 
SH3-containing Grb-like protein 3 (SH3GL3)
Sp1
TAFII130
Cdc42-interacting protein 4 (CIP4)
The interactions of huntingtin can be altered by the increase in CAG repeats 
in mutant huntingtin.  For example, the WW-domairi proteins, HYPA, HYPB and 
HYPC, interact with the proline-rich region adjacent to the polyglutamine region 
of both wild-type and  mutant huntingtin.  This  interaction  is  increased  as the 
polyglutamine  repeat  increases  (Faber et al.  1998).  HYPA  and  HYPC  are 
known to be involved in pre-mRNA splicing, whereas HYPB has been identified 
as a transcription factor (Passani et al. 2000;  Rega et al., 2001).  It is therefore 
suggested that altered mRNA synthesis and processing may play a role in HD 
pathogenesis.
Using  the yeast two-hybrid  system,  recent  research  found  that full  length 
huntingtin  interacts with  both  Sp1  and  TAFII130  (Dunah  et al.,  2002).  The
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TAFII130 the  interaction  is  unaffected  by the  polyglutamine length.  Sp1  is a 
transcription  factor  whose  main  function  is  recruitment  of  the  general 
transcription  factor,  TFIID  to  DNA.  TAFII130  forms  part  of a  multi-subunit 
complex with TFIID, Tata binding protein (TBP) and many other TBP-associated 
factors (TAFs).  This suggests that the CAG repeat expansion in htt may disrupt 
transcription through  its interaction with transcription factors.  It has also been 
shown that Sp1  binds more tightly with the soluble form of huntingtin than the 
aggregated form (Li et al., 2002b) and this interaction may lead to the reduction 
in expression of Sp1-regulated genes.
One study showed that mutant htt exon  1  protein was able to interact with 
p53 and the co-activator CBP and co-repressor mSin3 in  vitro (Steffan et al.,
2000).  These  three  proteins  are  involved  in  p53-mediated  transcriptional 
regulation and therefore the results also implicate transcriptional dysregulation 
in HD pathogenesis.
N-CoR  represses  transcription  through  the  formation  of  a  complex  of 
repressor proteins  including  mSin3  and  histone deacetylases.  Boutell  et al. 
(1999) showed that the N-terminus of huntingtin  interacts with  N-CoR but this 
interaction  is  CAG  repeat  length  dependent.  The  same  group  also 
demonstrated that  in  HD the  localisation  of N-CoR and  mSin3  is  altered.  In 
control brains, using immunohistochemistry, both N-CoR and mSin3A showed a 
nuclear and cytoplasmic distribution but in HD brains, the nuclear staining was 
no longer seen.  mSin3A immunoreactivity also localized to approximately 5% 
of the  total  number  of neuronal  intranuclear  inclusions  (Nils)  when  mSin3A 
immunoreactivity  was  compared  to  N-terminal  huntingtin  immunoreactivity 
(Jones,  1999).  This again supports the idea that normal transcriptional activity 
may be distributed in HD.
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Following  the  discovery  of the gene  affected  in  HD,  a  transgenic mouse 
model of HD was created (Manigiarini et al.,  1996).  The model was developed 
by expressing  a construct of exon  1   of human  huntingtin carrying a  (C A G )i3 o  
repeat  expansion  and  262  b f>  of  intron  1   under  the  control  of  the  human 
huntingtin  promoter  (Mangiarini  et al.,  1996) (figure  1.40).  This produces a 
protein that corresponds to approximately the first 90 amino acids of normal 
huntingtin  (CAG21)  and  represents  about  3%  of  the  wild-type  protein 
(Sathasivam  et  al.,  1999).  The  HD  transgenic  mice  were  created  by 
microinjection of the construct into single cell  CDAxC57BI/6 mouse embryos. 
Six lines were established and four contain different expanded CAG repeats of 
a  size that  is  usually associated  with  the juvenile form  of the disease:  R6/0 
(C A G )i4 2 »   R6/1  (CAG)h5,  R6/2 (CAG)i45 and  R6/5  ( C A G ) i35- i56-  Of these mice 
the R6/0 mRNA is not translated, whereas the R6/1, R6/2 and R6/5 all produce 
full  length mRNA and protein expressed at differing  levels.  An additional two 
lines,  HDex6 and  HDex27 contained  a  normal sized  repeat of (CAG)i8   as  a 
control.  The size of the  repeat length was determined  by  PCR-amplification 
followed by sequence analysis (Mangiarini eta!.,  1996).
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Figure 1.40
The construct of the R6/2 transgenic line (UTR = untranslated region, TGA = stop codon).
The R6/2 transgenic mouse line has been extensively studied and greatly 
helped in the understanding of the molecular pathology of HD. The R6/2 mouse 
model  of HD  is  used  exclusively  in  my studies.  The  R6/1  and  R6/5  lines do 
develop  a  phenotype  but the  R6/2  is  the  most  aggressive  and  the  disease 
progression is in a number of weeks rather than months.  The age of disease
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(table 1.2).  The cause of death is generally unknown.  The mutation in these 
mice is not acting at the mRNA level as huntingtin protein can be detected upon 
western blot using N-terminal huntingtin antibodies (Davies et al.,  1997).  These 
animals do develop behavioral problems similar to those seen in HD, including 
in-coordination,  abnormal  involuntary  movements,  seizures and  weight  loss. 
Despite this, these mice do not show specific neuronal cell loss in the striatum 
like human patients.  However, this is consistent with the idea that it is neuronal 
dysfunction that  is  responsible for the symptoms of the disease,  rather than 
neuronal death.
2 - - - -
3 - - -
3.5 - - -
4 - - +
4.5 - - +
5 + - - +
6 ++ - + ++
7 ++ + + - + ++
8 +++ + - + ++ +
9 +++ + + + +++ +
10 +++ ++ + + + ++ + +
II +++ +++ ++ +++ +++ +
12 +++ +++ ++ +++ +++ ++
13 +++ ++ + +++ ++ + + + + ++
Table 1.2
A  table  showing  the  correlation  between  symptomatic  onset  and  weight  loss  with  the  appearance  of 
nuclear inclusions and nuclear indentation in R6/2 mice (taken from Davies et al.,  1997).
A variety of mouse models of Huntington’s disease have now been created. 
Although  the  R6/2  transgenic  mice  are  the  most  extensively  studied,  other 
mouse models have also been generated that express a mutant truncated HD 
gene or full length HD gene that has been added to the normal mouse genome 
which,  already has two wild-type murine HD genes.  Knock-in  mouse models 
have been engineered as well and replicate the exact human mutation found in
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endogenous  murine  HD  gene  (for  a  comprehensive  review  of  the  mouse 
models of HD,  see Menalled and Chesselet, 2002;  Rubinsztein, 2002;  Hickey 
and Chesselet, 2003).
1.6-5 The Neuronal Intranuclear Inclusion
Immunocytochemical studies of the R6/2 transgenic mouse brains showed 
that  mutant  huntingtin  is  also found  in  both  the  cytoplasm  and  the  nucleus.
Using  antibodies  raised 
against  the  N-terminal  of 
huntingtin,  Davies  et  al.
(1997)  revealed  additional 
staining  in  the  R6/2  mice 
compared  to  that  seen  in 
control  mice.  A  ‘densely 
stained  circular  inclusion’ 
was  seen  within  neuronal 
nuclei.  Antibodies  against 
ubiquitin  also  labeled  the 
neuronal  intranuclear 
inclusion (Nil) (figure 1.41). 
Nils show immunoreactivity for the N-terminus of htt but are not immunoreactive 
for antibodies to the C-terminus of htt.  Immuno-electron  microscopy studies 
revealed that these nuclear inclusions were not the nucleolus or Cajal body of 
the cell’s nucleus (Davies et al.,  1997).  The ultrastructural morphology of Nils 
was  originally  described  as  a  pale,  granular  and  fibrous  structure  that was 
approximately 2  in diameter.  Other nuclear changes seen  using  electron 
microscopy  include  a  membrane  invagination,  an  increase  in  nuclear  pore 
density,  lipofuscin  accumulation,  condensation  of  chromatin  and  neuronal 
shrinkage (Davies et al.,  1999).  It has also been shown that Nil appear before 
the onset of symptoms.  Nils have previously been described at EM in biopsies 
from human HD tissue (Roizin et al.,  1979) and human HD post-mortem tissue 
(DiFiglia et al.  1997; Becher et al.  1998; Gourfinkel-An et al.,  1998).  In addition
Figure 1.41
Light  photomicrograph  of  R6/2  transgenic  striatum  at  low 
power.  Nils  labelled  by  anti-ubiquitin  antibody  are  seen  as 
immunoreactive foci.
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been seen in both  HD post-mortem tissue and  HD transgenic mice (DiFiglia et 
al.  1997; Bates etai,  1998).  The dystrophic neurite inclusions (DNIs) have also 
been  shown  to  be  immunoreactive  for  the  N-terminus  of  huntingtin  and 
ubiquitin.
The presence of Nils has been shown in most of the CAG repeat disorders, 
including SCA1  (Skinner et al,  1997) and MJD/SCA3 (Paulson etai,  1997).  It 
has also been shown that when CAG repeats are introduced into a gene for a 
protein  that  never  normally  contains  a  polyglutamine  sequence,  nuclear 
inclusions are formed  and  produce a  neurological  phenotype.  Ordway  et al.
(1997)  added  a  transgene  containing  146  CAG  repeats  into  the  HRPT 
(hypoxanthine-phosphoribosyltransferase)  gene.  The  protein  containing  the 
long  polyglutamine  repeat  was  expressed  and  nuclear  inclusions  were 
observed.  Even though  a  neurological  phenotype was  seen,  no evidence of 
neurodegeneration was observed (Ordway et al.,  1997).
However,  a  study  by  Chai  et al.  (2001)  suggests  that the  context  of the 
protein  in  which  the  CAG  repeat  is  mutated  does  play  an  important  role  in 
pathology.  When full length and truncated ataxin-3 (mutated in SCA3 (chapter 
1.7))  inclusions  were  studied^ it  was  found  that  nuclear  factors,  CBP  and 
Mastermind-like-1  (MAML1) colocalised only to Nil formed by full length ataxin- 
3, whereas the splicing factor SC35 colocalised only to Nils formed by truncated 
fragment  ofoteixin-3.  It  is  therefore  suggested  that  the  protein  sequence 
surrounding the CAG repeat plays a role in which other proteins are recruited to 
Nils.
Several studies indicated that it is the presence of the mutant protein in the 
nucleus  that  determines  whether  it  forms  aggregates  or  not.  Saudou  et al.
(1998)  showed  that  when  mutant  huntingtin  was  transfected  into  cultured 
striatal neurons and nuclear localisation was blocked, no Nils were formed and 
neurodegeneration was  not induced.  When  a  construct in which the  nuclear 
localisation  signal  of a  different CAG  triplet  repeat disease  protein,  ataxin-1 
(mutated in SCA1  (chapter 1.7)) was mutated and  used to generate transgenic 
mice, these mice did  not develop a disease either (Klement et al.,  1998).  This 
also suggests that the nuclear localisation of the protein plays a crucial role in 
cellular toxicity.
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Subsequent analysis has also revealed many other components colocalise 
to the Nil in mouse and cell culture as well as in human tissue.  These include 
chaperones  Hsc70,  Hsp70,  Hsp40,  BiP  &  HDJ-2  and  the  20S,  19S  &  11S 
subunits of the 26S proteasome, SUMO-1, a-synuclein and transcription factors 
CBP,  TBP,  Sp1,  TAFII130  and  mSin3A  (Huang  et al.,  1998b;  Boutell  et al., 
1999;  Davies et al.,  1999; Jones,  1999;  Shimohata et al., 2000a; Steffan et al., 
2000;  Nucifora et al., 2001; Suhr et al., 2001; Waelter et al. 2001; Dunah et al., 
2002; Kim et al., 2002; Li et al., 2002b; Yu et al., 2002).  Some of these studies 
suggest  that  the  proteins  are  sequestered  into  the  Nil  and  the  normal 
localisation  for  the  given  protein  is  depleted.  The  consequence  of  the 
sequestration of these proteins into the Nil may leave the molecule inactive and 
therefore disrupt normal cellular functions (Nucifora et al.,  2001;  McCampbell 
and Fischbeck, 2001).
However, Yu et al. (2002) investigated the expression and localisation of the 
transcription factors CBP, TBP and Sp1  in transgenic mouse models of HD.  All 
three proteins were shown to have a diffuse nucleoplasmic distribution that was 
similar to control brains as well being localised in the Nil.  Western blots were 
also used to show that CBP was not trapped in the Nil. Together these results 
suggest that disruption  to  transcription  in  HD  may  be  as  a  result  of altered 
interactions  of  htt  with  transcription  factors  and  not  due  to  the  irreversible 
sequestration of the proteins in Nils.
Supporting this further is a recent study that demonstrated the dynamics of 
inclusions.  HeLa or 023 cells were cotransfected with constructs encoding Htt- 
150Q together with 19Q-GF, TBP-GFP or Hsp70-YFP (Kim et al., 2002) and the 
dynamic properties of the proteins were compared using fluorescence recovery 
after  photobleaching  (FRAP)  or fluorescence  loss  in  photobleaching  (FLIP). 
The  FRAP  experiments  revealed  that  TBP  has  a  slower  recovery  time 
compared to Hsp70 and the results demonstrated that inclusions have different 
molecular  interactions  with  different  associated  proteins.  The  FLIP  analysis 
showed that Hsp70 could be released from the inclusion therefore suggesting 
that the surface of Nils  have the ability to  bind  and  release molecules.  The 
findings  also  imply  that  the  molecules  seen  to  colocalise  with  Nils,  using
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Stenoien et al.  (2002) also demonstrated the dynamic nature of Nils using an 
expanded  ataxin-1  construct  in  HeLa  cells  and  FRAP  analysis.  The  results 
demonstrated  that two  different types  of  inclusions  existed;  ones  with  rapid 
exchange of components with the nucleoplasmic pool and ones that have slow, 
varying exchange.
1.6.7 Mechanisms Underlying HD Pathology
The  pathogenic  mechanism  of  the  mutant  huntingtin  has  yet  to  be 
discovered.  Various  mechanisms  have  been  suggested  to  account  for  the 
neurodegeneration  in  HD.  These  include  defects  in  energy  metabolism, 
oxidative stress  and  glutamate excitiotoxicity.  The  mechanism  by which  the 
CAG  repeat  expansion  ultimately  causes  pathology,  however,  still  remains 
unclear.  One proposed  pathway involves transcription.  It is suggested that 
mutant huntingtin with an increase in CAG repeats may resemble a transcription 
factor because many other proteins containing  high  numbers of CAG  repeats 
are  themselves  transcription  factors  (Cha,  2000).  Cha  proposes  several 
different modes of action for mutant huntingtin in transcription dysregulation; (1) 
A ‘gain of function’ resulting from the increase in CAG repeat length leading to 
direct  binding  of mutant  htt to  DNA,  disrupting  normal  transcription.  (2) The 
binding of huntingtin to transcription factors resulting in an inactive complex that 
may  repress  transcription.  (3)  Huntingtin  may  bind  to  co-repressor proteins 
making them inactive and therefore increasing transcription of normally inactive 
genes.  (4)  Transcription  factors  may  be  sequestered  by  htt  reducing  their 
‘normal’ levels within the cell.
1.6.8 Gene Expression Changes
A study using a combination of mircoarray and Northern analyses to assess 
the changes in mRNA levels showed that the expression levels of some genes 
were  affected  in  R6/2  transgenic  mice  (Luthi-Carter  et  al.,  2000).  These 
included  increases  and  decreases  in  transcription.  The  data  implicated 
dysregulation  of  mRNAs  encoding  neurotransmitter  receptors  and  related 
second  messenger systems as an early part of HD pathology.  A further study
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detected after four weeks of age that coincides with early pathology and early 
symptoms  in the  R6/2  mice (Luthi-Carter et al.,  2002b).  It was also  revealed 
that alterations in gene expression were not specific to the brain;but were also 
seen in skeletal muscle.
Research  by  the  same  group  again  has  also  shown  gene  expression 
changes are not limited to HD but can also been seen in another mouse model 
of a different polyglutamine disease, DRPLA (Luthi-Carter et al., 2002a).  Some 
of the gene expression changes seen were specific to the DRPLA mouse but 
several of the same changes were also seen in the HD mouse.  This suggests 
that some altered gene expressions are caused  by an expanded  CAG  repeat 
independently of the context of the protein it is located in, whereas,  others are 
dependent on the protein context.  It has also been shown that mice expressing 
a larger N-terminal mutant huntingtin fragment showed fewer gene expression 
changes  compared  to  mice  expressing  a  shorter  htt  fragment  (Chan  et al.,
2002).  This data is suggested to also support the idea that htt protein context is 
important  in  the  pathology of HD  and  can  influence the  CAG  repeat-related 
alterations of mRNA expression.
1.6.9  Changes to Transcriptional Pathways
Several  recent  studies  have  suggested  that  altered  interactions  with 
transcription co-activators or co-repressors may cause the pathology of HD and 
include  p53,  CBP,  Sp1,  TAFII130,  N-CoR  and  mSin3A  (Steffan  etai.,  2000; 
McCampbell etai., 2000; Shimohata et al., 2000b; Nucifora et al., 2001;  Dunah 
et al.,  2002;  Jones  et al.,  1999).  The altered  interactions  have already been 
discussed  (chapter 1.6.3) and  all  implicate transcriptional dysregulation  in  HD 
pathogenesis.
Steffan et al.  (2001) have also shown that the N-terminus of huntingtin can 
interact and  bind  directly with  CBP and  P/CAF  (p300/CBP-associated  factor) 
not  through  their  polyglutamine  domain^ but  through  their  acetyltransferase 
domain.  In free-cell assays, the presence of huntingtin exonl  protein with  51 
CAG  repeats lead to a decrease in  activity of CBP,  p300 and  P/CAF,  and,  in 
cultured cells, the expression of huntingtin exonl  protein with 103 CAG repeats
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decrease  in  histone  acetylation was  more  distinct with  larger  polyglutamine 
repeats.
The decrease  in  histone acetylation  is suggested to  cause a decrease  in 
gene  expression  and  therefore  it  has  been  proposed  that  the  use  of  a 
compound to inhibit cellular histone deacetylation could compensate for the loss 
of acetyltransferase activity.  In a Drosophila model of HD, with both  C A G 9 3  or 
C A G 48,  that was  given  histone  deacetylase  inhibitors  in  food,  the flies  lived 
longer  and  there  was  a  decrease  in  the  level  of  neurodegeneration  seen 
(Steffan et al., 2001). This is summarized in figure 1.42.  Further studies have 
also demonstrated that histone deacetylase inhibitors can  reduce cell  loss  in 
different models of polyglutamine diseases (McCampbell et al., 2001; Hockly et 
al.,  2003;  Ryu et al.,  2003).  These findings also support the hypothesis that 
part of the pathology of HD may be caused by transcriptional dysfunction.
a
b
c
Figure 1.42
Diagram showing the potential mechanisms of Huntington’s disease and gene expression 
(taken  from  Bates,  2001).  (A)  Complexes  containing  activator  proteins  and 
acetyltransferases  turn  on  transcription  whereas  repressor  complexes  and  histone 
deacetylases  (HDACs)  switch  expression  off.  (B)  Mutant  huntingtin  inhibits  histone 
acetylation by blocking histone acetylases or sequestering them into inclusions (Steffan et 
al.,  2001),  resulting  in  decreased  transcription.  (C)  The  balance  between  histone 
acetylation  and  deacetylation  can  be  improved  by  molecules  that  inhibit  histone 
deacetylation.
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8 4 INTRODUCTIONIt  is  apparent  HD  and  the  polyglutamine  diseases  do  have transcriptional 
changes  but whether these are  primary  or secondary  responses to the  CAG 
expansion remains to be discovered.  These experiments have lec\  to possible 
therapeutic  targets,  in  the  form  of  histone  deacetylase  inhibitors  and  could 
potentially be used in patients.
1.7 Other Repeat Diseases
Triplet repeat diseases can be categorized into two subclasses based on the 
location of the repeat in the gene.  In the first class the repeat is located in the 
coding sequence of the gene and this group of disorders is collectively referred 
to  as the ‘polyglutamine diseases’.  The  second  class  has the  repeat in  non­
coding sequences of the gene and includes Fragile X and myotonic dystrophy.
1.7.1 Polyglutamine Diseases
As well as Huntington’s disease,  at least eight other late-onset progressive 
neurodegenerative disorders are caused by an expansion of CAG trinucleotide 
repeats coding for polyglutamine in  unrelated  proteins (See Table  1.3).  They 
include  spinal  and  bulbar  muscular  atrophy  (SBMA),  dentatorubral  and 
pallidoluysian  atrophy  (DRPLA)  and  a  number  of  spinocerebellar  ataxias 
(SCAs).  Despite the fact that the CAG repeat is found within different proteins 
the  effects  are  similar.  All  the  disorders  result  in  neurodegeneration  of  a 
specific population of neurons  and  neuronal  intranuclear inclusions  (Nils) are 
formed.
Generally the  disease-causing  length  of the  CAG  repeat  is 40  or greater 
whereas  healthy  individuals  have  CAG  repeats with  fewer  residues.  Larger 
CAG  repeats  result  in  an  earlier age  of onset  and  the  disease  severity  also 
increases.  Observations have shown that the polyglutamine repeat itself plays 
a central role in pathogenesis of these diseases and the presence of the CAG 
repeat expansion imparts a ‘gain-of-function’ to the protein.
The study of transgenic animal  models and  human  post-mortem tissue for 
each of the triplet repeat diseases has lead to the identification of Nils that stain 
positively for the  expanded  CAG  repeat protein  and  ubiquitin  (Davies  et al.,
85 INTRODUCTION1997; Paulson etai.,  1997; Skinner et al.,  1997; Hayashi etai., 1998; Holmberg 
et al.,  1998;  Li et al.,  1998;  Koyano et al.,  1999).  Ultrastructurally all the Nils 
appear to have the same morphology (figure 1.43). The only exception to this is 
SCA6 where studies have differing results; Ishikawa et al. (1999) first suggested 
that mutated ataxin-6 is only found  in cytoplasmic inclusions in  Purkinje cells 
that do  not stain  positively for ubiquitin.  However,  the same group,  in 2001, 
then demonstrated that small inclusions could be identified using a monoclonal 
antibody  1C2 that recognises expanded  polyglutamine tracts (Ishikawa et al.,
2001).  It has also been shown that the Nils  recruit many proteins like those 
seen in  HD and these include  NEDD8,  various chaperones,  26S proteasome 
complex,  CBP,  PML and  PQBP-1  (polyglutamine (Q) tract binding  protein-1) 
(Stenoien et al.,  1999; Chai et al.,  1999; Yamada et al.,  2001; Okazawa et al.,
2002).
Figure 1.43
Electron
micrographs of Nils 
(arrows) in neurons 
from SCA3 brain (A) 
and DRPLA 
transgenic mouse 
brain (B).  Scale 
bars = 0.2  (taken 
from Yamada et al., 
2001).
The  spinocerebellar ataxias  (SCAs)  and  dentatorubral  and  pallidoluysian 
atrophy (DRPLA) are dominantly inherited neurological disorders characterized 
by  degeneration  of the  cerebellum,  spinocerebellar  tracts  and  brain  stem 
neurons.  The clinical features shared by the SCAs are ataxia, dysarthria and 
eventual bulbar dysfunction.  The gene products in most of the SCAs are novel 
proteins  of  unknown  function  and  the  2  exceptions  are  SCA6  and  SCA17: 
SCA6  gene  product  is  the  -1A  voltage-gated  calcium  channel  (CACN1A1) 
(Zhuchenko et al.,  1997) and in SCA17 it is the transcription factor TBP that is 
mutated (Nakamura etai., 2001).  Ataxin-3 has been suggested to be a histone- 
binding  protein that has the  ability to  repress transcription  (Li  et al.,  2002b).
8 6 INTRODUCTIONAtrophin-1  has  also  been  implicated  in  a  role  in  transcriptional  repression 
(Wood  et al.,  2000).  The  normal  subcellular localisation  of the each  protein 
varies.
Spinal  and  bulbar  muscular  atrophy  (SBMA)  is  an  X-linked,  recessive 
neurodegenerative  disease  that  typically  causes  progressive,  symmetric 
wasting and weakness, initially of the proximal muscles of the hip and shoulder 
(Ringel et al.,  1978).  Androgen insensitivity is also seen and frequently causes 
breast development  in  males.  It was the first  member of the  polyglutamine 
diseases to be identified when it was discovered that exon  1   of the androgen 
receptor (AR) in SBMA patients had an expanded (CAG)n  repeat.  It was also 
the  first  member of the  class  in  which  the  normal  functions  of the  disease- 
causing protein was known (La Spada et al.,  1991).  Immunocytochemistry has 
shown that the normal cellular distribution of the AR protein  is not affected  in 
SBMA  but there  is  additional  immunoreactivity  in  the form  of Nils  (Li  et al.,
1998).
HD huntingtin 6-39 35-180 cytoplasmic 
and nuclear
Bates  et  al.. 
1997
SCAI ataxin-I 6-44 39-82 nuclear Skinner  el  of., 
1997
SCA2 ataxin-2 17-31 36-63 cytoplasmic Huynh  el  al.. 
I 999
SCA3 ataxin-3 12-41 62-84 cytoplasmic 
and nuclear
Tait et al..  1998
SCA6 CACNAIA 4-18 21-33 cell membrane Ishikawa  el  al.. 
1999
SCA7 ataxin-7 4-35 37-306 nuclear Cancel  el  al., 
2000
SCAI 7 TBP 29-42 47-55 nuclear Nakamura  el 
al.. 2001
DRPLA atrophin-l 6-36 49-84 cytoplasmic Knight  el  al.. 
1997
SBMA androgen
receptor
10-36 40-62 cytoplasmic 
and nuclear
Li el of..  1998
Table 1.3
A table summarising the features of diseases caused by expanded CAG tracts (adapted from 
Cummings and Zoghbi, 2000).
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The  non-coding  nucleotide  repeat  diseases  are  caused  by  a  large  and 
variable  repeat expansion that is  located  in the  non-coding  part of the gene. 
They result in  multiple tissue dysfunction or degeneration.  The phenotype of 
each disease can also vary and this may be due to a marked degree of somatic 
heterogeneity.  Individuals that  have  an  intermediate  sized  expansion  often 
show no clinical symptoms but transmission to the next generation leads to the 
larger mutations.
Fragile  X 
syndrome
FMR1 FMRP CGG 6-53 >230 loss of 
function
Fu etai., 
1991
Fragile  XE 
syndrome
FMR2 FMRP-2 GCC 6-35 >200 loss of 
function
Knight et al., 
1993
Friedreich
ataxia
X25 Frataxin GAA 7-35 >100 loss of 
function
Campuzano 
etai.,  1996
Myotonic 
Dystrophy 1
DMPK DMPK CTG 5-37 >50 loss of 
protein 
function, gain 
of mRNA 
function
Davies etai., 
1992
Myotonic
Dystrophy2
ZNF9 ZNF9 CCTG 6-26 75-11,000 loss of 
protein 
function, gain 
of mRNA 
function
Liquori et al., 
2003
SCA8 SCA8 - CTG 16-37 110-250 loss of 
function ?
Koob et al. 
1999
SCA12 SCA12 PPP2R2
B
CAG 7-28 55-78 loss of 
function
Holmes ef 
al.. 2001
Table 1.4
A table  summarising the features  of diseases  caused  by  expansion  of non-coding  nucleotides  (adapted 
from Cummings and Zoghbi, 2000).
Not all the repeat sequences are the same in this group of disorders (CGG, 
GCC, GAA, CTG, CCTG AND CAG) and the number of repeats can vary from 
50 to  over  10  thousand.  The  actual  repeat  sequence  and  its  location  with 
respect to the given gene are both important factors in the mechanism for each 
of the diseases.  The pathological mechanism for each disease is different and 
is dependent upon either the loss of function of a particular protein or in some
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each  of  these  disorders  are  summarised  in  table  1.4  and  some  will  be 
discussed more fully.
1.7.3  Fragile X Syndrome
Fragile  X  syndrome  is  the  most  common  form  of  inherited  mental 
retardation.  The gene mutated is FMR1 that is highly conserved and consists of 
17 exons.  Located at the 5’-untranslated region (5’-UTR) of the transcript is a 
CGG trinucleotide repeat (Hoogeveen et al.,  2002).  The normal repeat length 
and  content  is  highly  polymorphic  and  ranges  from  6  to  53.  In  Fragile  X 
patients,  the CGG  is greatly expanded to over 230  repeats and the transcript 
becomes  abnormally  hypermethylated  resulting  in the  silencing  of the  FN\ftl 
gene  (Jin  and  Warren,  2000).  Fragile  X  is  therefore  caused  by the  loss  of 
FMR1  gene product.  Repeats of 60 to 230 are called premutations and normal 
transcripts  and  proteins  levels  are  seen  but  are  very  unstable  during 
transmission  to  offspring.  This  expansion  can  only  occur  by  maternal 
transmission.  Affected  males  have  a  more  severe  phenotype due to the X- 
linkage.
The protein encoded  by FMR1  gene is fragile X mental  retardation  protein 
(FMRP)  and  it  has  been  implicated  in  RNA  binding  and  may  play  a  role  in 
translational control (Siomi et al.,  1993).  The subcelluar localisation of FMRP 
shows that it has a cytoplasmic and  nuclear distribution.  An immuno-electron 
microscopy  study  (Willemsen  et  al.,  1996)  demonstrated  that  FMRP  is 
associated  with  the  granular component  of the  nucleolus.  FMRP  has  also 
been shown to be a nucleocytoplasmic shuttling protein that selectively binds to 
a  subset of mRNAs,  forms  messenger ribonucleoprotein  (mRNP)  complexes 
and  associates with  translating  ribosomes  (Ceman  et al.,  1999).  The  same 
investigation  also  showed that  FMRP  interacts with  C23  (nucleolin)  that  is  a 
nucleolar protein that forms part of the mRNP complexes.  It is suggested that 
part of the molecular basis of Fragile X is the translational  overexpression  of 
selected mRNA due to the loss of FMRP (Warren,  Neuroscience 2004).
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Individuals with  a  premutation  were  originally  believed  to  have  no  clinical 
symptoms  but  a  number  of  investigations  have  shown  some  premutation 
carriers  have  tremor  with  ataxia,  mild  learning  disabilities  and  emotional 
problems  (Hagerman  et al.,  2002).  It has been shown that individuals with a 
premutation  have  increased  FMR1  mRNA  levels  that  can  be  up  to  8  times 
higher than normal and slightly reduced FMRP protein levels (Kenneson et al.,
2001).  It is suggested that there is impairment in the translation process and a 
compensatory induction of FMR1  mRNA synthesis.  A recent study has shown 
that  the  expanded  CGG  tract  in  the  5’-UTR  of  FMR1  mRNA  impedes  the 
translation of FMRP in a length-dependent manner (Napierala et al., 2005).
Post-mortem examination of the brains of elderly, symptomatic premutation 
carriers  revealed  the  presence  of  intranuclear  inclusions  in  neuronal  and 
astrocytic nuclei of the cortex that stained positively for ubiquitin (Greco et al.,
2002).  The inclusions were found  in all cases examined and  it is suggested 
that it is the increased mRNA levels that are important for the formation of the 
inclusion and play a role in the development of the clinical symptoms seen  in 
premutation carriers.
A  ‘knock-in’  CGG  triplet  repeat  mouse  has  been  generated  carrying  98 
repeats,  which  is  in  the  premutation  range  (Willemsen  et  at,  2003). 
Immunohistochemical  investigations  in  these  mice  have  demonstrated  the 
presence of inclusions in neurons as well (figure  1.44).  Ubiquitin, 20S core of 
the proteasome and  Hsp40 all colocalise in the inclusion but FMRP does not. 
When  the  presence  of total  DNA  or  RNA  in  the  inclusions was  investigated 
neither was found  but the group  does  not  rule  out the  possibility that  FMR1 
transcripts may be present but not detected to date.
A  Drosophila  model  of fragile  X  premutation  also  forms  inclusions  that 
contain  ubiquitin,  parts of the  proteasome and  chaperones  (Jin  et al.,  2003). 
These  results  indicate  that  the  ubiquitin/proteasome  pathway  is  somehow 
involved  (like  in the polyglutamine diseases)  but it is  important to  remember 
that the CGG repeat is not translated,  it is only transcribed, and therefore it is 
not  mutant  protein  that  is  being  misfolded  or targeted  for degradation.  The 
Drosophila model also demonstrates that the CGG expansion alone can cause
9 0 INTRODUCTIONneurodegeneration  and  is  therefore  an  example  of  RNA-mediated 
neurodegeneration.
Figure 1.44
Immunohistochemical localisation of ubiquitin (green) and ethidiumbromide staining total RNA (red) in 
a  neuron from an expanded repeat mouse (72 weeks).  Overlay of the two images demonstrates that 
ethidiumbromide  staining  does  not  localise to  ubiquitin  positive  intranuclear inclusions.  X700  (taken 
from Willemsen et al., 2003).
1.7.5  Myotonic Dystrophy
Myotonic Dystrophy (DM) is the most common form of muscular dystrophy 
affecting adults.  Myotonia, muscle weakness and progressive muscle wasting 
characterise the disease.  Phenotypes are  highly variable and  anticipation  is 
shown.  Two different loci for DM have been identified.  The most common form 
is DM1 that accounts for 98% of cases.  DM1  is caused by a CTG trinucleotide 
expansion in the 3’-UTR of Myotonic Dystrophy Protein Kinase (DMPK).  DM2 
is  caused  by  a  tetranucleotide  expansion  (CCTG)  in  intron  1   of zinc finger 
protein 9 (ZNF9) (Liquori et al., 2001).  In DM1  and DM2 transcripts containing 
the expanded  repeats form  nuclear foci within  DM  cells.  Despite the  repeat 
expansion occurring in unrelated genes, the phenotypes seen in DM1  and DM2 
are so similar that a common mechanism has been suggested.  One suggestion 
is that the novel ‘gain of function’ is not related to the protein^ but to the mRNA 
transcript.  The foci seen  in  both  DM1  and  DM2 cells may sequester various 
other  proteins  in  a  similar  mechanism  that  is  suggested  to  be  part  of the 
problem in the polyglutamine diseases.  It has been shown that proteins related 
to Drosophila muscleblind proteins colocalise with the foci (Fardaei et al., 2002) 
(figure  1.45).  The  functional  role  of  these  proteins  is  not  understood  in 
mammalian  cells  but one  study  demonstrates  that the  muscleblind  proteins 
regulate alternative splicing  of specific pre-mRNAs  (Ho  et al.,  2004).  Altered
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et al.,  2001;  Savkur et al.,  2004).  These findings suggest that an  important 
feature  of the  RNA-mediated  pathogenesis  model  for  DM  is  the  disrupted 
splicing of specific pre-mRNA targets.
J
Figure 1.45
Transient expression  of GFP-tagged  muscleblind  protein  in control  (A)  and  DM1  cells  (B-D).  In  DM1 
cells muscleblind protein is localised to nuclear foci (B).  In DM1  cells DMPK expanded RNA transcripts 
are  seen  in  nuclear  foci  as  well  (C).  Merged  images  show  that  muscleblind  and  the  transcripts 
colocalise (D) (taken from Fardaei etai., 2002).
1.7.6  SCA8
SCA8 is another disease where the symptoms include a progressive ataxia 
with cerebellar atrophy and  is caused  by an expanded  CTG  repeat in the 3’- 
terminal exon (Koob et al.,  1999).  The size of the CTG repeat that causes the 
disease ranges from  110 to 250, surprisingly, shorter or longer repeat lengths 
do not produce the disease.  The SCA8 transcripts containing the CTG repeat 
are  alternatively  spliced  and  polyadenylated  and  are  primarily  expressed  in 
brain tissue (Nemes et al.,  2000).  The  SCA8 transcript does  not encode a 
protein, as no open reading frames (ORFs) are present.  It is believed that the 
spliced  transcripts  do  not  function  as  mRNA  but  are  organised  as  natural 
antisense transcripts that possibly regulate the expression of other genes.
When  a genetic modifier screen was  performed  using  SCA8(CTG)118 as 
the  phenotype,  mutations  in  four genes were found  (Mutsuddi  et al.,  2004). 
One of these genes was Muscleblind that is implicated in DM and implies that 
there  are  parallels  between  DM  and  SCA8.  Differences  between  the 
phenotypes of these diseases  may be explained  by the different expression 
patterns of the their transcripts (Mosemiller et al.,  2003).  The multi-systemic 
features of DM1  and  DM2 are consistent with the broad expression of DMPK 
and ZNF9 transcripts, whereas, SCA8 transcripts are predominantly expressed
9 2 INTRODUCTIONin the brain, which is the major site of pathology in SCA8.
Discovering the mechanism by which these untranslated repeat expansions 
cause neurodegenerative diseases is now important and it is possible that RNA 
may be uncovered as the cause of more diseases.
1.8 Aims and Objectives
The aim of this work is to investigate the morphology of three nuclear sub- 
domains (the nucleolus, the Cajal body and the speckles)  in the nuclei of neu­
rons within  the  mouse  striatum.  A molecular characterisation  of each  of the 
subdomains will also be undertaken.  The results of these studies will then be 
compared  to  a  mouse  model  of  Huntington’s  disease,  the  R6/2  transgenic 
mouse and a mutant mouse lacking the nuclear protein p80 coilin, the p80 coilin 
knock-out mouse.
It has been well documented that alterations to each of these subdomains 
occur in  response to changes in cellular activities.  Therefore, any differences 
seen  in the organisation of the R6/2  nuclei or the p80  KO  nuclei compared to 
that of the wild type nuclei, will help to gain a better understanding of the cellu­
lar pathways affected in these two mutant mice.
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Materials and Methods 
2.1 Tissue Preparation
Animals  were  anesthetized  with  an  overdose  of sodium  pentobarbitone 
(Sagatal,  loo mg/kg,  intraperitoneally)  and  perfused  through  the  left  cardiac 
ventricle with  35  to  50  ml  of a  2%  paraformaldehyde/lysine/periodate  (PLP) 
fixative  in  phosphate buffer (pH  7.4) or 4%  paraformaldehyde with or without 
0.1% gluteraldehyde.  The brains were removed after decapitation and  placed 
in the appropriate fresh fixative.
2.1.1 Tissue Preparation for Electron Microscopy
Brains for standard transmission electron microscopy (TEM) were placed in 
a  fresh  solution  of  4%  paraformaldehyde  with  0.1%  gluteraldehyde  for  a 
minimum  of 24  hours  at 4°C.  Brains  for  immuno-electron  microscopy  were 
placed  in  either  2%  PLP  fixative  in  phosphate  buffer  (pH  7.4)  or  4% 
paraformaldehyde with  or without  0.1%  gluteraldehyde for a  minimum  of 24 
hours at4 0C  depending  on which  antibody was  being  used  (table  2.1).  After 
post-fixation,  brains  were  bonded  using  superglue  (cyanoacrylate)  to  the 
mounting block of a Vibratome Series 1000. The Vibratome reservoir was filled 
with 0.1 M phosphate buffer and coronal sections were cut of either 50 or 200 jm\ 
and collected into ‘dimple tray’ containing 0.11\ phosphate buffer.
2.1.2 Tissue Processing for Electron Microscopy
For standard TEM 200 yiA thick sections were osmicated (60 mins 1  % Os04 
in 0.1  M phosphate buffer at 4°C) and then en-bloc stained in a solution of 2% 
uranyl  acetate  (in  0.1 /A sodium  acetate) for 45  minutes  at4°C.  The sections 
were then dehydrated though a graded ethanol series (25%,  50%,  70%,  90%, 
100%  x4);  and  cleared  in  propylene  oxide  (100%x4).  Sections  were  then 
incubated  in a solution of 50% araldite resin in propylene oxide for 45 minutes 
and  then  left in  pure araldite  resin  on  a  rotator overnight.  The sections were
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at 60% to polymerise the araldite resin.
The striatum from the embedded sections were superglued onto resin blocks 
and  the  block  face  was  polished  until  smooth.  Using  a  Reichert  Ultracut 
ultramicrotome  semithin  (1 pm)  sections  were  cut  with  glass  knives.  The 
semithin  sections  were  collected  on  glass  slides,  dried  on  a  hot  plate  and 
counter-stained with toludine blue.  These sections were then viewed under a 
light  microscope  to  ensure  the  correct  area  of  brain  was  being  examined. 
Ultrathin  sections  (approximately 70  i\fl\) were cut  using  a diamond  knife and 
only sections that were silver-gold were collected on copper-mesh grids.  When 
the sections had dried onto the grids, they were then counter-stained with lead 
citrate  for  approximately  4  minutes  and  viewed  in  a  Jeol  1010  electron 
microscope.
2.1.3  Immunocytochemistry For Electron Microscopy
Vibratomed sections of brain (50 jLift) were incubated free-floating in primary 
antibody that was  diluted  to  the  appropriate  concentration  in  either  primary 
antibody buffer or phosphate buffer, for 72 hours at4 °C.  Depending on which 
antibody was being  used either 2%  PLP or 4% paraformaldehyde fixed tissue 
was used (table 2.1).  The sections were then washed in the correct buffer and 
incubated in either biotinylated or immunogold secondary antibodies.
Sections that were  incubated with  biotinylated  secondary antibodies were 
then  visualised  using  HRP-DAB  reaction  product  (chapter  2.2.2)  For 
immunogold, sections were incubated in immunogold secondary antibodies at a 
concentration  of  1:200  in  phosphate  buffer overnight at 4 °C.  Sections were 
then  fixed  in  0.1%  gluteraldehyde  for  10  minutes  at  room  temperature. 
Sections were then silver-enhanced using Nanoprobes HQ Silver Enhancement 
Kit.  This was carried  out  in the dark for approximately 5  minutes.  Sections 
were then washed in acetate followed by phosphate buffers and processed for 
TEM.
The immunogold sections were osmicated in 1% osmium tetraoxide (in 0.1 
phosphate buffer) for only 7 minutes at  °C as the silver enhancement reaction 
product can be removed by the osmium solution. Similarly, sections processed
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The sections were then washed and dehydrated as for standard TEM (chapter 
2  1.2).  Neither process involves en-bloc staining with uranyl acetate, although 
individual sections can be stained with lead citrate.
2.2 Tissue Processing
2.2.1 Tissue Preparation for Light Microscopy
Brains for  light  microscopy were  placed  in  2%  PLP  fixative  in  phosphate 
buffer (pH  7.4) for 4 to  6  hours  before  being  transferred  to  a  cryoprotectant 
solution of 30% sucrose in 0.1 M Tris (pH 7.4) for 48 ta at 4°C.  Brains that had 
been  placed  in  30%  sucrose  were  mounted  in  Tissue-Tek  OCT  compound 
(Miles  Laboratories),  frozen  with  powdered  solid  CO2,  and  sectioned  in  the 
coronal plane at 40 pm on a Leica SM2000R sledge microtome. Sections were 
collected using a paintbrush and then put serially in a ‘dimple tray’ filled with the 
correct buffer, and, stored aU°C until needed.
2.2.2 Immunocytochemistry For Light Microscopy
Sections were incubated free-floating in primary antibodies that were diluted 
to  the  appropriate  concentration  in  primary  antibody  buffer  (0.1 M  Tris-HCL, 
0.3% Triton and 0.02% sodium azide) or phosphate buffer at 4 °C for 72 hr. The 
sections were washed  in the appropriate buffer prior to  being  processed with 
biotinylated  secondary  antibody  for  2  hours  at  room  temperature  and  at  a 
concentration of 1:200.  Sections were washed again before being transferred 
into an ABC  solution  (VectorLabs) for a further 2  hours at a  concentration  of 
1:100 and at room temperature.  The solution ABC consists of 10 jjV  avidin,  10y\ 
of biotinylated horseradish peroxidase and 980pl of buffer.
After washing in buffer, a solution of 3,3”diaminobenzidine (DAB) (containing 
25 jjg DAB,  33 fA hydrogen  peroxide  and  100 ml of  buffer)  was  then  used  to 
localise the sites of peroxidase activity.  Sections were examined under a light 
microscope  periodically  until  an  appropriate  level  of  staining  was  seen. 
Sections were washed again and then mounted onto gelatinised slides.
97  MATERIALS & METHODSThe slide-mounted sections were allowed to air dry for at least 24 hours 
before finally  being  passed  though  an  ascending  ethanol  series  (70%,  80%, 
90%, 95%,  100% x2) to dehydrate and cleared in two changes of Histoclear for 
10 minutes.  Slides were then coverslipped,  using  DPX as a mountant, which 
was allowed to harden before viewing.
2.2.3  Immunocytochemistry For Immunofluorescence
Sections  for  immunofluorescence were  incubated  free-floating  in  primary 
antibodies that were diluted to the appropriate concentration in primary antibody 
buffer  (0.1  fATris-HCL,  0.3%  Triton  and  0.02%  sodium  azide)  or  phosphate 
buffer atft-°C for 72 hrs as with the other labelling protocols.  If double-labelling 
was being performed, sections were incubated in a solution that contained both 
primary antibodies.  However, each primary antibody must have been raised in 
a different host species,  as this is the basis for differentiation between labels. 
After incubation  in  primary  antibody/antibodies,  the  sections were washed  in 
0.1 A\ phosphate  buffer and  then  incubated  in  secondary antibody/antibodies 
conjugated to a fluorophore diluted to a concentration 1:100 in 0.1 \\ phosphate 
buffer for two hours in the dark.  If double-labelling was being carried out, the 
secondary antibodies must all be conjugated to different florophores e.g.  FITC 
or TRITC,  and, they must not be raised in the same species that was used to 
raise any of the primary antibodies.  For these reasons,  a series of secondary 
antibodies all raised in donkey and conjugated to a variety of fluorophores were 
used.  The  fluorophore-conjugated  secondary  antibodies  are  from  Jackson 
Immunochemicals.  Sections were then washed in 0.1 fH  phosphate buffer in the 
dark.
The sections were then labelled with pyronin Y or DAPI.  For DAPI labelling, 
the sections were mounted on glass slides and,  before the sections dried, the 
slides are coated with Vectashield DAPI mounting medium, which contains the 
nucleic acid-counterstaining fluorophore DAPI,  coverslipped and sealed with a 
small rim of clear nail varnish.
Sections to  be  stained  with  pyronin  Y were  incubated  for 2  minutes  in  a 
diluted pyronin Y solution (1:6000 dilution in phosphate buffer of a  10  nvfl stock 
from Sigma).  The sections were then washed  in buffer and mounted on glass
9*  MATERIALS & METHODSslides. To mount the coverslips, MOWIOL/Dabco, was used and this hardens so 
no nail varnish was needed.  All slides were stored at4 °C in the dark until they 
were analysed using a Leica confocal microscope.
Fibrillarin
Pollard,  Scripps Research Institute, La 
Jolla, USA
72B9 Mouse 1:1000 4% 10mAb/PB
Fibrillarin
Pollard, Scripps Research Institute, La 
Jolla, USA
17C12 Mouse 1:1000 4% 16mAb/PB
Fibrillarin Abeam, Cambridge,  UK Ab5821 Rabbit 1:1000 4% 10mAb/PB
Nopp140
U.T Meier, Albert Einstein College of 
Medicine,  New York, USA
RF12 Rabbit 1:1000 4% PB
GAR1
W. Filipowi, Friedrich Miescher Institut, 
Basel,  Switzerland - Rabbit 1:1000 4% 1°mAb
C23
Santa Cruz, Autogen Bioclear, 
Wiltshire, UK
H-250 Rabbit 1:1000 4% PB
B23 Abeam, Cambridge, UK Ab15440 Rabbit 1:1000 - -
Topo II
Santa Cruz, Autogen Bioclear, 
Wiltshire, UK
H-286 Rabbit 1:1000 PLP 1°mAb
UBF
Santa Cruz, Autogen Bioclear, 
Wiltshire, UK
H-300 Rabbit 1:1000 4% rm Ab
RNA Pol I 
(RPAA194)
Santa Cruz, Autogen Bioclear, 
Wiltshire, UK
N-16 Goat 1:1000 PLP/4% PB
HSC70
Santa Cruz, Autogen Bioblear, 
Wiltshire, UK
K-19 Goat 1:1000 PLP/4% rm Ab
p80 coilin A.I. Lamond,  University of Dundee, UK 204/10 Rabbit 1:1000 PLP/4% 1°mAb
SMN BD Transduction Lab, Oxford, UK 610646 Mouse 1:1000 PLP/4% 1°mAb
SMN
G.  Dreyfoss, University of 
Pennsylvania, USA
18163 Mouse 1:1000 PLP/4% 1°mAb
Gemin2 G. Dreyfoss, University of 
Pennsylvania, USA
2E17 Mouse 1:1000 PLP/4% rm Ab
Gemin4 G. Dreyfoss, University of 
Pennsylvania, USA
17D10 Mouse 1:1000 PLP/4% 1°mAb
Gemin3/
DP103
BD Transduction Lab, Oxford, UK 612152 Mouse 1:1000 PLP/4% 1°mAb
U2’snRNP EuroDiagnostica, Mansfield,  UK 4G3 Mouse 1:1000 PLP/4% 1°mAb
EWS
Santa Cruz, Autogen Bioclear, 
Wiltshire, UK
N-18 Goat 1:1000 PLP PB
PAP Santa Cruz, Autogen Bioclear, 
Wiltshire,  UK
V-18 Goat 1:1000 PLP rm A b
Profilin Santa Cruz, Autogen Bioclear, 
Wiltshire, UK
N-20 Goat 1:1000 PLP PB
CPSF-1
Santa Cruz, Autogen Bioclear, 
Wiltshire, UK
N-20 Goat 1:1000 PLP PB
SC-35 Sigma, Dorset,  UK S4045 Mouse 1:1000 PLP/4% 1°mAb
HYPA M E. MacDonald, Massachusetts 
General Hospital,  Boston, USA
AF-1 Rabbit 1:1000 PLP/4% rm Ab
HYPC
M E. MacDonald, Massachusetts 
General Hospital,  Boston, USA
CF-1 Rabbit 1:1000 PLP/4% 1°mAb
TMG Oncogene, Merck Biosciences, 
Nottingham, UK - Mouse 1:1000 PLP/4% 1°mAb
PSP1 A. Fox, University of Dundee, UK - Rabbit 1:1000 PLP/4% 1°mAb
Huntingtin Santa Cruz, Autogen Bioclear, 
Wiltshire, UK
N-18 Goat 1:1000 PLP/4% rm Ab
Table 2.1
A table showing the different antibodies used throughout this thesis.  In the Fixation column,  PLP =2% 
paraformaldehyde/lysine/periodate  (PLP)  fixative  in  phosphate  buffer  (pH  7.4)  and  4%  =  4% 
paraformaldehyde.  In  the  Solution  column,  1°mAb  =  primary  antibody  solution  and  PB  =  0.1/4 
phosphate buffer.
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CHAPTER 3
3.1  Ultrastructure of Neuronal Nucleus
Most  (90  to  98%)  of striatal  neurons  have  a  smooth  nuclear  membrane 
(Kemp  and  Powell,  1971)  and  a  predominantly  dispersed  configuration  of 
chromatin  with  occasional  small  aggregates  of condensed  chromatin.  This 
ultrastructure  corresponds  to  a  single  type  of  neuron,  the  medium  spiny 
projection cell. To ensure that the same cell type was being compared only non­
indented nuclei were examined.
3.1.1 Ultrastructure of Neuronal Nucleolus
The structure of a typical mammalian nucleolus has been well documented 
(chapter  1.1.2  and  figure  3.1)  and  it  is  suggested  that  the  formation  and 
maintenance  of  nucleolar  morphology  relies  upon  rRNA  transcription  and 
processing.  To determine the  ultrastructural features  of neuronal  nucleoli,  I 
have analysed the nucleoli of striatal neurons in the normal 10*week-old mouse. 
Nuclei containing nucleoli were randomly sampled.
The  nucleolus  is  easily  identifiable  in  an  ultrathin  section  under  the 
transmission  electron  microscope  (TEM).  It  is  a  spherical,  electron-dense 
organelle that is located in the nucleus of the cell.  From my analysis of striatal 
neurons, most cells are mononucleolated (88%) and occasionally binucleolated 
(12%).  I did not see a nucleus that contained more than 2 nucleoli.  The mean 
number of nucleoli per cell is 1.11+/-0.03.
After closely examining the ultrastructure of the striatal nucleoli, it is possible 
to distinguish two classes:
Type I)  Closed-reticulate structure (CRS)
Type II)  Open-reticulate structure (ORS)
CRS  nucleoli  were  seen  in  44%  of the  cells  that were  examined  (graph
IOI RESULTS3.1  A).  These  nucleoli  have  an  ordered  structure  (figure  3.2A)  but  it  is  not 
possible  to  distinguish  clearly  the  3  components  that  constitute  a  ‘classic’ 
nucleolus: the fibrillar centres (FCs), the dense fibrillar component (DFC) and 
the granular component (GC).  It is possible to see very small  FCs, which are 
round,  low-density fibrillar areas.  The FCs are surrounded by what appears to 
be  a  dark,  granular material,  which  constitutes the  majority  of the  nucleolar 
volume.  It is not possible to clearly differentiate the dense fibrillar component 
from the granular component.  These nucleoli  are spherical  and  the average 
diameter is 0.83+/-0.03  |aw\  (graph 3.1B).
The  CRS  nucleoli  occasionally  have a  perinucleolar cap  structure  (PNC). 
The PNC is generally smaller than the nucleolus and appears to be composed 
of a material that is less electron dense than the fibrillar-granular component of 
the nucleolus.  There seems to be no actual connection between the PNC and 
the fibrillar-granular component of the nucleolus and in some nuclei, there even 
appears to be a small gap between the two structures.
The second  class of nucleoli  seen  in  striatal  neurons,  the ORS,  does  not 
have  an  evenly  distributed  morphology  and  was  observed  in  56%  of nuclei 
examined (graph 3.1 A).  In a typical mammalian cell the FCs accounts for only 
2% of the nucleolus (Shaw and Jordan,  1995); but these striatal nucleoli have 
one or two very large FCs, together with several small FCs (figure 3.2B).  These 
FCs are not evenly distributed within the individual nucleoli.  In some cases the 
FCs  appear to  be  exposed  to  the  nucleoplasm  and  not  surrounded  by  the 
dense fibrillar component as characteristically observed  in many cell types by 
many investigators.  Like the CRS nucleoli,  it is not possible to distinguish the 
dense fibrillar component from the granular component.
Some ORS nucleoli also have a PNC.  It is smaller than the nucleolus and 
has the same appearance as that seen in CRS nucleoli.  The ORS nucleoli are 
not as  uniformly spherical as the CRS  nucleoli and their average diameter is 
0.90+/-0.03  j a w  (graph 3.1B).
In both classes some nucleoli are surrounded by what appears to be a halo 
of electron-dense particles.  I believe this to be perichromatin granules (PG) and 
perichromatin fibrils (PFs) that have associated with condensed  perinucleolar 
chromatin  at  the  nucleolar  periphery.  The  PGs  and  PFs  can  be  seen  to 
completely encircle the nucleolus or just part of it.
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Figure 3.1
Schematic Diagrams Showing the Organisation of Nucleoli.
(A) A typical nucleolus from a mammalian nucleus.  Small compact areas of DFCs surround the 
FCs and the GC accounts for the majority of the nucleolus.
(B)  In  striatal  neurons  of a  10-week-old  mouse,  nucleoli  with  small  FCs  surrounded  by  an 
entanglement  of  DFC  and  GC  can  be  seen  and  have  been  classed  as  closed-reticulate 
structure (CRS) nucleoli.
(C)  A  second  class  of nucleoli  can  be  seen  in  striatal  neurons,  the  open-reticulate  structure 
(ORS)  nucleoli.  These  nucleoli have very large  FCs that occupy a considerable volume of the 
nucleolus.
(D) In R6/2 transgenic mouse, a third class of nucleoli can be seen in the striatal neurons.  The 
nucleoli  in  these  cells  is  segregating  and  the  FCs  are  medium  sized  and  numerous.  The 
entanglement of DFC  and  GC  is forming  small  microspheres as well  as  areas of nucleoli that 
seem to be empty of any component.
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Graph 3.1
Analysis of the Class and Diameters of Nucleoli in Murine Striatal Nuclei
(A) A histogram showing the percentages of nucleoli that show an open-reticulate structure (ORS) or a closed- 
reticulate structure (CRS) in 10-week-old mice.  A 95% confidence interval that the probability of ORS is 
between 46% and 65% and for CRS is between 35% and 54%.
(B) A histogram showing the average diameters of ORS or CRS nucleoli in  10-week-old mice.  It is possible to 
see that ORS nucleoli have a slightly larger average diameter than the CRS nucleoli.  Error bars are standard 
errors of mean.
1 0 4 RESULTSFigure 3.2
Electron Micrographs of Nucleoli from Striatal Neurons
(A)  Fine structure of a Closed-reticulate structure (CRS)  nucleolus (n) from a 
striatal neuron of a  10-week-old mouse.  The majority of the nucleolus is com­
posed of an intermingled mass of dense fibrillar component (DFC) and granu­
lar component (GC).  Fibrillar centres (FCs) are very small.  A CB (white ar­
row) can be seen and there is a perinucleolar cap (PNC) (*).  It is also possi­
ble to see perichromatin granules (PGs) (white arrowhead).
(B)  Same as  (A)  but this electron  micrograph  shows a  nucleolus that has an 
Open-reticulate  structure  (ORS).  This  nucleolus (n)  has very  prominent FCs 
(black arrow) that are exposed to the nucleoplasm.  It is also possible to see 
PGs (white arrowhead).
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The  Cajal  body  (CB),  originally described  by Cajal  in  1903  in  a  variety of 
neurons,  is a round-to-oval structure seen  in the nucleus and  it has been well 
documented  (chapter  1.2.1  and  Gall,  2003).  I  have analysed  CBs  in  striatal 
neurons from the 10-week-old mouse to determine their organisation and their 
spatial relationship to other nuclear subdomains.  Out of 100 nuclei observed at 
the TEM level,  only 28% of nuclei had a clearly distinguishable CB.  The CBs 
seen where situated  in 2 different localisations within the nucleus:  free in the 
nucleoplasm or associated with the nucleolus.
In all the striatal  neurons examined,  most CBs appeared to have a similar 
morphology and are identifiable as an oval to round structure composed of both 
granules and dense coiled threads embedded in a lower density matrix. 79% of 
CBs  seem  were  nucleolar-associated  and  only  21%  were  free  in  the 
nucleoplasm (graph 3.2A).  In a few neurons,  CBs occurred that had a dense 
fibrillar structure that was very compact and  had  no amorphous matrix.  From 
TEM  analysis  alone  it  is  not  possible to  decide  if these  are  indeed  CBs  or 
nuclear bodies (NB) of a different type.
The nucleolar-associated CBs have an average diameter of 0.23+/-0.02 pm 
(graph 3.2B) and  protrude from the nucleolar periphery (figure 3.3A).  In most 
cases  the  CB  is  found  to  be juxtaposed  to  the  nucleolus  but can  easily  be 
distinguished from the nucleolus as the electron dense strands and granules of 
the  CB  have  a  different  morphology  from  either the  GFC  or the  GC  of the 
nucleolus.  The  less  dense fibrillar matrix  of the  CB  appears to  be  in  direct 
contact with the nucleolus.
The  free/nucleoplasmic  CBs  have  an  average diameter of 0.28+/0.03 y»* 
(graph 3.2B) and do not appear to be associated with any other nuclear domain 
(figure 3.3B).  Many CBs have tiny fibrils radiating into the nucleoplasm from the 
amorphous matrix.
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Graph 3.2
Analysis of Cajal Bodies in Murine Striatal Nuclei
(A) A histogram showing the percentages of CBs that are either free in the nucleoplasm or nucleolar- 
associated and found at the periphery of the nucleolus in 10-week-old mice.  It is possible to see that most of 
the CBs in the striatal neurons are nucleolar-associated CBs.  A 95% confidence interval that the probability of 
nucleolar CBs is between 70% and 86% and for free CBs is between 14% and 30%.
(B) A histogram showing the average diameters of free or nucleolar-associated CBs in 10-week-old mice.  Free 
CBs appear to have larger average diameters compared to those of the nucleolar-associated CBs.  Error bars 
are standard errors of mean.
RESULTSFigure 3.3
Electron Micrographs of Cajal Bodies from Striatal Neurons
(A) The ultrastructure of a nucleolar-associated CB from a striatal neuron of 
a  10-week-old mouse (black arrows).  The nucleolar CB is in direct contact 
with  the periphery of the nucleolus.  The CB  is composed of dense coiled 
threads embedded  in  a  less dense matrix.  The  nucleolus (n)  has an  ORS 
morphology and a PNC (*).
(B) The fine structure of a free, nucleoplasmic CB (black arrows) from a stri­
atal neuron of a 10-week-old mouse.  This CB has the same morphology as 
the nucleolar CB^but does not appear to have a spatial relationship with any 
other nuclear domain.  Note the small fibrils  (white arrowheads) projecting 
from the CB periphery.
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The nuclear subdomains that are known as speckles contain pre-messenger 
RNA (pre-mRNA) splicing factors and at the ultrastructural level are composed 
of  interchromatin  granule  clusters  (IGCs)  and  perichromatin  fibrils  (PFs) 
(chapter 1.3).  I have investigated the morphology of the speckles and IGCs in 
the  striatal  neurons  of the  10-week-old  mouse.  Although  it  is  possible  to 
distinguish IGCs from the chromatin in the nucleoplasm of the nucleus without 
antibodies (figure 3.4), it has been hard to quantify the shape and number per 
nuclei.  Unlike  the  CB  or  nucleolus,  the  IGCs  do  not  have  a  very  obvious 
morphology and this makes quantifying them via electron microscopy difficult. 
Speckles  are  composed  of  numerous  granules  that  are  connected  via  thin 
fibrils, which are the PFs.  Each nucleus contains a varying number of speckles, 
which have an irregular shape and differing diameter.
1 0 9 RESULTSFigure 3.4
Electron micrographs of Speckles from Murine Striatal Neurons
(A) The fine structure of speckles (black arrowheads) in a striatal neuron 
from  10-week-old mouse.  Perichromatin fibrils (PFs) and  interchromatin 
granule clusters (IGCs) correspond to speckles at the ultrastructural level. 
IGCs represent the main part of speckles and comprise granules that ap­
pear to be connected with fibres.
(B) Same image as (A) but the IGCs have been highlighted in pale blue.
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Use  of  immunocytochemical  methods  have  localised  a  large  number  of 
nuclear proteins to specific subcompartments of the cellular nucleus.  However 
the  vast  majority  of  such  studies  have  utilised  human  cells  in  culture  with 
antibodies generated against the human protein sequence.  Few studies have 
investigated  nuclear  localisation  in  murine  cells  and  even  fewer  in  murine 
neuronal  cells.  In  these  studies  I  have  attempted  to  define  the  molecular 
organisation of the murine neuronal nucleus using antisera to a large number of 
neuronal proteins.
3.2.1  Molecular Composition of Neuronal Nucleolus
The  molecular  organisation  of the  nucleolus  in  striatal  neurons  can  be 
examined  using  a  variety  of  well-characterised  antibodies  and  different 
nucleolar  proteins  have  been  shown  to  localise  to  the  different  structural 
components of the  nucleolus:  the fibrillar centres,  the  dense fibrillar and  the 
granular  components  (figure  3.5).  Using  this  as  a  guide,  I  analysed  the 
distribution of a number of key nucleolar factors in murine striatal neurons.
Immunocytochemical  identification  of the  dense fibrillar component of the 
nucleolus is most usually achieved with antibodies to the protein fibrillarin.  One 
such  antibody that  has  been  used  in  many studies  is  a  monoclonal  antibody 
termed  72B9.  Immunocytochemistry  using  a  number  of  different  fibrillarin 
antibodies localised fibrillarin to the nucleolus and to the nucleolar-associated 
and nucleoplasmic Cajal bodies (CBs) (figure 3.6B).  The immunoreactivity for 
all the fibrillarin antibodies revealed an intense staining of one or more nucleoli 
per nucleus,  which  could  be seen  as a  spherical  structure  located  within the 
nucleus  at  low  magnification  (figure  3.6C).  When  the  magnification  was 
increased,  many  nucleoli  appeared  to  stain  uniformly  and  completely 
encompassed one to three small accessory Cajal bodies.
Two other nucleolar proteins that are suggested to be localised to the same 
region of the nucleolus (the dense fibrillar component)  as fibrillarin are GAR1 
and  Nopp140.  Immunocytochemistry for a  GAR1  antibody  revealed  a  similar 
staining  pattern to that seen for fibrillarin;  round  structures  located within the
h i RESULTSnucleus  and  frequent  accessory  Cajal  bodies  (data  not  shown). 
Immunoreactivity for a  Nopp140  antibody  showed  nucleoplasmic staining  as 
well  as  nucleolar labelling  (figure  3.6D).  Very distinct and  intense staining  of 
nucleolar-associated  Cajal  bodies,  which varied  in  number from  one to three 
were  seen.  Antibodies  to  both  proteins  also  occasionally  labelled 
nucleoplasmic CBs.
C23 (nucleolin) is a nucleolar protein found in the granular component of the 
nucleolus,  together  with  B23  (nucleophosim).  Unfortunately,  antibodies 
generated  against  B23  showed  no  staining  of the  nucleolus  revealing  only 
nucleoplasmic staining.  However an antibody against C23 did show staining of 
the nucleolus together with  nucleoplasmic labelling (figure 3.6E). The staining 
pattern  for  C23  revealed  a  rim  of  immunoreactivity  at  the  periphery  of the 
nucleolus and no CB staining.
Upstream binding factor (UBF) is another nucleolar protein and it has been 
used  as a  marker for fibrillar centres.  Immunoreactivity for the  UBF antibody 
revealed nucleolar staining but a different pattern was seen from that of other 
nucleolar proteins  (figure 3.6A).  At the light microscopy  level,  some  nucleoli 
appear to stain  as an  accumulation of small foci.  RNA  polymerase  I  is  also 
localised  to  fibrillar  centres  but when  I  used  an  antibody  to  this  protein  no 
staining of fibrillar centres was seen.  Instead nucleoplasmic immunoreactivity 
was  seen  with  infrequent,  irregular  nuclear foci  that were  very  small  (figure 
3.6F).
DNA  topoisomerase  II  (topo  II)  is  an  essential  enzyme  that  mediates  a 
variety  of chromosome  activities  including  transcription,  recombination,  and 
chromosome  condensation  and  has  been  localised  to  the  nucleolus  using 
immunocytochemistry (Zini et a/.,  1994).  In the nuclei of striatal neurons in the 
mouse, an antibody against topo II  revealed nucleoplasmic staining as well as 
labelling of the nucleolus (data not shown).  The immunoreactivity appeared to 
be similar to that seen for C23 with a rim at the edge of the nucleolus but also 
included complete labelling of adjacent Cajal bodies.
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Figure 3.5
Schematic Diagram Showing the Molecular Organization of Nucleoli.
Different nucleolar proteins  (coloured text)  have  been  shown  to  localise to 
different structural regions of the nucleolus; dense fibrillar component (black), 
granular component (dark grey) and the fibrillar centres (grey).
113 RESULTSFigure 3.6
Molecular Composition of Nucleoli from Striatal Neurons
Photomicrographs showing immunoreactivity for a variety of nucleolar proteins in striatal neurons from 10- 
week-old  mouse.  The  UBF  (A),  fibrillarin  (B/C),  Nopp140  (D),  C23  (E),  and  RNA  Polymerase  I  (F) 
immunoreactive nucleoli are indicated with arrows.
The  UBF  (A)  immunoreactivity  reveals  a  pale  nucleoplasm  with  infrequent  nucleolar  staining.  The 
nucleolar immunoreactivity appears as spherical foci in the nucleus (black arrows).
The fibrillarin  (B)  immunoreactivity using  17C12  antibody  shows  an  intense  nucleolar staining  (black 
arrows) with  diffuse  nucleoplasmic stain.  It is  possible to  see that some  nuclei contain  more than  1  
nucleolus.
The fibrillarin (C) immunoreactivity using Abeam antibody also shows intense nucleolar staining  (black 
arrows) and a diffuse nucleoplasmic stain.
The Nopp140 (D) immunoreactivity reveals a pale nucleoplasmic stain together with nucleolar staining 
(black arrow).  The nucleolar staining appears as a spherical structure that has a pale centre and a more 
intense peripheral ring.  It is also possible to distinguish nucleolar-associated CBs (white arrowhead).
The C23 (E) immunoreactivity shows nucleolar staining as a round nuclear foci  (black arrows) which has 
an outer ring of more intense staining.  Nucleoplasmic staining can also be seen and some nuclei have 
more RNA POL I (F) immunoreactivity shows nucleoplasmic staining with infrequent, irregular nuclear foci 
(black arrows).  (A-F) Scale bar= 10, po*
114 RESULTSFrom my ultrastructural analysis of the murine striatum, it appears that most 
striatal  nuclei  contain  only one  nucleolus.  To  confirm  this  result,  100  nuclei 
were analysed and the number of nucleoli seen  using three different nucleolar 
markers were  recorded.  The average  numbers were as follows for fibrillarin 
1.21+/-0.04,  Nopp140  1.21+/-0.04  and  C23  1.21+/-0.04  (graph  3.3A).  The 
antibody from Abeam against fibrillarin  showed  that 79%  of nuclei  contained 
one nucleolus and only 21% contained two nucleoli.  Similar results were seen 
with Nopp140 and C23 (graph 3.3B).
I  have  further  analysed  the  ultrastructural  distribution  of some  of these 
proteins.  Using  pre-embedding immuno-electron microscopy with  DAB,  I was 
able to see that fibrillarin  had a heterogeneous distribution over the nucleolus 
and  was  localised  to  the  entanglement  of  dense  fibrillar  component  and 
granular component of the nucleolus (figure 3.7A/B).  Unfortunately none of the 
other nucleolar antibodies worked due to the fixation needed for the antibodies 
to work (table 2.1) and the fixation needed for immuno-EM.
In  the  course  of my  studies  I  looked  at the  distribution  of the  chaperone 
Hsc70 and,  using  light microscopy, the staining  appeared to concentrate in a 
spherical structure in the striatal nuclei (data not shown).  The immunoreactivity 
was  not like that for fibrillarin as the staining was  heterogeneous.  When this 
was repeated for pre-embedding immuno-electron microscopy with DAB, it was 
clear that Hsc70 was localised to the nucleolus but only at the periphery (figure 
3.7C/D).
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Graph 3.3
Analysis of the Molecular Composition of Nucleoli in Murine Striatal Nuclei
(A) A histogram showing the average number of nucleoli per nuclei when analysed with antibodies to three 
different nucleolar proteins in 10-week-old mouse. Error bars are standard errors of mean.
(B) A histogram showing the percentage of nuclei that contained either one or two nucleoli when quantified 
with antibodies to three different nucleolar proteins in 10-week-old mouse.  Most nuclei when analysed with 
any of the three proteins have only one nucleolus
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Molecular Composition of Nucleoli from Striatal Neurons
(A) and (B) Electron micrographs of fibrillarin immunoreactivity in striatal neurons from  10- 
week-old  mouse.  The  immunoreactivity  clearly  shows  that fibrillarin  is  localised  to  the 
entanglement of Dense Fibriilar Component and the Granular Component of the nucleolus 
(black arrows).
(C)  and  (D)  Electron  micrograph  of Hsc70  immunoreactivity  in  striatal  neurons from  10- 
week-old  mouse.  The  staining  reveals  that  Hsc70  is  localised  to  periphery  of  the 
nucleolus (black arrows).
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The functional  role of the Cajal  body (CB)  has yet to  be defined^but it has 
been suggested to play a role in snRNP biogenesis because of the functions of 
some of the proteins that have been shoMto concentrate in  CBs.  I  analysed 
the  molecular  composition  of CBs  in  the  murine  striatum  at  different  ages. 
Using  immunocytochemistry  I  have  defined  CBs  as  a  nucleoplasmic  foci 
staining intensely with a given antibody.
p80 coilin is a nucleoplasmic-shuttling phosphoprotein that is known as the 
molecular marker of CBs (chapter 1.2.2) and  immunocytochemistry using the 
204/10 p80 coilin antibody (a gift from A.I Lamond, Dundee,  UK) revealed CBs 
as  well  as  a  diffuse  nucleoplasmic  staining  (figure  3.8A).  Using  light 
microscopy,  the  number of p80  coilin  positive  CBs  ranged  from  1   to 4  and, 
when  100  nuclei were analysed, the average number of per nuclei being 2.29 
+/-0.1  at 4 weeks of age and 2.35 +/-0.09 at 12 weeks of age (table 3.1). The 
size of p80 coilin positive CB within nuclei varied and as the average diameter 
was generally less than 0.5 pm it was not possible to measure them  using the 
light  microscope.  This  staining  pattern  did  not  change  from  4  weeks to  12 
weeks.
snRNPs  (small  nuclear  ribonucleoprotein  particles)  have  previously  been 
reported  to  accumulate  in  CBs  as  part  of  a  maturation  pathway  and 
immunocytochemistry using an antibody generated against U2” snRNP labelled 
CBs (figure 3.8E). The average number of CBs that contained U2” snRNP was 
0.88+/-0.06 at 4  weeks  of age  and  at  12 weeks  of age this  number had  not 
changed and remained at 0.88+/-0.06 (table 3.1).
p8Q coilin 2.29+7-0  1 2.4+7-0.08 2.35+7-0.09
U2" snRNP 0.88+/-0.06 0.89+7-0.06 0.88+7-0.06
Table 3.1
A  table  showing  the  average  number  of  CBs  per  nucleus  for  either  p80  coilin  or  U2”  
snRNP at different ages.
118 RESULTSFigure 3.8
Light Microscopy Immunostaining of Cajal Bodies from Murine Striatal Nuclei.
Photomicrographs  showing  immunoreactivity  for  a  variety  of  Cajal  body  proteins  in  nuclei  of  striatal 
neurons from  10-week-old  mice.  The p80 coilin  (A),  SMN  (B),  Gemin2 (C),  Gemin4  (D),  U2 snRNP  (E), 
Gemin3  (F),  PAP  (G)  and  EWS  (H)  immunoreactive  CBs  are  indicated  by  black  arrows  and  a  diffuse 
nucleoplasmic stain can also be seen.  The p80 coilin (A) immunoreactivity shows that more than  one CB 
can be seen using this CB marker whereas immunoreactivity for all the other CB proteins reveal only one 
CB per nucleus.  Scale bar = 10  ym
119 RESULTSSMN, the Survival of Motor Neuron protein, has been seen in CBs and gems 
depending  on  the  cell  type  (chapter  1.2.6).  In  murine  striatal  neurons, 
immunoreactivity for an antibody against SMN was localised to nuclear foci as 
well as showing a diffuse nucleoplasmic and cytoplasmic staining pattern (figure 
3.8B).  Due to the number and size of these foci,  I  believe that they are CBs. 
Usually  only  one  CB  per  nuclei  was  seen  with  the  SMN  antibody  but 
occasionally nuclei did contain 2-3 CBs and the average number was  1.16 +/- 
0.06 at 10 weeks of age (graph 3.4A). SMN can be found in the nucleus as part 
of a macromolecular complex, the SMN Complex, and Gemin2 to 7 have been 
shown to form part of this complex (chapter 1.2.8).  Antibodies against Gemin2 
and  Gemin4  both  showed  a  similar  staining  pattern:  cytoplasmic,  faint 
nucleoplasmic  and  bright  CB  (figure  3.8C/D).  Gemin4  did  not  label  the 
nucleolus although it is suggested that it has been detected there (Charroux et 
a/.,  2000).  The Gemins,  like SMN,  more frequently stained  only one  CB  per 
nuclei with the average for Gemin2 being 1.09+/-0.06 at 10 weeks of age (graph 
3.4A).  Graph 3.4A shows that at 10 weeks of age in the murine striatum, the 
only  Cajal  body  protein  on  average  to  be  found  in  more  than  one  CB  per 
nucleus was p80 coilin.  The other Cajal body proteins that I analysed generally 
were only found to localise in one CB per nucleus and this did not change from 
4 weeks to 12 weeks of age.
Antibodies against other proteins that have been previously shown to 
localise  in  CBs were also  used to see where they were distributed  in  murine 
striatal  nuclei.  Cleavage  and  polyadenylation  specificity  factor  (CPSF)  is 
involved  in  mRNA  polyadenylation  and  plays  a  role  in the splicing  of single- 
intron pre-mRNAs.  It has been suggested that  it has a CB or gem localisation 
(Hofmann  et a/.,  2002).  Profilin binds to and sequesters actin monomers and 
therefore  is  involved  in the  regulation  of actin  polymerisation.  Although  it  is 
found  in axonal and dendretic processes in the mouse brain,  more recently it 
has been found  in CBs (Giesemann et al.,  1999;  Skare et al.,  2003).  SmB  is 
one of the core  proteins that are found  in  all  major snRNPs,  which  form the 
major component of the spliceosome.  A diffuse distribution of CPSF,  profilin 
and SmB immunoreactivity was observed in the nucleoplasm (data not shown). 
Gemin3 forms part of the SMN complex and  interacts with SMN  (Campbell et 
al.,  2000).  Poly(A)  polymerase (PAP)  is  involved  in the  polyadenylation of 3’
120 RESULTSprime ends of mRNA (Schul et al.,  1996).  Ewing’s sarcoma (EWS)  is a  RNA" 
binding  protein  and  it  also  interacts  with  SMN  (Young  et  al.,  2003). 
Immunoreactivity for Gemin3, PAP and EWS appeared as darkly stained foci in 
the nucleus and the size of these foci are characteristic of Cajal bodies but they 
appeared infrequently (figure 3.8F-H).
I  used  pre-embedding  immuno-electron  microscopy with  DAB for some of 
the  antibodies  against  CB  proteins  to  see  if  the  structures  seen  at  light 
microscopy correlated with the CBs seen ultrastructurally, and, to see if there 
was a difference in staining  between the CB at different localisations.  Using 
anti-p80 coilin it was possible to see staining associated with the nucleolus as 
infrequent nucleolar-associated  CBs  (figure 3.9A-B)  or a very thin  ring  at the 
nucleolar periphery (figure 3.9C-D).  This technique allowed the visualisation of 
on average only one CB per nuclei and as the immunocytochemistry performed 
at  light  microscopy  showed  nuclei  contained  1-3  CBs,  it was  apparent that 
immuno-electron microscopy was not going to allow me to see all CBs, which 
proteins they contained, and, their relationships with other nuclear domains.
To tackle this problem, I used double labelling confocal microscopy.  Pyronin 
Y labels RNA and as the nucleolus contains a high focal concentration of RNA it 
can be clearly distinguished in the nucleus, which contains a lower, more diffuse 
distribution of RNA.  Pyronin Y can be seen in the red channel of the confocal 
microscope  so  it can  be  used  in  conjunction  with  the fluorescent secondary 
antibody FITC.  I used Pyronin Y with either p80 coilin or SMN antibodies to see 
if the number of CBs was different depending on which CB marker was being 
used  to  visualise  them  and  to  ascertain  if  CBs  in  different  localisation’s 
(nucleolar-associated  or free)  have  different  molecular  compositions  (figure 
3.10).
The confocal microscope allows entire nuclei to be visualised by carrying a Z- 
series scan.  Although  it was thought that many antibodies only penetrate the 
top one to two microns of tissue, from my confocal studies this was seen to be 
inaccurate.  The average diameter of a murine striatal nucleus is approximately 
10  pm   and  when  a  Z-series was  completed  antibody staining  could  be  seen 
throughout the whole nucleus.
121 RESULTSFigure 3.9
Molecular Composition of Cajal Bodies Murine Striatal Nuclei
Immuno-Electron Microscopy of Cajal bodies in 10-week-old mouse with antibodies to p80 coilin
(A and  C)  Low power electron  micrographs of p80  coilin  immunoreactivity  (black arrows).  (B  and  D)
High power electron micrographs of p80 coilin immunoreactivity.
(A and B) A deposition of DAB reaction product labels a CB at the nucleolar periphery (black arrows).
(C  and  D)  A deposition  of DAB  reaction  product  labels the  periphery  of the  nucleolus with  no  visible 
Cajal bodies.
122 RESULTSFigure 3.10
Localisation of Cajal Bodies in Murine Striatal Nuclei
Confocal Microscopy Immunofluorescence of Cajal bodies in 10-week-old mouse
(A)  p80 coilin immunofluorescence (green) in conjunction  pyronin Y staining  (red) 
shows the  distribution  and  different  localisations of CBs  in  a  Z-series  stack.  In 
most visible nuclei it is possible to see between two and four nucleolar-associated 
CBs  (small white  arrows)  and  the  nucleolus can  be  seen  as  an  accumulation  of 
pyronin Y staining in the nucleus.
(B)  SMN  immunofluorescence  (green)  in  conjunction  pyronin  Y  staining  (red) 
shows the distribution and different localisations of CBs in a Z-series stack.  Most 
nuclei show one CB that is nucleolar-associated (white arrows).
123 RESULTSUsing the confocal microscope,  I analysed  100 reconstructed nuclei, which 
contained  CBs that were immunoreactive for either p80 coilin or SMN  (figure 
3.10A-B).  Labelling with the 204.9  p80  coilin  antibody coupled  with  a  FITC 
labelled secondary antibody showed striatal  nuclei contained  between one to 
four CBs (table 3.2) and, like those seen using light microscopy, varied in size 
from approximately 0.1  p rv\  to 0.3  jjm  in diameter (figure 3.10A).  The average 
number of CBs  per nucleus was 2.53+/-0.09 (graph  3.4B) and 47% of nuclei 
contained 2 CBs (table 3.2).  When the p80 coilin antibody was substituted with 
SMN antibody only one to two CBs were seen per nucleus (table 3.2). 84% of 
nuclei contained only one SMN positive CB and the average number of CBs per 
nucleus was 1.16+/-0.04 (graph 3.4B).
Table 3.2
A  table  showing  the 
percentage of nuclei that 
contained  1,2,3 or 4 CBs 
containing  either  p80
coilin  or  SMN.  Chi-
Square  test  for
independence  (X2S = 
53.43; p<0.001).
The  localisation  of CBs was  analysed  in  murine  striatal  nuclei  using  the 
same two CB protein  antibodies and  CBs were recorded as either nucleolar- 
associated  or free  in  the  nucleoplasm.  Anti-p80  coilin fluorescence showed 
89% of the total number of CBs were found to be nucleolar-associated and only 
11% of CBs were free in the nucleoplasm  (graph  3.4C).  99% CBs  identified 
using  SMN  antibody were nucleolar-associated  (graph 3.4C) and all of these 
CBs appeared to  be similar in size whereas p80 coilin  positive CBs varied  in 
size. p80 coilin and SMN fluorescence staining also revealed that some nuclei 
contained  both  nucleolar-associated  and  free  CBs.  For p80  coilin  CBs  this 
occurred in 10% of the total number of nuclei analysed but for SMN CBs it was 
only seen in 1% of nuclei.
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Graph 3.4
Analysis of the Molecular Composition of Cajal Bodies in Murine Striatal Nuclei
(A) A histogram showing the average number of CBs per nuclei when analysed with antibodies to different CB 
proteins using a light microscope in 10-week-old mouse.  Apart from p80 coilin, all other CB proteins only 
reveal one CB per nucleus on average.  Oneway ANOVA (F = 47.63; p<0.001).  Error bars are standard errors 
of mean.
(B) A histogram showing the average number of CBs per nuclei when analysed with antibodies to either p80 
coilin or SMN using a confocal microscope in 10-week-old mouse.  A Z-series was performed and entire nuclei 
reconstructed and CBs counted. p80 coilin appears to be present in more CBs compared to SMN.  Student’s 
unpaired f-test (t = 15.40; ***p<0.001).  Error bars are standard errors of mean.
(C) A histogram showing the percentage of CBs that are either free or nucleolar-associated  seen  using either 
antibodies  to  p80  coilin  or SMN  in  10-week-old  mouse.  Very  few  free  SMN  positive  CBs  were  seen.  Chi- 
Square test for independence (X2S = 8.95; p<0.01).
125 RESULTSAs  the  confocal  microscope  allows  double  labelling  to  be  performed,  I 
decided to ascertain whether murine striatal nuclei contained gems by seeing if 
SMN  and  p80 coilin  are found  in the same  nuclear structure.  Using  DAPI  to 
show the  nucleus  and  FITC  and  TRITC  secondary  antibodies  I  was  able  to 
show that SMN and p80 coilin do colocalise in CBs (figure 3.11).
Ever  since  Cajal  first  identified  CBs  in  neuronal  cells  and  called  then 
Accessory bodies of the nucleolus, it has been assumed that the nucleolus and 
Cajal bodies have a close relationship.  This relationship is not only a spatial 
relationship due to their often close localisation  but it is  molecular as well.  A 
number of nucleolar proteins have been reported to colocalise in CBs (chapter 
1.2.5).  To see  if this occurs  in  murine striatal  nuclei,  I  used  double  labelling 
confocal  microscopy to  analyse the  relationship  between  p80  coilin  and  the 
nucleolar protein fibrillarin.  Immunofluorescence for p80 coilin  labelled  CBs 
and  the  nucleoplasm  whereas  immunofluorescence  for  fibrillarin  revealed 
nucleoli  and  some  nucleolar-associated  CBs as expected.  When  a Z-series 
stack  was  performed  through  entire  nuclei  and  the  two  sets  of 
immunofluorescence overlaid it was possible to see that the p80 coilin positive 
CBs  were  associated  with  the  nucleolus  and  colocalised  with  the  fibrillarin 
positive  CBs  at  the  periphery  of  the  nucleolus  (figure  3.12)  and  some 
nucleoplasmic CBs (data not shown).
126 RESULTSFigure 3.11
Molecular  Composition  of  Cajal  Bodies  from  Murine  Striatal 
Nuclei
Confocal Microscopy Immunofluorescence of Cajal bodies 
Triple  labelling  indirect  immunofluorescence  using  antibodies 
to p80 coilin  (A) and  SMN  (B) together with  DAPI to show the 
nucleus  (blue).  The  immunofluorescence  for  both  proteins 
reveals  one  nuclear  foci  (white  arrows)  and  when  they  are 
overlaid  (C)  it  is  possible  to  see  that  p80  coilin  and  SMN 
colocalise  (yellow)  in  the  same  nuclear  foci  which  is  a  CB 
(white  arrow)  but the  colocalisation  is  not complete  as  some 
red is visible.
127 RESULTSFigure 3.12
Confocal Microscopy  Immunofluorescence of Cajal  Bodies from  Murine 
Striatal Nuclei
Double  labelling  indirect  immunofluorescence  using  antibodies  to 
fibrillarin (A) and p80 coilin (B).
(A)  Fibrillarin  immunofluorescence  reveals  specific,  nucleolar  staining 
that is indicated by white arrows.  The immunofluorescence of fibrillarin 
is  not solid  throughout the  nucleolus  but appears to  have  an  irregular, 
‘patchy’ distribution.
(B)  p80 coilin  immunofluorescence  reveals Cajal  bodies  (white arrows) 
and a nucleoplasmic distribution that excludes the nucleolus.
(C) The overlay of (A) and (B) shows that the CBs revealed,  using a p80 
coilin  antibody,  are  nucleolar-associated  CBs  (white  arrows)  and  that 
these CBs also contain fibrillarin (yellow).
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Many proteins that are involved in pre-messenger RNA splicing are found in 
speckles,  I  have  analysed  the  molecular composition  of speckles  in  striatal 
neurons of the mouse.  A monoclonal anti-splicing factor SC35 antibody reacts 
with  2  non-snRNP  splicing  factors:  SC35  and  with  the  SC35-related  factor 
SF2/ASF.  Immunocytochemistry using this antibody labels SC35 as a speckled 
pattern  in  the  nucleoplasm,  excluding  the  nucleolus  (figure  3.13A).  The 
speckled distribution consists of numerous irregularly shaped nuclear foci that 
are  all  suggested  to  be  interconnected.  Two other proteins  involved  in  pre- 
mRNA  splicing,  HYPA  and  HYPC  also  showed  a  similar  speckled  staining 
pattern  (figure  3.13B).  An  antibody  specific  for  2,2,7-trimethylguanosine 
(m3G/TMG),  which  forms  part  of a  complex with  snRNPs,  labels TMG  as  a 
speckled  pattern  occupying  a  portion  of  the  nucleoplasm  excluding  the 
nucleolus (figure 3.13C).
A recently identified nuclear domain that is closely related to the speckle is 
the paraspeckle (Fox et al., 2002) and a protein that has been shown to localise 
to  paraspeckles  is  Paraspeckle  Protein  1  (PSP1).  To  see  if murine  striatal 
nuclei have paraspeckles, double labelling immunofluorescence was performed 
using an antibody to PSP1  and an antibody against a protein that is localised to 
speckles, TMG (figure 3.14).  Immunofluorescence for both antibodies showed 
a nuclear distribution  but when the images were overlaid only a small area of 
co-localisation  was  seen  and  therefore  striatal  neuronal  nuclei  do  contain 
paraspeckles.
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Figure 3.13
Light Microscopy  Immunostaining of Speckles from Murine Striatal 
Nuclei
Photomicrographs  showing  immunoreactivity  for  a  variety  of 
speckle  proteins  in  striatal  neurons from  10-week-old  mice.  The 
SC35 (A),  HYPA (B)  and TMG  (C)  proteins localise  in  a  speckled 
nuclear  pattern  and  are  also  diffusely  distributed  throughout  the 
nucleoplasm (black arrows).
130 RESULTS3.3 Ultrastructure of R6/2 Neuronal Nucleus
In  10-week-old R6/2 transgenic mice, nuclei of striatal neurons have a round 
to oval shape and frequently have a prominent membrane invagination.  They 
have a normal, dispersed distribution of chromatin with the occasional body of 
condensed chromatin.
3.3.1  Ultrastructure of R6/2 Neuronal Nucleolus
To study the effects of Huntington’s disease (HD) on nucleolar morphology, I 
have analysed  nucleoli of the striatal neurons in  10^/veek-old  R6/2 transgenic 
mice.  Nuclei containing nucleoli were randomly sampled.
From  my analysis of R6/2  striatal  neurons  it is  possible to determine that 
most cells are mononucleolated  (87%) and  occasionally binucleolated  (13%). 
No nuclei contained more than 2 nucleoli.  The mean number of nucleoli per cell 
is 1.13+/-0.03.
Using  the  previously described  nucleolar classes/ultrastructures  (chapter 
3.1.2),  it is possible to divide the R6/2 nucleoli into the same classes:  closed- 
reticulate structure (CRS) and open-reticulate structure (ORS).  However, there 
is  also  a  third  class  that  has  not  been  reported  in  the  wild  type  neuronal 
nucleus.  I  have  termed  this  the  segregating  structure  (SS)  and  it  will  be 
described below.
The CRS was seen  in  37% of the cells that were examined  (graph  3.5A), 
and it is defined as an ordered ultrastructure that reveals small fibrillar centres 
(FCs) surrounded by a dense material that consists of an entanglement of the 
dense  fibrillar  component  (DFC)  with  the  granular  component  (GC)  (figure 
3.15A).  These nucleoli are spherical and have an average diameter of 0.84+/- 
0.04  (graph 3.5B).
The CRS nucleoli can have a perinucleolar cap (PNC) and it is an electron 
dense structure that lies adjacent to the nucleolus.  It seems to be composed of 
matter that iS v  similar in appearance to the FCs.  It has an irregular shape and 
can be smaller or larger than the nucleolus itself.  Perichromatin granules (PGs) 
and perichromatin fibrils (PFs) are also seen at the nucleolar periphery.
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Graph 3.5
Analysis of the Class and Diameters of Nucleoli in R6/2 Striatal Nuclei
(A) A histogram showing the percentages of nucleoli that show an open-reticulate structure (ORS), a closed- 
reticulate structure (CRS) ora segregating structure (SS) in 10-week-old R6/2 transgenic mice.  A 95% 
confidence interval that the probability of ORS is between 33% and 52%, for CRS is between 28% and 47%, 
and for SS is between 14% and 30%.
(B) A histogram showing the average diameters of ORS, CRS and SS nucleoli in 10-week-old R6/2 transgenic 
mice.  It is possible to see that SS nucleoli have a slightly larger average diameter compared to the ORS and 
CRS nucleoli. Error bars are standard errors of mean.
133 RESULTSFigure 3.15
Electron micrographs of Nucleoli in R6/2 Striatal Nuclei
(A) The ultrastructure of a CRS nucleolus (n) from a striatal neuron of 1(hweek-old R6/2 transgenic mouse. 
This nucleolus has small FCs that are engulfed in a twisted mass of DFC and GC.  There is a CB  (white 
arrow) and a  neuronal  intranuclear inclusion (nii).  It is also possible to see perichromatin granules (PGs) 
(white arrowhead).
(B)  The  ultrastructure  of an  ORS  nucleolus  (n)  from  a  striatal  neuron  of  10-week-old  R6/2  transgenic 
mouse.  As in (B) large FCs are visible (black arrows) that are surrounded by the DFC/GC entanglement.
(C) The ultrastructure of a  segregating structure (SS)  nucleolus (n) from a striatal neuron of 10-week-old 
R6/2 transgenic mouse.  The compact nucleolar morphology appears to  be fragmenting.  Medium sized 
FCs  (black arrows) are seen and the  DFC/GC  seem to forming  small  microspheres that are segregating 
from each other.  Due to this fragmenting intranucleoar vacuoles appear to be present (black arrowheads). 
A perinuceloar cap (PNC) (*) is also present together with a neuronal intranuclear inclusion (nii).
134 RESULTSThe ORS was seen in 42% of nuclei that were examined (graph 3.5A) and in 
this  class  of  nucleoli,  a  very  disordered  ultrastructure  can  be  seen  (figure 
3.15B).  Some  FCs  of the  ORS  nucleoli  are  very  large  and  can  occupy  a 
substantial portion of the nucleolar volume.  Smaller FCs are seen too and both 
types of FCs are frequently located  at the periphery of the  nucleolus and  not 
engulfed by the dense material that constitutes the rest of the ORS nucleolus. 
Similar to the CRS nucleoli this dense material seems to be composed of the 
DFC and the GC entangled together.
The  ORS  nucleoli  can  also  have  a  PNC,  PGs  and  PFs,  all  of which  are 
similar to that described for the  CRS  nucleoli.  The  ORS  nucleoli  are  not as 
spherical  as  the  CRS  nucleoli  and  the  average  diameter  is  0.89+/-0.04 pi* 
(graph 3.5B).
The third class of nucleolus,  seen  only in the  R6/2  striatal  neurons,  is the 
segregating  structure  (SS).  The  SS  nucleoli  showed  alterations  in  the 
organisation of nucleolar components that were not observed in either the CRS 
or the ORS  nucleoli  (figure  3.15C).  A frequent change was the formation  of 
numerous FCs that are larger than the FCs of the CRS but not as greater size 
as  those  in  the  ORS.  The  GC/DFC  entanglement  appears  to  be  forming 
microspheres which are  seen  as  particles  surrounded  by  a  clear  halo.  This 
causes the formation of intranucleolar vacuoles.  The nucleolus appears to be 
segregating and fragmenting.
The SS nucleoli are seen in 21% of cells observed (graph 3.5A) and have an 
average diameter of 0.99+/-0.06  p iA  (graph 3.5B).  These nucleoli have a very 
irregular  shape  and  they  can  also  have  a  PNC  that  resembles  that  of the 
CRS/ORS nucleoli as well as PGs and PFs.
3.3.2 Ultrastructure of R6/2 Neuronal Cajal Bodies
As  part  of  the  study  on  the  effects  of  HD  on  the  neuronal  nuclear 
ultrastructure,  I  decided to examine the  morphology and  distribution  of Cajal 
bodies in R6/2 transgenic mouse at 10 weeks of age.  At the ultrastructural level 
only  28%  of striatal  neurons  examined  contained  a  distinct  CB.  The  basic
135 RESULTSmorphology of the CBs in R6/2 nuclei was the same as that seen in the normal 
murine  neuronal  nuclei.  Most CBs were of round to oval  in  shape and  were 
composed  of coiled  strands  of fibrillar  material  surrounded  by  a  low-density 
amorphous matrix.  Many CBs also had tiny fibrils radiating from their periphery 
into the nucleoplasm.
On examining the spatial relationship between the CBs in the R6/2 neurons 
and other nuclear domains a striking discovery was made.  The CBs frequently 
occurred  in  association with  the  nucleolus  (31%)  or free  in  the  nucleoplasm 
(23%)  but  most  were  seen  in  close  proximity  to  the  neuronal  intranuclear 
inclusion  (NII)  (46%)  (graph  3.6A).  There were no morphological differences 
between the CBs in any localisation (figure 3.16).  The average diameter of the 
nucleolar-associated,  nucleoplasmic  and  Nil-associated  CBs  were  0.24+/- 
0.03 pm, 0.28+/-0.03 pw  and 0.36+/-0.02 pm  respectively (graph 3.6B).
The  nucleolar-associated  CBs  are  seen  to  protrude  from  the  nucleolar 
periphery and are in direct continuity with the nucleolus.  In some cases the Nil- 
associated CBs are seen to be in direct contact with the NII periphery or the tiny 
fibrils radiating from the CB are touching the NII.  Infrequently, it was possible to 
see a CB in close proximity to the nucleolus and a Nil.
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Graph 3.6
Analysis of Cajal Bodies in R6/2 Striatal Nuclei
(A) A histogram showing the percentages of CBs that are free in the nucleoplasm, nucleolar-associated or Nil- 
associated in  10-week-old R6/2 transgenic mice.  Nearly half the CBs are Nil-associated in the R6/2 striatal 
neurons. A 95% confidence interval that the probability of nucleolar CBs is between 23% and 41 %, for free 
CBs is between 16% and 32%, and for Nil CBs is between 37% and 56%.
(B) A histogram showing the average diameters of free, nucleolar-associated or Nil-associated CBs in  10- 
week-old R6/2 transgenic mice.  The Nil-associated CBs appear to have greater average diameters compared 
to those of the free or nucleolar-associated CBs. Oneway ANOVA (F = 5.94; p<0.01).  Error bars are standard 
errors of mean.
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Electron micrographs of Cajal Bodies from R6/2 Striatal Neurons
(A) The ultrastructure of a nucleolar-associated CB (black arrow) from a striatal neuron from  10-week-old 
R6/2 transgenic mouse.  The CB is in direct contact with the nucleolar periphery.  The CB is composed of 
dense coiled threads embedded in a less dense matrix. The nucleolus (n) has a SS morphology and has a 
perinucleolar cap (PNC) (<»).
(B) The fine structure of a free, nucleoplasmic CB (black arrow) in a striatal neuron from  10-week-old R6/2 
transgenic mouse.  The  CB  is  composed  of dense  coiled  threads  that  are  embedded  in  an  amorphous 
matrix.  It is possible to see small fibres radiating from the edge of the CB  (white arrowheads).  The CB 
does not have any spatial relationship with other nuclear domains.
(C) The ultrastructure of a  Nil-associated CB  (black arrow) from a striatal neuron from  10-week-old  R6/2 
transgenic mouse.  The CB  is in direct contact with a  Nil  (nii) and  has the characteristic CB morphology. 
Small radiating fibres can be seen around the CB (white arrowhead) together with fibres that appear to be 
connecting the CB to the NII (pink arrowhead).
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I have analysed the morphology of speckles in  10-week-old R6/2 transgenic 
mice.  Speckles are the nuclear domains where pre-mRNA splicing factors are 
localised  and  are  composed  of  interchromatin  granule  clusters  (IGCs)  and 
perichromatin fibrils (PFs) at the ultrastructural level.  Due to the irregular shape 
of the  IGCs,  which  constitute  the  major  part  of  speckles,  it  has  not  been 
possible to quantify the speckles in the R6/2 transgenic mouse.  It is possible to 
identify them and distinguish the numerous granules that are interconnected via 
thin fibrils, which are the PFs (figure 3.17).
3.3.4 Ultrastructure of R6/2 Neuronal NII
In  10-week-old  R6/2 transgenic mice  neuronal  intranuclear inclusion  (Nil) 
can  be seen in the nucleus of striatal neurons.  NIIS are round structures that 
are easily distinguishable from the  surrounding  chromatin.  They are  pale  in 
appearance and  composed  of fine granular material  (figure  3.15A  &  3.16C). 
Occasionally,  Nils  may  have fibrous elements,  but these  are  relatively  rare. 
Nils are approximately 1.5 to 2 pm in diameter.
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Figure 3.17
Electron micrographs of Speckles from R6/2 Striatal Neurons
(A)  The fine  structure  of speckles  (black  arrowheads)  in  a  striatal  neuron 
from  10-week-old  R6/2 transgenic mouse.  The  speckles  are  composed  of 
perichromatin  fibrils  (PFs)  and  interchromatin  granule  clusters  (IGCs). 
IGCs represent the main part of speckles and comprise of granules that ap­
pear to be connected with fibres.
(B) Same image as (A) but the IGCs have been highlighted in pale blue.
1 4 0 RESULTS3.4 Molecular Composition of R6/2 Neuronal Nucleus
In these studies  I  have attempted to analyse the molecular organisation  of 
the R6/2 transgenic mouse neuronal nucleus using the same antisera that was 
used to ex^rfhine the murine neuronal  nucleus.  I wished to determine  if there 
were any changes  in the subnuclear localisation  of proteins found within the 
nucleus due to HD.
3.4.1  Molecular Composition of R6/2 Neuronal Nucleolus
As  described  previously  the  nucleolus  has  been  shown  to  contain  three 
structurally  distinct  regions:  the  fibrillar  centres,  the  dense  fibrillar  and  the 
granular  components  (figure  3.5).  To  see  if  any  changes  occur  in  the 
distribution of nucleolar proteins  in  HD,  a  number of nucleolar markers were 
examined using immunocytochemistry.
Fibrillarin  is  one  nucleolar protein  that  is  used  as  a  marker of the  dense 
fibrillar  component  of the  nucleolus.  In  the  nuclei  of  R6/2  striatal  neurons 
fibrillarin  immunoreactivity was  localised to the  nucleolus  (figure 3.18A).  No 
nucleoplasmic staining  was  seen  but  intense,  spherical  nucleoli were visible 
together with  nucleolar-associated  Cajal  bodies.  It was  also  possible to see 
free Cajal bodies labelled with fibrillarin immunoreactivity.
The  nucleolar protein,  Nopp140,  has been  reported to be  localised  in the 
dense fibrillar component of the  nucleolus and  in the  R6/2  striatal  nuclei,  an 
antibody  against  Nopp140  revealed  nucleoplasmic  and  nucleolar  staining 
(figure 3.18C).  At high  magnification this nucleolar immunoreactivity could  be 
seen  as  a  ring  at  the  nucleolar  periphery  with  a  pale  centre.  Nucleolar- 
associated Cajal bodies could be seen as very distinct structures adjoining the 
nucleolus while free Cajal bodies were also visible.
C23  (nucleolin)  is another nucleolar protein and  it is  usually located  in the 
granular component.  An  antibody  against  C23  showed  pale  nucleoplasmic 
immunoreactivity and  nucleolar staining (figure 3.18B).  At high magnification, 
staining  of the  nucleolus  appears  to  be  only  a  subtle  ring  at the  nucleolar 
periphery and  infrequent free  CBs.  B23  (nucleophosim)  is  also  reported  to 
localise to the granular component of the nucleolus but when I used an antibody
141 RESULTSto this protein no immunoreactivity could be seen in the R6/2 transgenic mouse.
A nucleolar protein that is used as a marker for fibrillar centres is upstream 
binding factor (UBF).  Unfortunately the  UBF antibody revealed  no staining  in 
the  R6/2  transgenic  mouse.  RNA  polymerase  I  is  also  localised  to fibrillar 
centres  and  when  I  used  an  antibody  against this  protein  a  heterogeneous 
nucleoplasmic staining was seen (figure 3.18E).
An  essential  enzyme that mediates  a variety  of chromosome activities  is 
DNA  topoisomerase  II  (topo  II)  and  it  has  been  shown  to  localise  in  the 
nucleolus (Zini et a/.,  1994).  In the nuclei of R6/2 striatal neurons, an antibody 
against topo II shows nucleoplasmic labelling as well as staining the nucleolus 
(figure 3.18D).  The immunoreactivity is a rim at the edge of the nucleolus and 
adjoining nucleolar-associated Cajal bodies.  No free Cajal bodies were seen.
I analysed 100 nuclei to establish the average number of nucleoli per nuclei. 
In  R6/2  striatal  nuclei  the  average  numbers  seen  were  as  follows  fibrillarin 
1.14+/-0.04,  Nopp140  1.20+/-0.04  and  C23  1.27+/-0.04  (graph  3.7A).  The 
antibody from Abeam  against fibrillarin  showed  that 86%  of nuclei  contained 
one nucleolus and only 14% contained two nucleoli.  Similar results were seen 
with Nopp140 and C23 (graph 3.7B).
As I had discovered that the chaperone Hsc70 was localised to the nucleolar 
periphery in nuclei of murine striatal neurons using immuno-EM (chapter 3.2.1),
I  decided to  look at the localisation of this protein  in the  R6/2 striatal  nuclei. 
Using pre-embedding  immunogold electron microscopy it was possible to see 
that  Hsc70  did  not  localise  to  the  periphery  of  the  nucleolus  in  the  R6/2 
transgenic mice.  Instead Hsc70 colocalised with the Nil (figure 3.19).
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Figure 3.18
Molecular Composition of Nucleoli from R6/2 Striatal Neurons
Photomicrographs showing immunoreactivity for a variety of nucleolar proteins in striatal neurons 
from  10-week-old  R6/2  mouse.  The fibrillarin  (A),  C23 (B),  Nopp140 (C),  Topo  II  (D) and  RNA 
polymerase  I  (E) immunoreactive nucleoli are indicated with arrows.  Fibrillarin  immunoreactivity
(A)  using  Abeam  antibody  shows  intense  nucleolar  staining  (black  arrows).  C23  (B) 
immunoreactivity  reveals  nucleolar  staining  as  spherical  nuclear  foci  (black  arrow). 
Nucleoplasmic staining can also be seen together with a free CB  (white arrowhead).  Nopp140
(C)  immunoreactivity  shows  a  pale  nucleoplasmic  stain  together with  nucleolar staining  (black 
arrow).  The  nucleolar staining  appears  as  a  spherical  structure  that  has  a  pale  centre  and  a 
more intense peripheral ring.  It is also possible to distinguish free CB (white arrowhead).  Topo II
(D)  immunoreactivity  shows  a  pale  nucleoplasmic  stain  together with  nucleolar  staining  (black 
arrow). The nucleolar staining appears as a spherical structure that has a pale centre and a more 
intense  peripheral  ring.  It  is  also  possible  to  distinguish  nucleolar-associated  CB  (white 
arrowhead).  RNA  polymerase  I  (E)  immunoreactivity  reveals  heterogeneous  nucleoplasmic 
staining.
Scale bar = 10  |jrv\
143 RESULTSB
_  100
®   90
80
70
60
w  50  u \  JU
u
3
Z
4-
0
(Q  
C 
V 
u
*   10 
o
40
30
20
Fibrillarin  C23  Noppl40
Nucleolar Protein
1   2
Fibrillarin  C 23
Nucleolar Protein
Noppl40
Graph 3.7
Analysis of the Molecular Composition of Nucleoli in R6/2 Striatal Nuclei
(A) A histogram showing the average number of nucleoli per nuclei when analysed with antibodies to three 
different nucleolar proteins in 10 week old R6/2 transgenic mouse. Error bars are standard errors of mean.
(B) A histogram showing the percentage of nuclei that contained either one or two nucleoli when quantified 
with antibodies to three different nucleolar proteins in 10 week old R6/2 transgenic mouse.  Most nuclei when 
analysed with any of the three proteins have only one nucleolus.
1 4 4 RESULTSFigure 3.19
Distribution of Hsc70 in R6/2 Striatal Neurons
Electron micrograph of Hsc70 immunoreactivity in  striatal  neurons from a  10-week-old  R6/2 
transgenic mouse.  Pre-embedding  immuno-gold  reveals that  Hsc70  is  localised  NII  (black 
arrow) and not the nucleolus (n).
145 RESULTS3.4.2 Molecular Composition of R6/2 Neuronal Cajal Body
Immunocytochemical studies were carried out, using antibodies to the same 
Cajal body proteins in R6/2 mouse striatum that were used to analyse the wild 
type mouse striatum, at different ages to see if any changes in distribution were 
seen due to HD.  To determine the average number of CBs stained positively 
for a given antibody, the number of CBs seen within  100 nuclei were counted. 
These counts were carried out at 4, 10 and 12 weeks of age in the R6/2 mouse 
(table 3.3).
pSQ coilin 2.54*7-0.09 1.16*7-0.05 1.13*7-0.04
U2' snRNP 0.91 *7-0.04 0.85*7-0.04 0.84*7-0.04
SMN 0.99*7-0.04 0.96*7-0.04 0.96*7-0.04
Gemin2 0.87*7-0.04 0.78*7-0.04 0.94*7-0.05
Table 3.3
A table showing the average number of CBs per nucleus in R6/2 neurons for a number of 
different CB proteins at different ages.
At  4  weeks  of  age  the  antibody  against  p80  coilin  revealed  a  diffuse 
nucleoplasmic staining pattern with  1   to 4 CBs, of different sizes, labelled and 
the average number of CBs per nucleus was 2.54+/-0.09.  At 10 and  12 weeks 
of age, there was a decrease in the number of CBs seen to contain p80 coilin. 
The nucleoplasmic stain was still seen  but generally only one  large CB was 
present (figure 3.20A).  The average number of CBs fell to  1.16+/-0.05 for 10 
weeks of age and 1   13+/-0.04 for 12 weeks of age.
An antibody against U2” snRNP (small nuclear ribonucleoprotein particles) 
revealed generally one CB per nucleus (figure 3.20E) and this staining pattern 
that did  not  change  over the time  period  studied  (0.91+/-0.03,  0.85+/-0.04, 
0.84+/-0.04 at 4, 10, 12 weeks of age respectively).  SMN, the survival of motor 
neuron protein, was seen  in CBs as well as having a cytoplasmic and diffuse 
nuclear distribution (figure 3.20B).  The mean number of CBs containing SMN
146 RESULTSdid not significantly change over the time period with the averages being 0.99+/- 
0.04, 0.96+/-0.04 and 0.96+/-0.04 for 4,  10 and 12 weeks respectively.  Gemin2 
and  Gemin4 showed a very similar distribution as SMN:  localised to CBs,  the 
cytoplasm and  the nucleoplasm (figure 3.20C-D).  For Gemin2 there was no 
significant change in the average number of CBs from 4 to  12 weeks (0.87+/- 
0.04, 0.78+/-0.04, 0.94+/-0.05 at 4,  10,  12 weeks of age respectively).  Graph 
3.8A shows that in the  R6/2 transgenic mouse  at  10 weeks of age,  all  Cajal 
body proteins were generally only found to reveal one CB per nucleus.
Antibodies  against  other  proteins  that  have  been  previously  shown  to 
localise in  CBs were also used to see where they were distributed  in  murine 
striatal  nuclei.  Cleavage  and  polyadenylation  specificity  factor  (CPSF)  is 
involved in mRNA polyadenylation and splicing of single-intron pre-mRNAs.  It 
has been previously reported in CBs or gems (Hofmann et a/., 2002).  Profilin is 
involved in the regulation of actin polymerisation and suggested to be found in 
CBs (Giesemann et al.,  1999; Skare et a/.f 2003).  Poly(A) polymerase (PAP) is 
involved in the polyadenylation of 3’ prime ends of mRNA (Schul et at.,  1996). 
Ewing’s  sarcoma  (EWS)  is  a  RNA  binding  protein  and  has  been  shown  to 
interact with SMN (Young et a/., 2003). SmB is one of the core proteins that are 
found  in  all  major  snRNPs,  which  form  the  major  component  of  the 
spliceosome. Gemin3 forms part of the SMN complex (Campbell et al., 2000). 
Immunoreactivity for all  of these proteins did  not show any  labelling  of Cajal 
bodies in the R6/2 transgenic mouse striatum  apart from Gemin3 which was 
seen to infrequently localise to CBs (data not shown).
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Figure 3.20
Light Microscopy Immunostaining of Cajal Bodies from R6/2 Striatal Nuclei 
Photomicrographs showing  immunoreactivity for a variety of Cajal  body proteins  in  striatal 
neurons of 10-week-old  R6/2 mice.  The p80 coilin (A), SMN  (B),  Gemin2 (C), Gemin4 (D) 
and  U2  snRNP  (E)  immunoreactive  CBs  are  indicated  by  black  arrows  and  a  diffuse 
nucleoplasmic stain can also be seen.  Immunoreactivity for all CB proteins reveal only one 
CB per nucleus.  Scale bar = 10
148 RESULTSThe  results from  the  light  microscopy  study  showed  that the  Cajal  body 
proteins  studied  did  localise  to  CBs  in  the  R6/2  striatal  neurons  but  no 
information  about  which  type  of  CB  (nucleolar-associated,  free  or  Nil- 
associated) contained which CB protein could be ascertained.  Pre-embedding 
immuno-electron microscopy with DAB was carried  out on  10-week-old  R6/2 
mice  using  antibodies for some  of the  CB  proteins.  Although  staining  was 
achieved  (figure  3.21A-B),  the  same  problems that were  met  in the  normal 
study occurred:  when  using  the TEM  only one  CB was seen  in  most of the 
70 nm ultrathin sections and from the light microscopy study it is clear that some 
antibodies  stain  more  than  one  CB.  Immuno-electron  microscopy  could 
therefore not help to reveal all possible types of CB containing each of the CB 
proteins in one nucleus.
Confocal microscopy was undertaken to identify different nuclear proteins 
within different nuclear domains.  By using DAPI to reveal the nucleus together 
with a CB protein antibody and an antibody against huntingtin (htt) to show the 
NII,  it was  possible to see one  large  CB  containing  either p80 coilin  or U2” 
snRNP (figure 3.21 C-D) that was associated with the Nil.  However, it was still 
not possible to see where the nucleolus was in relation to the CB and the NII.
Pyronin  Y  is  known  to  label  RNA  and  therefore  is  a  good  substance  to 
identify the nucleolus as it has a high RNA content.  Pyronin Y can be seen  in 
the red channel of the confocal microscope so it can be used in conjunction with 
the  fluorescent  secondary  antibody  FITC.  I  performed  a  Z-series  scan  on 
striatal nuclei from 10-week-old R6/2 mouse that had been labelled with Pyronin 
Y and either p80 coilin or SMN antibodies.
I  analysed  100  reconstructed  nuclei  that  contained  CBs  that  were 
immunoreactive for either p80 coilin or SMN (figure 3.22).  The 204.9 p80 coilin 
antibody  coupled  with  a  FITC  secondary antibody showed  that  R6/2  striatal 
nuclei  generally contained  between  1   or 2  CBs  per nucleus  (table  3.4)  and 
infrequently nuclei with 3 or 4 CBs were seen.  The average number of CBs per 
nucleus was 1.53+/-0.07 (graph 3.8B) and 60% of nuclei contained only one CB 
(table 3.4).  When p80 coilin antibody was replaced with the SMN antibody on 
most occasions only one CB was seen per nucleus (table 3.4).  93% of nuclei 
contained  only  one  SMN  positive  CB  and  the  average  number  of CBs  per 
nucleus was 1.07+/-0.03 (graph 3.8B).
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Figure 3.21
Molecular Composition of Cajal Bodies R6/2 Striatal Nuclei
Immuno-Electron Microscopy of Cajal bodies in 10-week-old R6/2 transgenic mouse.
A discrete deposition of DAB reaction product labels a CB with antibodies to p80 coilin
(A)  and  U2” snRNP  (B)  (black arrowheads).  A single stained  nuclear foci is seen with  both
antibodies.  Nil can also be seen (black arrows).
Confocal  Microscopy  Immunofluorescence of Cajal  bodies  in  10-week-old  R6/2  transgenic 
mouse
Triple labelling indirect immunofluorescence using antibodies to U2” snRNP (C) and SMN (D) 
together with an antibody to huntingtin (htt) to reveal the Nil and DAPI to show the nucleus.
(C)  U2”  snRNP  immunofluorescence  (green) with  htt  immunofluorescence  (red)  and  DAPI 
(blue).  The SMN protein is localised in a CB (green) that is associated with a Nil (red).
(D) SMN  immunofluorescence (red) in conjunction htt immunofluorescence (green) and DAPI 
(blue) shows a Nil-associated CB (red) that contains the protein SMN and a Nil (green).
150 RESULTSFigure 3.22
Localisation of Cajal Bodies from R6/2 Striatal Nuclei
Confocal Microscopy Immunofluorescence of Cajal bodies in  10-week-old R6/2 
transgenic mouse
(A)  p80  coilin  immunofluorescence  (yellow)  in  conjunction  with  pyronin  Y 
staining  (red)  shows the distribution and  different localisations of CBs  in  a Z- 
series stack.  In most visible nuclei it is possible to see one prominent free CB 
(small white arrows) that is not associated with  nucleolus.  The nucleolus can 
be seen as a spherical accumulation of pyronin Y staining in the nucleus.
(B)  SMN  immunofluorescence  (green)  in  conjunction  pyronin Y  staining  (red) 
shows the  distribution  and  different  localisations  of CBs  in  a  Z-series  stack. 
Most nuclei show one CB that is free in the nucleoplasm (white arrows).
RESULTSTable 3.4
A  table  showing  the  percentage  of 
R6/2 nuclei that contained  1,2,3 or 4 
CBs  containing  either  p80  coilin  or 
SMN.  Chi-Square  test  for 
independence (X2S = 31.56; p<0.001).
The localisation of the p80 coilin or SMN positive CBs in the reconstructed 
nuclei was also analysed.  Of the total number of p80 coilin positive CBs, 56% 
were seen to be nucleolar-associated and 44% were free in the nucleoplasm 
(graph  3.8C).  48%  of  the  CBs  identified  using  the  SMN  antibody  were 
nucleolar-associated and 52% were free in the nucleoplasm (graph 3.8C).  The 
immunofluorescence using either p80 coilin or SMN antibody showed that some 
nuclei in the R6/2 striatum contained both nucleolar-associated and free CBs. 
For p80 coilin-positive CBs, this occurred in 28% of the total number of nuclei 
analysed,but for SMN-positive CBs, it was only seen in 2% of nuclei.
To see  if the percentage of free CBs seen to contain either p80  coilin  or 
SMN were actually Nil-associated CBs, triple labelling immunofluorescence was 
carried  out.  Pyronin  Y  was  used  together  with  a  huntingtin  (htt)  antibody 
coupled with a FITC secondary antibody and a p80 coilin antibody coupled with 
a Cy5 secondary antibody (figure 3.23).  The Cy5 secondary antibody bleached 
very  rapidly  and  only  10  nuclei  could  be  reconstructed.  7  of  the  nuclei 
contained  Nil-associated  CBs  that  were  p80  coilin  positive  and  3  nuclei 
contained CBs that were associated with the nucleolus.
To confirm that p80 coilin and SMN proteins were found in the same CBs, in 
the R6/2 transgenic mouse striatum, triple labelling  immunofluorescence was 
carried out using DAPI, to reveal the nucleus together with p80 coilin antibody 
coupled with a TRITC secondary antibody and  SMN  antibody coupled with a 
FITC  secondary  antibody  (figure  3.24).  It was  possible to  see that the  CB 
proteins colocalised in the same CB.
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Graph 3.8
Analysis of the Molecular Composition of Cajal Bodies in R6/2 Striatal Nuclei
(A) A histogram showing the average number of CBs per nuclei when analysed with antibodies to different CB 
proteins using a light microscope in 10-week-old R6/2 transgenic mouse.  Apart from p80 coilin, all other CB 
proteins only reveal one CB per nucleus on average.  Oneway ANOVA (F = 68.53; p<0.001).  Error bars are 
standard errors of mean.
(B) A histogram showing the average number of CBs per nuclei when analysed with antibodies to either p80 
coilin or SMN using a confocal microscope in 10 week old R6/2 transgenic mouse.  A Z series was performed 
and entire nuclei reconstructed and CBs counted. p80 coilin appears to be present in more CBs compared to 
SMN. Student’s unpaired f-test (/= 6.04; ***p<0.001).  Error bars are standard errors of mean.
(C) A histogram showing the percentage of CBs that are either free or nucleolar-associated  seen  using either 
antibodies to p80 coilin or SMN in 10-week-old R6/2 transgenic mouse.
153 RESULTSFigure 3.23
Molecular Composition of Cajal Bodies from R6/2 Striatal Nuclei 
Confocal Microscopy Immunofluorescence of Cajal bodies
Triple  labelling  indirect immunofluorescence  using  antibodies to  p80  coilin  (blue),  huntingtin  (green)  and 
pyronin Y staining  (red).  From the Z-series stack it is possible to see that a CB (blue)  is associated with 
the Nil (green).  The CB is also in very close proximity to the nucleolus (red).
154 RESULTSFigure 3.24
Molecular Composition of Cajal Bodies from R6/2 Striatal Nuclei 
Confocal Microscopy Immunofluorescence of Cajal bodies 
Triple labelling  indirect immunofluorescence using  antibodies to 
p80  coilin  (A)  and  SMN  (B)  together  with  DAPI  to  show  the 
nucleus  (blue).  The  immunofluorescence  for  both  proteins 
reveals  one  nuclear  foci  (white  arrows)  and  when  they  are 
overlaid  (C)  it  is  possible  to  see  that  p80  coilin  and  SMN 
colocalise (yellow) in the same nuclear foci which is a CB (white 
arrow)  but  the  colocalisation  is  not  complete  as  some  red  is 
visible.
155 RESULTSThe localisation of Gemin3 was also analysed  using  confocal  microscopy. 
When  Gemin3  was  used  in  conjunction  was  pyronin  Y  and  a  Z-series  scan 
performed,  immunofluorescence  revealed that Gemin3  localised to  nucleolar- 
associated CBs and not nucleoplasmic CBs (figure 3.25).
From my earlier analysis of the molecular composition of the R6/2 neuronal 
nucleolus,  it was seen that some  nucleolar proteins  not only  localised  to the 
nucleolus but could also be seen in CBs, both nucleolar-associated and free.  I 
performed double labelling immunofluorescence to see if the nucleolar protein 
positive CBs at either localisation  (nucleolar or free) colocalised with the p80 
coilin positive CBs.  p80 coilin immunofluorescence revealed CBs (figure 3.26A) 
that  were  either  nucleolar-associated  or  free  in  the  nucleoplasm  while  the 
immunofluorescence  for  fibrillarin  showed  one  large  nuclear  foci,  which 
corresponded to the nucleolus, and smaller nuclear foci (figure 3.26B).  When 
these images were viewed together it was clear that the smaller foci seen with 
the  fibrillarin  immunofluorescence  were  also  labelled  with  the  p80  coilin 
immunofluorescence  (figure  3.26C).  The  smaller foci  corresponded  to  CBs, 
which  could  be free  or  nucleolar-associated.  Therefore,  the  free  p80  coilin 
positive CBs also contain fibrillarin.
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Molecular Composition of Cajal Bodies from R6/2 Striatal Nuclei 
Confocal Microscopy Immunofluorescence of Cajal bodies
Gemin3 immunofluorescence (green) in conjunction with pyronin Y staining  (red),  in this 
nucleus it is possible to see one  prominent nucleolar-associated  CB  (white arrow).  The 
nucleolus can be seen as a spherical accumulation of pyronin Y staining in the nucleus.
157 RESULTSFigure 3.26
Confocal  Microscopy  Immunofluorescence  of  Cajal  Bodies  R6/2  Striatal 
Nuclei
Double labelling indirect immunofluorescence using antibodies to fibrillarin (A) 
and  p80 coilin  (B).  (A)  Fibrillarin immunofluorescence reveals that the protein 
is found in nucleoli (white arrowheads) and nuclear foci (pink arrows).
(B) p80 coilin immunofluorescence shows the protein to be in one discrete CB 
(white arrows).
(C) When both proteins are viewed together it is possible to see that fibrillarin 
and p80 coilin colocalise in a free CB (white arrows).  No colocalisation of the 
two proteins is seen in the nucleolus (white arrowhead).  Scale bar = 5pm
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I have analysed the molecular composition of speckles in striatal neurons of 
the R6/2 transgenic mouse.  Many proteins that are involved in pre-messenger 
RNA  splicing  accumulate  in  speckles.  Immunocytochemistry  using  the 
monoclonal  antibody  against  splicing  factor  SC35  did  not  show  the  usual 
‘speckled’ pattern of staining, instead, a diffuse nucleoplasmic pattern was seen 
(figure 3.27A).  When the staining pattern of 2 other proteins involved  in pre- 
mRNA splicing,  HYPA  and  HYPC,  were  examined,  they  revealed  infrequent 
speckle staining with many nuclei only exhibiting a nucleoplasmic pattern (figure 
3.27B).  An antibody specific for 2,2,7-trimethylguanosine (m3G/TMG), which 
forms part of a complex with snRNPs, shows TMG to have a speckled pattern 
occupying a portion of the nucleoplasm excluding the nucleolus (figure 3.27C). 
The speckled distribution consists of numerous irregularly shaped  nuclear foe; 
that are suggested to be interconnected.
The  paraspeckle  is  a  recently  identified  nuclear  domain  that  is  closely 
related to the speckle (Fox et a/., 2002) and  Paraspeckle Protein  1   (PSP1) is a 
protein that has been shown to localise to paraspeckles.  To see if R6/2 striatal 
nuclei have paraspeckles, double labelling immunofluorescence was performed 
using an antibody to PSP1  and an antibody against a protein that is localised to 
speckles, TMG (figure 3.28).  Immunofluorescence for both antibodies showed 
a  nuclear distribution  but when the images were overlaid only a small area of 
co-localisation  was  seen  and  therefore  striatal  neuronal  nuclei  do  contain 
paraspeckles.
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Light Microscopy Immunostaining of Speckles from R6/2 Striatal 
Nuclei
Photomicrographs  showing  immunoreactivity  for  a  variety  of 
speckle  proteins  in  striatal  neurons  from  10-week-old  R6/2 
transgenic mice.
(A) SC35 protein immunoreactivity does not show the “speckled’ 
pattern of nuclear staining.
(B)  HYPA protein  immunoreactivity shows infrequent nuclei that 
have  the  characteristic  ‘speckled’  distribution  pattern  (black 
arrows).
(C) TMG protein localises in a speckled nuclear pattern and also 
diffusely distributed throughout the nucleoplasm (black arrows).
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Molecular Composition of Speckles from R6/2 Striatal Nuclei 
Confocal  Microscopy  Immunofluorescence  of  speckles  and 
paraspeckles.
Double  labelling  indirect  immunofluorescence  using  antibodies 
to  PSP1  (A)  and  TMG  (B).  PSP1  immunofluorescence  shows 
the  protein to have a  punctate  nucleoplasmic distribution.  TMG 
immunofluorescence  reveals  the  protein  to  have  a  ‘speckled’ 
nuclear  pattern.  When  both  proteins  are  viewed  together  (C) 
only  small  areas  of  colocalisation  can  be  seen  (yellow)  and 
these appear to be at the edges of the TMG staining.
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Many studies have shown that an increasing number of proteins have been 
identified  that  colocalise  with  the  Nil  (chapter  1.6.6).  This  study  has  not 
concentrated on the molecular composition of the Nil  but has seen that Hsc70 
colocalises with the Nil.  It has also been possible to demonstrate that Nils do 
not contain RNA.  This is due to the results from the confocal studies that used 
pyronin  Y  and  an  antibody  against  huntingtin.  The  immunofluorescence for 
huntingtin  did  not colocalise with  the  immunofluorescence for  pyronin Y  and 
therefore  showed  the  nucleolus  (pyronin  Y)  and  the  Nil  (huntingtin)  where 
separate structures (figure 3.23).  The fact that the Nil did not stain for pyronin 
Y suggests that it contains no RNA.
3.5  Ultrastructure of p80 coilin KO Neuronal Nucleus
In 20-week-old  p80 coilin  knock-out mice nuclei of striatal  neurons have a 
round to oval shape and have a normal, dispersed distribution of chromatin with 
the occasional body of condensed chromatin.
3.5.1  Ultrastructure of p80 coilin KO Neuronal Nucleolus
To study the effects of the deletion of the Cajal  body protein  p80 coilin on 
nucleolar  morphology  I  have  analysed  nucleoli  of the  striatal  neurons  in  20- 
week-old p80 coilin knock-out mice.  Nuclei containing  nucleoli were randomly 
sampled.
From  my  analysis  of  p80  coilin  KO  striatal  neurons,  it  is  possible  to 
determine  that  most  cells  are  mononucleolated  (94%)  and  occasionally 
binucleolated  (6%).  No  nuclei  contained  more  than  2  nucleoli.  The  mean 
number of nucleoli per cell is 1.06+/-0.02.
It  is  possible to divide the  p80 coilin  KO  nucleoli  into the  same  nucleolar 
classes  that  were  described  previously  (chapter  3.1.1):  closed-reticulate 
structure (CRS) and open-reticulate structure (ORS).
The CRS was seen  in 41%  of the cells that were examined  (graph  3.9A),
RESULTSand the morphology reveals small fibrillar centres (FCs) surrounded by a dense 
material  that  consists  of  an  entanglement  of the  dense  fibrillar  component 
(DFC)  with  the  granular component  (GC).  These  nucleoli  are  spherical  and 
have an average diameter of 0.92+/-0.04  (graph 3.9B).
The CRS nucleoli can have a perinucleolar cap (PNC) and it is an electron 
dense structure that lies adjacent to the nucleolus.  It seems to be composed of 
matter that is similar in appearance to the FCs.  It has an irregular shape and 
can be smaller or larger than the nucleolus itself.  Perichromatin granules (PGs) 
and perichromatin fibrils (PFs) are also seen at the nucleolar periphery.
The ORS was seen in 59% of nuclei that were examined (graph 3.9A) and a 
very  disordered  ultrastructure  can  be  seen  in  this  class  of  nucleolus  (figure 
3.29A).  The  FCs  of the  ORS  nucleoli  can  be  very  large and  can  take  up  a 
significant portion of the nucleolar volume.  Smaller FCs are also seen and all 
FCs are frequently located at the periphery of the nucleolus and not engulfed by 
the dense material that constitutes the rest of the ORS nucleolus.  The dense 
material  seems to  be composed  of the  DFC  and  the  GC  entangled together. 
The ORS  nucleoli  are  not as  spherical  as the  CRS  nucleoli  and  the average 
diameter is 0.78+/-0.02 pm  (graph 3.9B).
ORS nucleoli can also have perinucleolar caps (PNC),  PGs and  PFs at the 
nucleolar periphery.
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Graph 3.9
Analysis of the Class and Diameters of Nucleoli in p80 coilin KO Striatal Nuclei
(A) A histogram showing the percentages of nucleoli that show an open-reticulate structure (ORS) or a closed- 
reticulate structure (CRS) in 20-week-old mice..  A 95% confidence interval that the probability of ORS is 
between 49% and 68% and for CRS is between 32% and 51 %.
(B) A histogram showing the average diameters of ORS or CRS nucleoli in 20-week-old mice.  It is possible to 
see that ORS nucleoli have a larger average diameter than the CRS nucleoli.  Student’s unpaired f-test (f = 
3.64; ***p<0.001).  Error bars are standard errors of mean.
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Micrographs from p80 coilin Knock-out Striatal Neurons
(A)  The  ultrastructure of a  nucleolus  and  nucleolar-associated  CB from a  striatal  neuron from a 
p80  coilin  knock-out  mouse  (black  arrows).  The  nucleolus  (n)  has  a  ORS  morphology.  The 
nucleolar  CB  (black  arrow)is  in  direct  contact  with  the  periphery  of the  nucleolus.  The  CB  is 
composed of dense coiled threads embedded in a less dense matrix.
(B)  The fine  structure of speckles  (black arrowheads)  in  a  striatal  neuron  from  a  p80  coilin  KO 
mouse.  Perichromatin  fibrils  (PFs)  and  interchromatin  granule  clusters  (IGCs)  correspond  to 
speckles at the ultrastructural level.  IGCs (black arrowheads) represent the main part of speckles 
and comprise granules that appear to be connected with fibres
Light  Microscopy  Immunostaining  of Nuclear Domains from  p80  coilin  KO  Striatal  Neurons .(C) 
Photomicrograph  showing  fibrillarin  using  17C12  antibody.  Intense  nucleolar staining  is visible 
(black arrows) with diffuse nucleoplasmic stain as well
(D)  Photomicrograph  showing  immunoreactivity  for  the  Cajal  body  protein  U2”  snRNP. 
Nucleoplasmic staining can  be seem together with a ’speckled’ pattern of immunoreactivity but no 
CB staining.
(E)  Photomicrograph  showing  immunoreactivity for the  Cajal  body  protein  Gemin2.  A  diffuse 
nucleoplasmic and cytoplasmic stain can be seen (black arrow) but no CB staining.
(C-E) Scale bar = 10  pm
165 RESULTS3.5.2 Ultrastructure of p80 coilin KO Neuronal Cajal Bodies
As part of the study on the effects of the deletion of Cajal body protein, p80 
coilin,  on  the  neuronal  nuclear  ultrastructure,  I  decided  to  examine  the 
morphology and distribution of Cajal bodies in p80 coilin knock-out mice at 20 
weeks  of  age.  At  the  ultrastructural  level,  only  17%  of  striatal  neurons 
examined contained a distinct CB and the basic morphology of the CBs in p80 
coilin KO nuclei was similar to that seen in the normal murine neuronal nuclei. 
The CBs were round to oval in shape and were composed of coiled strands of 
fibrillar  material  surrounded  by  a  low  density  amorphous  matrix.  Tiny  fibrils 
radiating from the periphery of the CB into the nucleoplasm could also be seen.
Most  CBs occurred  in  association  with  the  nucleolus  (89%)  and  very few 
were  free  in  the  nucleoplasm  (11%)  (graph  3.10A).  There  were  no 
morphological differences between the CBs in either localisation (figure 3.29A). 
The  average  diameters  of the  nucleolar-associated  and  nucleoplasmic  CBs 
were  0.19+/-0.02  and  0.18+/-0.01  (graph  3.10B).  The  nucleolar- 
associated  CBs  were  seen  to  be  in  direct  contact with  the  periphery  of the 
nucleolus.
3.5.3  Ultrastructure of p80 coilin KO Neuronal Speckles
I have analysed the morphology of speckles in 20-week-old p80 coilin knock­
out mice.  Speckles at the ultrastructural level are composed of interchromatin 
granule clusters (IGCs) and  perichromatin fibrils (PFs).  As  IGCs have a  non- 
uniform shape a  morphological quantification of the speckles  in the p80 coilin 
KO  mouse  was  not  possible.  However, it  was  possible  to  distinguish  the 
numerous granules that constitute the speckles (figure 3.29B).
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Graph 3.10
Analysis of Cajal Bodies in p80 coilin KO Striatal Nuclei
(A) A histogram showing the percentages of CBs that are either free in the nucleoplasm or nucleolar- 
associated and found at the periphery of the nucleolus in 20-week-old mice.  It is possible to see that most of 
the CBs in the striatal neurons are nucleolar-associated CBs. A 95% confidence interval that the probability of 
nucleolar CBs is between 81% and 94% and for free CBs is between 6% and  19%.
(B) A histogram showing the average diameters of free or nucleolar-associated CBs in 20-week-old mice. 
Nucleolar-associated CBs appear to have a slightly larger average diameter compared to those of the free 
CBs. Error bars are standard errors of mean.
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RESULTS3.6 Molecular Composition of p80 coilin KO Neuronal 
Nucleus
In these studies  I have attempted to describe the molecular organisation of 
the p80 coilin KO neuronal nucleus to determine if there are any changes in the 
distribution of nuclear proteins due to this deletion.  Due to the limited amount of 
tissue that  I  had,  only  some of the  previously  used  antisera  could  be studied 
and all mice used were 20-weeks-old.
3.6.1 Molecular Composition of p80 coilin KO Neuronal Nucleolus
To see if any changes occur to the nucleolus in p80 coilin KO fibrillarin was 
chosen as the nucleolar marker to be examined  using  immunocytochemistry. 
Fibrillarin  is a marker of the dense fibrillar component of the  nucleolus and  in 
the nuclei of p80 coilin KO striatal neurons, fibrillarin immunoreactivity, using the 
17C12  antibody,  was  localised  to  the  nucleolus  (figure  3.29C).  No 
nucleoplasmic staining was seen but intense,  irregularly shaped  nucleoli were 
visible together with nucleolar-associated Cajal bodies.
3.6.2 Molecular Composition of p80 coilin KO Neuronal Cajal Body
Immunocytochemical studies were carried out using antibodies to the same 
Cajal body proteins in p80 coilin KO mouse striatum that were used to analyse 
the mouse striatum to determine if CBs still exist in the striatum of the p80 coilin 
KO mouse after the deletion of the CB marker protein.
p80 coilin is a nucleoplasmic-shuttling phosphoprotein that is known as the 
molecular marker of CBs and immunocytochemistry using the 204/10 p80 coilin 
antibody (a gift from A.I Lamond, Dundee, UK) revealed no staining at all.
Immunoreactivity for SMN,  the  survival  of motor  neuron  protein,  together 
with Gemin2 and Gemin4 showed a cytoplasmic and diffuse nuclear distribution 
(figure  3.29E)  but  no  CB  staining.  An  antibody  against  U2”  snRNP  (small 
nuclear ribonucleoprotein  particles)  revealed a ‘speckled’ staining  pattern with 
no CB immunoreactivity (figure 3.29D).
168 RESULTSDiscussion
&
Conclusion
i69  DISCUSSION & CONCLUSIONSDiscussion
CHAPTER 4
4.1 The Ultrastructural Organisation of the Nucleus
It has been well established that the mammalian nucleus is a highly 
organised  structure  with  many  compartments  that  are  involved  in  gene 
transcription  and  RNA  processing  (Lamond  and  Earnshaw,  1998;  Dundr and 
Misteli, 2001).  Numerous studies on nuclear organisation  have used cultured 
cells to gain an  understanding of the structural and  molecular organisation of 
these domains and their spatial relationships (chapter 1).  Few research groups 
have looked at the organisation of neuronal nuclei that, unlike cultured cells, are 
fully differentiated interphase cells of extreme longevity and, therefore, are cells 
in which the cell cycle plays merely an initial role in influencing the architecture 
of the nucleus.
One Spanish  research  group  (Lafarga  et al.,  1994)  has spent many years 
analysing the organisation/structure of one type of neuron within the supraoptic 
nuclei (SON) (Berciano et al., 2001), but no studies, that I am aware of to date, 
have investigated the organisation of the nucleus of medium spiny neurons that 
are the  principle  cell  type within  the  striatum.  This  thesis  has  attempted  to 
determine the ultrastructural and molecular characterisation of the nucleus of a 
typical  murine  striatal  neuron  and  compare these findings  with  nuclei  of the 
same type of cells in a transgenic mouse model of a neurodegenerative disease 
in which the medium spiny neurons are the main site of pathology; Huntington’s 
disease (HD) (chapter 1.6).  In HD, the sequestration of nuclear factors into Nils 
(chapter  1.6.6)  and  the analysis of altered  mRNA levels  in  R6/2  mice  (Luthi- 
Cater  et  al.,  2000)  have  led  to  the  hypothesis  that  transcription  is  down- 
regulated and  part of the pathological mechanism of the disease (Cha,  2000). 
Transcription  can  be easily inhibited  in cultured  cells  using  a variety of drugs 
(chapter  1.4)  and  many  studies  have  documented  the  relocalisation  of 
numerous nuclear factors  in  transcriptionally arrested  cells as well  as distinct 
morphological changes.  I have used the findings from these studies to create a 
guide to show the altered localisations of nuclear proteins after transcription has 
been  inhibited.  Any  relocalisations  of proteins  seen  in  the  R6/2  nuclei  have
I7°   DISCUSSION & CONCLUSIONSthen been compared to this guide to see if there are any similarities.
The findings will also be compared to those obtained in a knockout mouse 
that  lacks  the  Cajal  body  specific  marker protein,  p80  coilin  (chapter  1.4.3). 
These findings will  provide an insight into the organisation of striatal  nuclei in 
vivo and highlight any alterations that occur in a neurodegenerative disease, or, 
following  the  deletion  of a  nuclear  protein.  The  observations  illustrate  the 
organisation  and  behaviour of nuclear subdomains  in  striatal  neurons  under 
different pathological situations.
4.1.1The Ultrastructural Organisation of the Nucleolus
Although it has been shown that the nucleolus of any mammalian cell has a 
very  heterogeneous  morphology  even  within  the  same  cell  type,  it  is  still 
believed that a very distinct overall structure can be distinguished and that this 
reflects the  metabolic activity  of that given  cell  at that given  time  (Shaw and 
Jordan,  1995).  Many  mammalian  nucleoli  are  composed  of  three 
ultrastructurally  distinct  regions;  fibrillar  centres  (FC),  the  dense  fibrillar 
component (DCF) and the granular component (GC) (chapter 1.1.2 and figure
3.1).  One  of the  first  noticeable  differences  between  nucleoli  within  striatal 
neurons and many other nucleoli from other mammalian cell types was that the 
striatal nucleoli had only two easily distinguishable regions.  The FCs appear as 
small, pale areas of the nucleolus that are mostly engulfed by an entanglement 
of the DFC and the GC which can be seen as a darker, electron dense material. 
This  arrangement  of  the  DFC  and  GC  has  been  noted  before  in  neurons 
(Peters et al.,  1991).  This observation is quite surprising as it is suggested that 
there is a gradual transition from FCs through the DFC to the GC.  The earliest 
transcriptional  events  occur  at  the  border  between  the  FCs  and  the  DFC 
(Carmo-Fonseca et al., 2000) and the pre-rRNA transcripts then move through 
the DFC  into the  GC,  being  processed as they proceed.  The finding that the 
DFC and  the  GC do  not exist as two  separate  regions  in the striatal  nucleoli 
could  suggest that all  processing  of rRNA occurs at the same time.  All post- 
translational modifications must take place in the same area of the nucleolus, 
even the late processing events, that are reported to occur in the GC (Scheer 
and  Hock,  1999).  A similar situation  is  seen  with  RNA  polymerase  II  driven
DISCUSSION & CONCLUSIONStranscription  where  pre-mRNA  splicing  takes  place  at  the  same  time  and 
location as transcription of the nascent pre-mRNA transcripts (Neugebauer and 
Roth,  1997).  It is suggested that co-transcriptional pre-mRNA processing is the 
result of the fast kinetics of processing  compared  to the  lengthy synthesis of 
complete pre-mRNA transcripts (Neugebauer, 2002).  This may also be true for 
rRNA transcription  and  processing  in striatal  nucleoli.  The  importance of co- 
transcriptional splicing is yet to be fully understood but it may play a role in the 
regulation and efficiency of RNA synthesis for both mRNA and rRNA.
The analysis  of the  nucleoli  in  murine  striatal  neurons  demonstrated  that 
most  nuclei  contained  only  one  nucleolus  and  that  these  nucleoli  may  be 
subdivided  into  subclasses  each  with  distinct  morphological  features.  The 
closed-reticulate  structure  (CRS)  was  seen  in  44%  of  nuclei  and  the  main 
feature  was  the  presence  of  very  small  FCs  that  were  numerous  and 
surrounded by an entanglement of the DFC and the GC (figure 3.2A).  Lafarga 
et  al.  (1991)  observed  nucleoli  of similar  morphology  after  the  osmotically 
induced activation of SON neurons in the rat.  The presence of many small FCs 
is thought to  indicate that the  nucleolus  is  highly active with  increased  rRNA 
transcription.  The  small  FCs  give  a  greater  surface  to  area  volume  ratio 
allowing the  nucleolus to  produce  more  rRNA.  Evidence  has  been  provided 
that the reduction in the fibrillar centre size is due to splitting of pre-existing FCs 
into smaller ones, resulting in an associated increase in their number (Ochs and 
Smetana,  1989).  A  study  using  a  formic  acid  silver  nitrate  staining  method 
showed the precise localisation of FCs, which appear as black dots.  Nucleoli 
from  activated  cells  demonstrated  a  greater number of small  FCs  (Derenzini 
and  Ploton,  1991).  The  area  occupied  by the  silver-stained  FCs  within  the 
nucleolus is suggested to  relate to the total  nucleolar volume and the level  of 
ribosome biogenesis.
The open-reticulate structure (ORS) seen in  56% of the nucleoli examined 
exhibits very prominent FCs that are large and  are not always surrounded  by 
the  mass of tangled  DFC  and  GC  (figure  3.2B).  Occasionally the  FCs were 
seen to be  in  direct contact with the  interchromatin  space/nucleoplasm.  The 
ORS nucleolar morphology appears to be characteristic of a nucleolus that has 
lower levels of protein synthesis compared to the activity of the CRS nucleolus 
(Lafarga et al.,  1998).  The large FCs may represent fewer rDNA transcription
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This  nucleolar  morphology  has  been  reported  in  granule  cells  of the  rat 
cerebellum (Lafarga et al.,  1998).  Most granule cells have low levels of protein 
synthesis  and  have  large  FCs  surrounded  by  the  DFC  and  the  GC.  The 
formation of few,  large FCs have also been seen in cycloheximide treated SON 
neurons  (Lafarga  et al.,  1994).  The  FCs were  also  seen  to  be  incompletely 
surrounded by the DFC resulting in their direct contact with the nucleoplasm.  It 
has also been shown that when secretion of vasopressin  has been completely 
suppressed by water load in SON neurons, the size of individual FCs was seen 
to double (Andersen  and  Keiding,  1990).  An  increase  in the size of FCs  has 
also been seen fibroblasts treated with Actinomycin D (Jordan and  McGovern, 
1981).  These  findings  support  the  idea  that there  is  a  negative  correlation 
between the size of FCs and the transcriptional activity of the nucleolus.
The average diameters of the CRS and  ORS  nucleoli were 0.83+/-0.03 pm 
and  0.90+/-0.03 pm,  respectively,  and  were  not  significantly  different.  The 
slightly larger size of the ORS  nucleoli could  be explained  by the presence of 
the larger FCs.  One study on pig embryo kidney cells (PK cells) has shown that 
the total volume of FCs does  not change with the activation  or inactivation of 
ribosomal  genes  (Zatsepina  et al.,  1988).  It  is  instead  the fragmentation  or 
fusion of existing, individual FCs that is observed and therefore the total volume 
of FCs  does  not  increase  or decrease.  It  has also  been  shown  that osmotic 
stimulation of SON neurons results in a significant increase in the nucleolar size 
(Lafarga et al.,  1991) and  SON  neurons with high secretory activity have large 
nucleoli (Andersen,  1990).
Figure 4.1
Schematic  diagrams  showing  the  different  nucleolar classes:  ORS  (A),  CRS  (B)  and  SS  (C).  The  ORS 
nucleoli have few,  large FCs (pale blue) whereas the CRS nucleoli  have numerous,  small FCs  (pale blue). 
In all classes of nucleoli, the  remaining part of the nucleolus is composed of the entanglement of the  DFC 
and the GC (dark blue).  The SS nucleoli appear to be segregating into microspheres.
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spiny neurons within the murine striatum may be due to the fact there are two 
different types of projection neurons within this population of neurons.  Type  I 
projection neurons mostly project to the substantia nigra pars reticulata (SNPr) 
and globus pallidus internal segment (GPi)/ entopeduncular nucleus (EP) and 
produce  the  neuropeptides,  substance  P  and  dynorphin  as  well  as  GABA 
(Bolam  et al.,  1983).  These  projection  neurons  express  predominantly  D1 
dopamine receptors (Gerfen et al.,  1990).  Type  II  projection  neurons,  on the 
other hand,  project to the  SNPr and  GPi/EP via the globus  pallidus external 
segment  (GPe)  and  subthalamic  nucleus  (STN)  respectively  (Gerfen  et al., 
1992).  These projection neurons secrete the neuropeptide enkephalin as well 
as GABA,  and  predominantly express  D2 dopamine  receptors  (Gerfen  et al., 
1990).
However,  another  level  of  organisation  exists  in  the  striatum. 
Neurochemical  heterogeneity exists  in  regions  of the  striatum  and  has  been 
described as ‘patch and matrix’.  Regions of striatal neurons that are rich in u- 
opiate,  receive input from the amygdala and  parts of the cortex and  synapse 
upon dopaminergic neurons of the substantia nigra pars compacta (SNPc) are 
termed ‘patches’ (Pert,  1976).  Whereas, the ‘matrix’ region consists of neurons 
rich in acetylcholinesterase, somatostatin and calbindin,  receive input from the 
thalamus  and  other  parts  of the  cortex  and  synapse  upon  the  output  nuclei 
(GPi/SNPr)  (Graybiel  and  Ragsdale,  1978;  Gerfen,  1985).  However,  the 
patches only account for fifteen percent of striatal cells (Johnston et al.,  1990) 
and therefore a ratio of 15% patch to 85% matrix would be expected.
The observed differences in the ultrastructure of the subclasses of nucleoli 
may represent type I or type II projection neurons or neurons from the patch or 
matrix regions, however, as no immunochemistry was carried out to distinguish 
either subpopulation of medium spiny neurons this cannot be answered within 
this study.  However, these levels of organisation within the striatum may play 
no  role  in the difference  in  nucleolar morphology.  An  alternative theory may 
explain the difference;  it may simply be that different neurons at different times 
have  a  different  rRNA transcriptional  activity within  the  same  populations  of 
neurons.  If it was possible to analyse the same neuron, hours or days later, a 
different morphology  may  be seen  but it just so  happens that any that given
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ORS nucleoli.
Both of these subclasses of nucleoli were seen in R6/2 transgenic mice and 
p80  coilin  knockout  mice.  In  the  R6/2  nuclei,  a  higher  percentage  of ORS 
nucleoli were seen than CRS nucleoli, which was similar to that seen in the wild' 
type striatal nuclei  (graph 4.1).  In the p80 coilin  knockout nuclei,  however,  a 
higher percentage of CRS nucleoli were seen (graph 4.1).  The only difference 
seen  in the  ultrastructure of nucleoli from  the  three  different mice was found 
within  the  nuclei  of the  R6/2  striatal  neurons.  The  nucleoli  seen  in  the  R6/2 
striatum  exhibited  a  third  structural  subclass:  the  segregating  structure  (SS). 
The SS nucleoli  have a  morphology that is very different from either the ORS 
nucleoli or the CRS  nucleoli  because these  nucleoli appear to be fragmenting 
into  microspheres,  and  no  longer  maintain  a  spherical  shape  in  the  nucleus 
(figure 3.15).  Nucleoli  in this subclass  have a  greater diameter than  both the 
ORS nucleoli and the CRS nucleoli seen in the R6/2 nuclei.  In the SS nucleoli, 
it is still possible to distinguish  individual  FCs surrounded  by the darker,  more 
electron  dense  material  that  constitutes  the  rest  of  the  nucleolus,  but 
intranucleolar vacuoles can also be seen.  However,  no  nucleoli were seen  in 
the  R6/2  neurons  that  were  completely  segregated  into  the  three  distinct 
components  that  is  the  nucleolar  ultrastructure  that  is  reported  to  be 
characteristic  of  a  completely  inactive  or  transcriptionally  arrested  nucleoli 
(Shaw  and  Jordan,  1995).  During  the  initial  phase  of osmotic  stress  when 
transcription  is  decreased,  SON  neurons  undergo  similar  nucleolar 
reorganisation:  the  segregation  of  different  regions  and  the  formation  of 
vacuoles that often contain microspheres (Lafarga et al.,  1991).
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*75  DISCUSSION & CONCLUSIONSThe findings of this ultrastructural study may therefore suggest a reduction in 
nucleolar transcription  rate  but  not  complete transcriptional  arrest  in  the  SS 
nucleoli.  This theory is also supported by the fact that the SS nucleoli, seen in 
the R6/2 neurons,  do not share the same morphological characteristics of the 
segregated  nucleoli  observed  in  a  study of partial deletion  of rRNA genes  in 
Xenopus (Miller and  Gonzales,  1976).  The nucleoli of these oocytes become 
very compact and  segregate completely into fibrillar and granular regions. The 
formation of microspheres and vacuoles within  nucleoli has been documented 
in  cycloheximide treated  SON  neurons  (Lafarga  et ai,  1994).  Cycloheximide 
treatment  inhibits  protein  and  rRNA  synthesis  and  this  study  revealed  a 
decrease in the size of nucleoli after drug treatment.  These results show that 
protein  synthesis  and  rRNA  synthesis  is  required  for  the  maintenance  of 
nucleolar morphology,but how the formation of microspheres occurs is not fully 
understood.
Any morphological changes seen  in the ultrastructure of the nucleolus are 
likely to  reflect a  change  or  problem  with  rRNA transcription  and  synthesis. 
Reorganisation of nucleolar components clearly reflects a substantial alteration 
of the transcription activity of ribosomal genes.  The reorganisation seen in the 
SS  nucleoli of the  R6/2 striatal  nuclei  may therefore  represent a disruption  in 
rRNA transcription or synthesis.  Roizin et ai  (1979) also observed changes in 
nucleolar morphology when  tissue from  HD  patient  biopsies  was  examined. 
The  altered  appearance  of the  nucleoli  was  suggested  to  reflect  defective 
protein  synthesis via the  nucleolus-ribosomal  system.  The  results from  this 
study do not support a model of HD where transcription of rRNA is completely 
arrested but it may possibly be decreased with disruption to protein synthesis as 
well.
4.1.2  The Ultrastructure of the Cajal Body
The  results of this study show that Cajal  bodies  (CBs)  in  striatal  neurons 
appear to have the characteristic CB morphology of a distinct electron dense, 
nuclear body composed of coiled fibrillar strands embedded  in an amorphous 
matrix (Lafarga et al.,  1983) and were seen in 28% of nuclei examined in 70 m  
ultrathin sections.  The CBs were either attached to the nucleolus or free in the
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greater number of nucleolar-associated  Cajal  bodies were seen compared to 
nucleoplasmic  CBs  (graph  4.2)  and  the  nucleolar  CBs  had  slightly  smaller 
diameters than the free CBs.  This greater number of nucleolar-CBs is possibly 
to be expected in neurons as Cajal did name CBs as ‘accessory bodies of Cajal’ 
due to their close association with the nucleolus.  However, in different neuronal 
types,  different frequencies  of nucleolar versus free  CBs  can  be  seen.  For 
example,  in  hamster facial  motor neurons  most CBs are  associated with the 
nucleolus^ but  in  pyramidal  neurons  of  the  hamster  cerebral  cortex 
nucleoplasmic CBs are most frequently seen  (Kinderman and  LaVelle,  1976). 
In  the  murine  striatal  nuclei  no  structures  that  resemble  gems  were  seen 
adjacent to either nucleolar or nucleoplasmic CBs.
From  the  ultrastructural  study  it was  not  possible  to  assess the  average 
number  of CBs  per  cell  because  the  ultrathin  sections  that were  examined 
under the TEM were very thin  (70 rw)  and  the average diameter of a  striatal 
neuronal nucleus is about 10 yw and so all CBs within one nucleus could not be 
visualised in one section.  It was possible to demonstrate that most CBs in the 
murine  striatal  nuclei  are  associated  with  the  nucleolus  and  serial  section 
reconstructions  that  have  been  carried  out  on  a  few  striatal  nuclei,  in 
conjunction with  M.Turmaine,  confirm this finding  (data  not shown).  It is the 
larger, free CBs that are reported to be associated with specific gene loci in the 
nuclei of HeLa cells (Platani et ai,  2000).  If this is true for all cell types,  it is 
therefore possible to conclude that only a small percentage of CBs (21%) in the 
striatal nuclei are associated with specific genes at any one time.
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<77  DISCUSSION & CONCLUSIONSMorphologically similar CBs were seen in both the striatal nuclei from  R6/2 
and  p80  coilin  KO  mice.  In  R6/2  transgenic  mice  there  were  more,  slightly 
smaller,  nucleolar-associated  Cajal  bodies  compared  to the  larger,  free  CBs 
(graph  4.2).  However,  in  the  R6/2  nuclei,  CBs  were  also  seen  at  a 
different/novel  localisation.  It  is well  documented  that  neuronal  intranuclear 
inclusions (Nils) are present in striatal nuclei of HD transgenic mice and human 
HD  post-mortem  brains  (chapter  1.6.5)  as  well  as  in  other  polyglutamine 
diseases and can be seen as a pale, spherical inclusion in the nucleus of R6/2 
striatal neurons (Davies et ai,  1997 and chapter 3.3.4).  When, in this work, the 
different localisations of CBs were analysed in the striatum of R6/2 mice nearly 
half the CBs were seen to be associated with the Nil (graph 4.2).  This is not the 
first  reported  observation  of  Nil-associated  CBs  as  Yamada  et  ai  (2001) 
demonstrated the same association in  DRPLA and MJD human brains as well 
as DRPLA transgenic mouse brains.  As with the findings in this study, the CB 
and Nil were seen either in direct contact with each other or connected to each 
other via fibres ( figure 3.16).
In  the  R6/2  nuclei,  only  28%  of nuclei  examined  had  a  visible  CB  but of 
those examined 46% of the CBs were seen juxtaposed to the Nil.  There was a 
significant  reduction  in  the  percentage  of  nucleolar-associated  CBs  but  the 
percentage of CBs that were nucleoplasmic was similar to that seen in the wild- 
type striatum (graph 4.2).  As a similar percentage of nuclei contained  CBs in 
the  R6/2 and the wild type  neurons, the R6/2 striatal  neurons appear to have 
lost  nucleolar-associated  CBs  and  gained  Nil-associated  CBs  that  have  a 
significantly larger diameter compared to the CBs at the two other localisations.
A reduction in the total number of CBs has been reported in transcriptionally 
inactive HeLa cells (Raska et ai,  1991),but no study has shown a decrease in 
one type  of CB  and  an  increase  in  another type  of CB.  One  study  showed 
differences in the frequency of nucleolar-associated CBs in three types (small, 
medium  and  large)  of trigeminal  ganglion  neurons  (TGN),  with  large  types 
having a higher level of transcriptional activity and the greatest number of total 
CBs  compared  with  small  and  medium  types  of TGN  neurons  (Pena  et al., 
2001).  The  large  TGN  neurons  also  had  a  higher  number  of  nucleolar- 
associated CBs.
Nucleolar  CBs  are  found  in  many  cell  types  and  are  seen  as  a  direct
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relationship  is  believed  to  support  the  view  that  CBs  can  assemble  at  the 
nucleolar surface in a transcription-dependent manner (Pena et ai, 2001).  It is 
suggested that the higher number of nucleolar-associated CBs seen in the large 
TGN  neurons could facilitate the targeting to the nucleolus of basic constituents 
of the pre-rRNA processing machinery in neurons with high cytoplasmic needs 
for ribosome biogenesis and therefore the decrease in  nucleolar CBs seen  in 
the R6/2 nuclei could represent a reduction in the need for ribosomes.
When  HeLa  cells  are  treated  with  the  protein  synthesis  inhibitor, 
cycloheximide, there are reported morphological changes to CBs (Lafarga et ai, 
1994  and  chapter  1.4.2)  and  CBs are found within the  nucleolus when  HeLa 
cells  are  treated  with  okadaic  acid,  a  serine-threonine  protein  phosphatase 
inhibitor (Lyon et ai,  1997 and chapter 1.4.2).  Another study showed a positive 
correlation between transcriptional activity and the number of CBs within nuclei 
(Pena etai, 2001  and chapter 1.2.14),but none of these studies show a loss of 
one type of CBs or an increase in CB diameter.
The  consequence  of  the  loss  of  nucleolar-CBs  and  the  gain  of  Nil- 
associated CB is not known.  What affect this novel association between the Nil 
and the  CB  has on  other nuclear subdomains  remains to  be discovered  and 
whether the association is as a result of changes in other subdomains is yet to 
be determined.
In the p80 coilin knockout striatal neurons, CBs were somewhat smaller than 
those examined  in the wild-type striatal  neurons  and were  less frequent with 
only 17% of nuclei containing a CB.  Also, 98% of the CBs in the p80 coilin KO 
nuclei were nucleolar-associated which was greater than the79% seen  in wild- 
type nuclei.  This suggests that the lack of p80 coilin leads to smaller CBs that 
are more frequently associated with the nucleolus.  Is this directly or indirectly 
due  to  the  deletion  of  p80  coilin?  There  appeared  to  be  no  structural 
differences  between the  CBs  in the  p80 coilin  KO and the wild-type  neurons 
despite  the  fact  that  the  marker  protein  for  Cajal  bodies,  p80  coilin,  is  not 
present.
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Nuclear speckles are involved in the maturation, trafficking and  recycling of 
pre-mRNA splicing factors and at the ultrastructural level are composed of two 
distinct regions (Dundr and Misteli, 2001  and chapter 1.3.1). The findings of this 
study reveal that interchromatin granule clusters (IGCs) in the nuclei of murine 
striatal  neurons  have the  characteristic  morphology that  is  reported  in  other 
cells  types  (Mintz  et at.,  1999).  The  IGCs  are  comprised  of closely  packed 
granules, 20-25 nfl  in diameter, which are seen in clusters that vary in size.
The  second  component  of  speckles  at  the  ultrastructural  level  is 
perichromatin fibrils (PFs).  The PFs originate from the edge of IGCs and  are 
distributed  throughout  the  nucleoplasm  (Spector,  1983).  In  murine  striatal 
nuclei, fine fibres can be seen emerging from the IGCs as well as the nucleolus. 
These PFs are reported to be the nascent transcripts as they have been shown 
to label with [3H]uridine (Fakan,  1994), but the IGCs are not sites of pre-mRNA 
splicing.  Splicing takes place co-transcriptionally at the periphery of the IGCs, 
which are suggested to supply splicing factors to transcription sites.
Due to the diverse structure and  varied  size  of IGCs  and  PFs,  it was  not 
possible  to  obtain  a  meaningful  quantification  of  speckles  from  the  70 m  
ultrathin sections as speckles occupy so much of the nuclear volume.  The only 
solution  would  have  been  to  carry  out  a  serial  section  through  a  complete 
nucleus to give a three-dimensional image of these complicated structures.  It 
was only possible to demonstrate their fine ultrastructure and confirm that it is 
possible to  distinguish  IGCs  and  PFs  in  the  nucleoplasm without the  use  of 
immunolabelling.
The same situation occurred when examining the morphology of speckles in 
R6/2  striatum  and  p80  coilin  KO  striatum.  Nuclei  from  both  mice  contained 
IGCs and PFs that showed the same characteristic morphology.  However, the 
IGCs seen in the R6/2 nuclei did seem more distinct than those seen in the wild- 
type  mouse  and  possibly  larger.  Large  IGCs  have  been  reported  in  SON 
neurons that have been treated with the protein  and  rRNA synthesis inhibitor, 
cycloheximide (Lafarga et ai,  1994) and  in cells where transcription has been 
arrested (Lafarga et al.,  1998).  In transcriptionally inactive cells it is possible to 
see enlarged clusters of IGCs that are very prominent and these resemble the
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specific antibodies (O’Keefe et al.,  1994).
However,  the  IGCs  seen  in  R6/2  nuclei  are  not  spherical  and  do  not 
resemble the enlarge clusters seen after cycloheximide treatment.  The fact that 
the IGCs in the R6/2 nuclei are slightly more distinct may indicate a slight down 
regulation  in  transcription  or rRNA and  protein  synthesis  but  not a  complete 
arrest of any of these processes.
4.1.4  The Ultrastructure of Nils
The  presence of Nils  in  R6/2  striatal  nuclei  has  been  documented  before 
(Davies et al.,  1997 and chapter 1.6.5), as well as in this study.  The findings of 
this study confirm the ultrastructural appearance of Nils within striatal nuclei to 
be a pale, granular inclusion that resembles no other structure in the  nucleus 
(figure 3.16C).  Nils have now been seen in all polyglutamine diseases (chapter
1.7.1)  and  similar  inclusions  have  been  reported  in  some  of the  non-coding 
repeat expansion disorders (chapter  1.7.2),but it is still  unclear as to the role 
they play in the pathology of these two groups of diseases.
Inclusions  have  also  been  seen  to  form  in  the  nucleus  when  protein 
synthesis is inhibited with cycloheximide (chapter 1.4.5).  In dehydrated rat SON 
neurons,  nuclear aggregates  have  been  seen  that are  morphologically  pale, 
granular structures (Lafarga et al.,  1993).  It is suggested that the formation of 
the inclusion reflects a dysfunction of the nucleolus as rRNA synthesis is also 
inhibited  by  cycloheximide.  However,  the  molecular  composition  of  these 
inclusions was not investigated and it remains unclear as to why dysfunction in 
the  nucleolus would  lead  to the formation  of an  inclusion.  The  formation  of 
inclusions  has  also  been  reported  in  liver  cells  that  were  treated  with 
Actinomycin  D  to  inhibit  transcription  (Reynolds  et al.,  1964  and  chapter
1.4.5).  These aggregates were not easily distinguishable and  have  not been 
reported in any of the other studies that involve transcriptional inhibition.
What cellular process leads to the formation of these nuclear inclusions (in 
neurodegenerative diseases and in experiments where drug treatment is used 
to  alter various  metabolic  activities)  remains  a  mystery, but  the  Nil  is  still  a 
distinct feature of them all.
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From the ultrastructural analysis of the three nuclear subdomains in murine 
striatal nuclei, it is possible to conclude the following:
1.  Not all striatal nucleoli exhibit the same nucleolar morphology.
2.  Most striatal Cajal bodies are nucleolar-associated
3.  Free  CBs  are  infrequently  present  in  striatal  nuclei.  They  are  slightly 
larger than  nucleolar-associated  CBs  and  it is  suggested  that these  CBs are 
associated with specific gene loci.
4.  Speckles can be seen in the striatal nuclei without immunolabelling.
From the  ultrastructural  study  on  three  subdomains  in  the  R6/2  nuclei,  it 
could be suggested that there may be a slight downregulation  in transcription, 
ribosome biogenesis or protein synthesis.  It must be noted that although these 
conclusions give an insight into the organisation of the nucleus, they do not give 
a complete understanding of the architecture of the neuronal nucleus as only a 
very thin  section  is  being  analysed  at any  one time.  For example,  from  the 
ultrastructural study, the only 28% of nuclei contained CBs.  To try and discover 
a more three-dimensional image of the striatal nucleus and the relationships of 
the three subdomains being analysed, other techniques must be used and the 
results combined.
4.2 The Molecular Composition of the Nucleus
To try and  understand  how the  ultrastructural  organisation  of the  nucleus 
reflects  the  functional  organisation,  the  molecular  characterisation  of  many 
nuclear subdomains has led  to the localisation of many nuclear processes to 
specific  nuclear  structures  (Lamond  and  Earnshaw,  1998).  Numerous 
experiments  have  now  highlighted  the  dynamic  nature  of  nuclear  proteins 
(Misteli et al.,  1997;  Platani  et al.,  2000;  Misteli,  2001)  and  how alterations in 
nuclear  localisations  of  certain  proteins  can  reflect  a  change  in  metabolic 
activity (Carmo-Fonseca etal.,  1992; Lafarga etai,  1994; Bregman etal.,  1995; 
Zeng etal.,  1997; Sleeman etal.,  1998; Pena etal., 2001).
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domains (nucleolus, Cajal body and speckles) studied ultrastructurally and try to 
build a detailed three-dimensional image of the murine striatal nucleus.  This will 
then be compared to the R6/2 transgenic mouse and the p80 KO mouse to see 
if  any  molecular  alterations  can  be  seen.  As  HD  is  suggested  to  have 
transcriptional  dysregulation  (chapter  1.6.7-9),  any  changes  reported  in  the 
R6/2  mouse  will  be  compared  to  the  alterations  seen  when  transcription  is 
inhibited with Actinomycin D to ascertain if any similarities can be identified.
4.2.1  The Molecular Composition of the Nucleolus
The  list  of  known  molecular components  of the  nucleolus  has  increased 
rapidly  since  the  development  of  mass-spectrometry-based  organellar 
proteomics  (Andersen  et al.,  2002).  In  2002,  Andersen  et al.  identified  271 
proteins that localised to the nucleolus and this number has since risen to 489 
proteins  that  can  be  seen  to  localise  to  nucleoli  after  cells  are  treated  with 
different  metabolic  inhibitors  (Andersen  et al.,  2005).  To  investigate  the 
molecular  composition  of  nucleoli  in  striatal  neurons,  immunocytochemical 
analyses  were  performed  using  a  number  of  antibodies  against  several 
nucleolar proteins.  Nucleolar proteins that are reported to localise to each of 
the three distinct regions of the typical  mammalian  nucleolus were examined 
(chapter 1.1.4 and figure 3.1).
When examined by light microscopy (using x 100 oil immersion objectives), 
the  immunoreactivity  for  fibrillarin,  GAR1  and  Nopp140  revealed  a  similar 
staining  pattern:  a  solid,  spherical  structure  in  the  nucleus  with  nucleolar- 
associated  Cajal  bodies  (CBs)  frequently  labelled  as  well  as  occasional 
nucleoplasmic CBs (figure 3.6B-D).  Nb nuclecpasmic staining could be seen 
for fibrillarin and  GAR1  but it was p re*|^^R o p p 140. The immunoreactivity 
for C23 showed a different staining pSffern: a circular ring around the nucleolar 
periphery, with a high level of nucleoplasmic staining and no visible CBs (figure 
3.6E). Topoisomerase II  revealed a similar staining pattern but it also included 
staining of nucleolar-associated CBs.  Antibodies against B23 unfortunately did 
not  reveal  a  staining  pattern for this  nucleolar protein  despite  many different 
fixation  protocols  being  tried.  An  antibody  against  upstream  binding  factor
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appeared  in  groups  (figure  3.6A).  Immunoreactivity  for  a  subunit  of  RNA 
polymerase  I  was  mainly  nucleoplasmic with  occasional  small,  nuclear foci 
(figure 3.6F).  A quantitative analysis of the nucleolar immunoreactivity in this 
study  supported  the  results  form  the  ultrastructural  investigation  that  most 
striatal nuclei contained on average only one nucleolus (graph 3.3).
The findings of this work demonstrate that nucleoli within  nuclei  of murine 
striatal  neurons are immunoreactive for several of the  most studied  nucleolar 
components.  The immunoreactive foci seen for the fibrillar centre (FC) marker 
protein,  UBF,  appeared to be smaller than those seen for the other nucleolar 
proteins.  From  the  ultrastructural  analysis  of striatal  nucleoli,  this  study  has 
shown that FCs can vary in size from either tiny foci seen  in closed-reticulate 
structure  (CRS)  nucleoli  that  can  only just  be  distinguished  or  larger,  more 
prominent  regions seen  in the open-reticulate  structure  (ORS)  nucleoli.  The 
staining  pattern  seen  for  anti-UBF  does  correlate  with  these  morphological 
findings and the larger, grouped foci seen probably represent the FCs of ORS 
nucleoli.  Although  UBF  has been  reported to  localise within the  DFC  as well 
(Shaw and  Jordan,  1995),  the staining  pattern for anti-UBF does  not support 
this in murine striatal nuclei.  RNA polymerase I is also proposed to be a marker 
for FCs, but the results seen in this study do not confirm this for striatal nucleoli 
as a more heterogeneous nucleoplasmic staining pattern was seen for anti-RNA 
polymerase I when compared to the staining for UBF.
Fibrillarin, GAR1  and Nopp140 are all reported to be markers for the dense 
fibrillar component (DFC) of nucleoli whereas B23 and C23 are suggested to be 
markers  for  the  granular  component  (GC)  (Shaw  and  Jordan,  1995).  The 
findings  of this  work  do  support the  idea  that C23  is  not found  in  the  same 
region as fibrillarin and  GAR1  because the staining  pattern for the respective 
antibodies were different.
The distribution  of fibrillarin was also  analysed  at the  ultrastructural  level 
using immuno-electron microscopy (figure 3.7A-B).  Fibrillarin immunoreactivity 
showed  a  heterogeneous staining  pattern within the  nucleolus that excluded 
FCs.  When  the  localisation  of  fibrillarin  was  examined  using 
immunofluorescence and a Z-series scan was performed that allowed the three 
dimensional reconstruction of the entire nucleus, it was possible to see that the
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The immunofluorescence for fibrillarin actually had a heterogeneous distribution 
within the nucleolus itself.  When a single section was analysed,  it was possible 
to see that the entire nucleolus did not contain immunofluorescence for fibrillarin 
and  patches  devoid  of immunofluorescence were  seen.  The  areas  with  no 
immunofluorescence are likely to correspond to the FCs.
The  distribution  of fibrillarin  using  either  immuno-electron  microscopy  or 
confocal  microscopy  revealed  a  heterogeneous  localisation  of this  nucleolar 
protein within the nucleolus.  The immunofluorescence results, together with the 
immuno-electron  microscopy  results,  clearly  showed  that  FCs  are  devoid  of 
fibrillarin.  The  immuno-EM  data  also  showed  that fibrillarin  has  an  irregular 
localisation  over the  remaining  region  of the  nucleolus.  The  ultrastructural 
analysis in this study suggested that the DFC and GC  of striatal nucleoli were 
arranged in an entanglement around the FCs as neither region could be clearly 
identified.  The  immuno-EM  for  fibrillarin  support  this  view  as  the 
immunoreactivity is  not seen  in distinct areas surrounding the  FCs that is the 
characteristic distribution of DFCs in many mammalian  nucleoli.
However,  a  difference  in  the  pattern  of  immunoreactivity  was  seen  for 
protein  markers of the  DFC  (fibrillarin,  GAR1  and  Nopp140) compared to the 
pattern  of immunoreactivity seen  for protein  markers  of the  GC  (C23).  This 
could  mean  that  even  though  the  DFC  and  the  GC  could  not  be  easily 
distinguished  using  EM,  on  a  molecular level,  the  two  nucleolar  regions  are 
distinct.  Double labelling immunofluorescence experiments would have shown 
if different nucleolar proteins, that appear to have a different staining pattern at 
light  microscopy,  do  actually  localise  to  different  nucleolar  regions. 
Unfortunately, the fixation protocols used to achieve immunoreactivity for many 
of the nucleolar protein antibodies at light microscopy did not work for confocal 
microscopy, or, the two antibodies for the two nucleolar protein that were to be 
compared  needed  different  fixation  protocols  to  work  and  so  could  not  be 
visualised  on  the  same  section  (table  2.1).  Similar  fixation  problems  arose 
when  trying  to  use  immuno-electron  microscopy to  study  the  ultrastructural 
localisation of many of the nucleolar proteins.
The fact that antibodies against B23 did not reveal any staining pattern does 
not necessarily mean that this nucleolar protein is absent from striatal nucleoli
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antibody to recognize the murine B23 epitope.
When  the  localisation  of  Hsc70  was  analysed  using  immuno-EM,  it was 
seen to localise to the periphery of the nucleolus in striatal nuclei (figure 3.7C- 
D).  Hsc70  is  one  of the  hsp/hsc70  family  of  heat  shock  proteins  that  are 
involved  in  many  cellular  processes  (Moon  et ai,  2001).  These  functions 
include the folding of newly synthesised proteins and the targeting of proteins to 
their correct localisation within the cell (Moon et al., 2001).  One study in HeLa 
cells showed that Hsc70 associated with the nucleolus but only after heat shock 
(Welch  and  Mizzen,  1988).  However,  the  presence  of  Hsc70  in  nucleoli  of 
control  9L  RBT  (rat brain  tumor)  cells  has  been  demonstrated  (Wang  et al., 
1998)jbut the role played by Hsc70 in the nucleolus is unclear.
The  localisation  of  the  same  nucleolar  proteins  were  analysed  in  R6/2 
transgenic mice striatal nucleoli.  A quantitative analysis also showed that most 
R6/2 striatal nuclei contained  only one nucleolus supporting the ultrastructural 
findings (graph 3.7).  The immunoreactivity for fibrillarin, C23,  RNA polymerase 
I  and  topoisomerase  II  were  all  similar to that  seen  in  the wild-type  nucleoli 
(figure  3.18).  Nopp140,  however,  revealed  a  less  intense  staining  of the 
nucleolus and  a more intense staining of CBs.  Immunoreactivity for fibrillarin, 
Nopp140  and  C23  definitely  revealed  nucleoplasmic  CBs  whereas 
topoisomerase did  not.  Hsc70 was no longer seen at the nucleolar periphery 
and was seen to colocalise with the Nil (figure 3.19).
A study that investigated the  effect of different metabolic inhibitors on the 
distribution of nucleolar proteins showed that the localisations of C23 and  B23 
were altered when Actinomycin D was used to inhibit the RNA polymerases in 
breast cancer cells  (Perlaky  et al.,  1997).  Both  nucleolar proteins  no  longer 
localised  to  the  nucleolus  but  showed  a  nucleoplasmic  distribution.  The 
presence of C23 in nucleoli of R6/2 striatal nucleoli could therefore suggest that 
these neurons are transcriptionally active.  After treatment with Actinomycin  D 
rat primary cerebellum  cultures also showed that fibrillarin  redistributes when 
the  activities  of all  the  RNA  polymerases  are  inhibited  (Raska  et al.,  1990). 
Immunoreactivity for fibrillarin  revealed  cap-like structures  at the edge of the 
nucleolus  that  colocalised  with  the  CB  marker  protein,  p80  coilin.  The 
localisation of fibrillarin  in the  R6/2 striatal  nucleoli was similar to that seen  in
186  DISCUSSION & CONCLUSIONSthe wild-type striatal  nucleoli and  can therefore possibly be  used  as  indicator 
that transcription has not been affected in the R6/2 nuclei.
Nopp140 is suggested to have several functions in the nucleolus and moves 
between  the  cytoplasm  and  the  nucleolus  as  well  as  moving  between  the 
nucleolus and  CBs (Snaar et al.,  2000).  The more prominent staining of CBs 
with  anti-Nopp140  in  this  study  suggests  that  there  may  be  tj  change  in 
distribution of Nopp140 in the nucleolus (a decrease) or CBs (an increase).
In R6/2 striatal nuclei, a redistribution of Hsc70 was also seen as it no longer 
localised to the nucleolar periphery and, instead, was seen to accumulate in the 
Nil.  A  study  by  Jana  et al.  (2000)  has  shown  that  Hsc70,  as well  as  other 
chaperones, can bind to polyglutamine proteins and that Hsc70 colocalised with 
the Nil  in mouse neuro2a cell  lines expressing truncated  N-terminal huntingtin 
with expanded polyglutamines.  This colocalisation was also seen in R6/2 mice 
but as the colocalisation was only seen in some of the nuclear inclusions.  It is 
therefore suggested that the chaperones are not involved in the aggregation of 
the mutant protein because if this were true all aggregates (nuclear or dendritic) 
would  contain  these  chaperones  (Jana  et al.,  2000).  The  consequence  of 
Hsc70  being  lost from  the  nucleolar periphery  in  the  R6/2  nuclei  may cause 
incorrect targeting of other nuclear proteins.
The findings of this study  show that there  is  not a  major difference  in the 
molecular composition of the R6/2 striatal nucleolus compared to that of the wild- 
type  striatal  nucleolus,  and  that,  only  one  of the  chosen  nucleolar  proteins 
revealed a slight redistribution together with the loss of Hsc70.  This suggests 
that,  despite the fact that 21% of nucleoli  in  R6/2  nuclei show an alteration  in 
their  ultrastructure,  the  segregating  structure  (SS),  the  nucleolar  proteins 
studied  are  still  recognized  by  the  antibodies  and  localised  to  nucleoli  in  a 
similar pattern that seen in the wild-type nucleoli.  The SS nucleoli seen in R6/2 
nuclei have alterations at the morphological level but not at the molecular level.
The ultrastructural analysis of the R6/2  nucleoli and the observation of the 
SS  nucleolar  morphology  has  lead  to the conclusion that these  nucleoli  may 
reflect  a  disruption  in  rRNA  transcription  and/or  protein  synthesis  as  the 
morphological  changes  resemble those  seen  in  cycloheximide  treated  SON 
neurons  (Lafarga et al.,  1994).  Few studies have analysed the distribution of 
nucleolar  proteins  in  cycloheximide  treated  cells  but  the  studies  that  have
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topoisomerase I, are not shown to redistribute after drug treatment (Buckwalter 
et  al.,  1996;  Zhang  et  al.,  1999).  It  could  therefore  be  predicted  that  the 
inhibition  of protein  synthesis  and  disruption  of rRNA transcription  does  not 
cause a re-distribution of nucleolar components like those seen when cells are 
treated  with  inhibitors  of all  RNA  polymerases,  like  Actinomycin  D  (chapter
1.4.1).  If this is correct, then the findings of this study that demonstrate that a 
proportion of nucleoli in R6/2 nuclei may have an altered ultrastructure but not a 
change in the localisation of nucleolar proteins would be expected.
Only the distribution  of fibrillarin was analysed  in the  p80  coilin  knockout 
mice  and  the  immunoreactivity seen with anti-fibrillarin antibodies  revealed  a 
similar staining pattern to that seen in the wilcLtype striatal nuclei:  a prominent 
spherical  structure with  nucleolar-associated  CBs.  The findings of this study 
show that the lack of p80 coilin does not affect the distribution of the nucleolar 
protein, fibrillarin.
4.2.2  The Molecular Composition of the Cajal Bodies
Like  the  nucleolus,  protocols  have  now  been  developed  that  allow  the 
isolation  of  Cajal  bodies  (CBs)  and  the  possible  identification  of  molecular 
constituents of the  isolated  nuclear organelle using  mass-spectrometry-based 
proteomics  (Lam  et al.,  2002).  Despite  the  identification  of  many  nuclear 
components that localise to CBs (Matera,  1999 and chapter 1.2.5), p80 coilin is 
still regarded as the molecular marker protein and is widely used to detect CBs. 
In this study,  antibodies to p80 coilin together with a  number of other nuclear 
proteins  that  are  found  within  CBs  were  used  to  analyse  the  molecular 
composition of murine striatal CBs.
Immunoreactivity for  p80  coilin,  survival  of  motor  neuron  protein  (SMN), 
Gemin2-4, U2” snRNP, poly(A) polymerase (PAP) and  Ewing’s sarcoma (EWS) 
all revealed bright nuclear foci when viewed under high power light microscopy 
(figure  3.20).  When  the  average  number of CBs  identified  per nucleus was 
compared for p80 coilin and  U2” snRNP, this study discovered that more p80 
coilin-positive  CBs  were  present  in  murine  striatal  nuclei  than  U2”snRNP- 
positive CBs (graph  3.4A).  From the light microscopy study,  on average only
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CBs  varied  in  number from  one to  four  per  nucleus.  These  results  did  not 
change from 4 to 12 weeks of age.
Similar  results  to  those  seen  for  U2”  snRNP  were  obtained  when  the 
average number of CBs containing SMN,  Gemin2 and Gemin4 were analysed. 
These results suggest that most striatal nuclei do have CBs and this differs from 
the 28% of nuclei seen to contain CBs  in the ultrastructural part of this study. 
The  results  also  highlight the fact that not all  CBs  have the same  molecular 
composition.  Gemin4  has  been  reported to  localise  in the nucleolus of HeLa 
cells (Charroux et al., 2000),but this was not seen in this study.
The results from the light microscopy study only revealed the presence of a 
particular protein  in  CBs  and the average number of CBs that contained that 
protein.  The  light microscopy study did  not show the  localisation  (nucleolar- 
associated  or nucleoplasmic) of the different CBs that were positively stained 
for  the  different  proteins.  Immuno-electron  microscopy  was  carried  out  on 
murine  striatal  neurons  to  analyse the  different  localisations  of different  CB 
proteins.  However, as only a 70 am  section was being examined and, therefore, 
on average, only one immunoreactive CB was visible, it was difficult to create a 
complete understanding of the organisation and distribution of all the CBs in an 
entire  nucleus.  Double labelling  confocal  microscopy was  used  to solve this 
problem  as  experiments  could  be  carried  out  using  secondary  antibodies 
conjugated  to  FITC,  which  can  be seen  in the green  channel,  and  pyronin Y 
stain that can  be seen in the red  channel and  labels RNA, therefore revealing 
the  nucleolus.  A Z-series scan  could  be performed  and  this would  allow the 
entire nucleus of a neuron to be reconstructed.
When the average number of CBs was counted for either p80 coilin or SMN 
immunofluorescence  similar results were  obtained  to  those  seen  in  the  light 
microscopy study,  with  p80  coilin  being  localised  to  more  CBs  compared  to 
SMN (graph 4.3).  Anti-SMN was mainly found to label only one CB per nucleus 
but infrequently labelled two CBs.  Anti-p80 coilin, on the other hand, revealed a 
more varied  number of CBs per nucleus with  nearly half the nuclei examined 
containing two CBs.  Occasionally nuclei were seen to contain three or four p80 
coilin-containing CBs.
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Graph 4.3
A graph showing the average number of 
CBs per nucleus that contained either 
p80 coilin or SMN in wild-type nuclei 
(blue) or R6/2 nuclei (pink).  For p80 
coilin, Student’s unpaired Mest (t =
9.25; ***p<0.001). For SMN, Student’s 
unpaired Mest (t = 2.00; *p<0.05). Error 
bars are standard errors of mean.
As the nucleolus could be easily identified due to the pyronin Y staining, the 
exact localisation of the CBs, immunofluorescence for either SMN or p80 coilin, 
could  be  recorded.  CBs  containing  SMN  were  seen  to  be  only  nucleolar- 
associated  while  p80  coilin  containing  CBs  were  seen  to  be  both  nucleolar- 
associated and free in the nucleoplasm (graph 4.4A-B).  The SMN-positive CBs 
were all of similar size whereas the p80 coilin-positive CBs varied in size.  The 
findings of this study therefore show that not all CBs  in  striatal  nuclei  are the 
same size or have the same protein composition.
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Graph 4.4
Graphs showing the percentage of the total number of CBs that were either nucleolar-associated or free 
in wild-type  mice  (blue) or R6/2  mice  (pink).  Graph A shows the  results for CBs containing  p80 coilin 
and  graph  B  shows  the  results  for  SMN-containing  CBs.  For  Graph  A,  Chi-Square  test  for 
independence  (X2S =  12.56;  p<0.01).  For  Graph  B,  Chi-Square  test  for  independence  (X2S =  4.03; 
p<0.05).
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reported previously.  Carmo-Fonseca et al. (1993) demonstrated that in primary 
rat neurons an  antibody against p80 coilin stained  nucleoplasmic CBs as well 
as “caps” of varying size at the nucleolar periphery.  The study showed that only 
the  larger “caps” stained  positively for snRNPs.  When  immuno-gold electron 
microscopy  was  used  to  investigate  the  ultrastructure  of the  “caps”,  it  was 
shown that the anti-p80 coilin staining at the nucleolar periphery corresponded 
to  small  CBs  (Carmo-Fonseca  et al.,  1993).  It  was  suggested  that  these 
structures  were  partially  assembled  CBs  that  were  either  assembling  or 
disassembling at the periphery of the nucleolus.  Another study on mammalian 
endothelial cells revealed that nuclei from these cells contained more p80 coilin- 
positive CBs when compared to the RNA-binding protein  pig  pen/TLS-positive 
CBs or fibrillarin-positive CBs (Alliegro and Alliegro,  1998).  This suggests that 
CBs might have different functions depending on their molecular composition.
From the light microscopy study of nucleolar proteins it can be seen that in 
murine striatal nuclei, nucleolar-associated CBs and nucleoplasmic CBs contain 
the nucleolar proteins fibrillarin, GAR1  and Nopp140.  Topoisomerase II is also 
found to localise within nucleolar-associated CBs but not free.  From the double 
labelling confocal microscopy experiments it was possible to see that fibrillarin 
was found  to  colocalise with  nearly all  the  p80  coilin-positive  CBs  that were 
either nucleolar-associated or nucleoplasmic in localisation.
The  presence  of  nucleolar  proteins  in  CBs  has  been  well  documented 
(Raska  et al.,  1990;  Raska,  1991;  Jimenez-Garcia  et  al.,  1994;  Meier  and 
Blobel,  1994)  and  supports  the  close  relationship  between  the  two  nuclear 
organelles meaning that the relationship is not just a spatial one but also on the 
molecular level.  Whether the nucleolar proteins carry out the same functions in 
CBs as they do in the nucleolus is not understood.
The molecular heterogeneity of CBs may therefore correspond to subsets of 
CBs that somehow exclude particular molecules, the  mechanism for which  is 
not  known.  The  subsets  of CBs  could  either  represent functionally  distinct 
subpopulations  of  CBs  or  reflect  different  stages  in  the  assembly  or 
disassembly of CBs.
Double labelling confocal  microscopy in this study also demonstrated that 
p80 coilin and SMN localised to the same nuclear foci,  ruling out the possibility
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results from  a  study that  investigated  the  distribution  of CBs versus gems  in 
different tissue types (Young et al., 2000).  In rabbit, pig and human brain cells 
independent gems were not observed and the CBs seen were large in size and 
frequently positioned adjacent to the nucleolus.  The same study also reported 
CB heterogeneity, as 10% of CBs seen were p80 coilin positive but lacked SMN 
protein.
The results of this study, on ultrastructural and molecular characterisation of 
the Cajal body,  have also shown that depending on which technique is used to 
analyses CBs, different average numbers per nucleus are seen.  For example, 
from the ultrastructural study, the average number of CBs per nucleus was only
0.28, whereas, at the light microscopy level, the average number of CBs ranged 
from 0.88 to 2.4 per nucleus.  This number rose further, when a Z-series scan 
was  performed  and  an  entire  nucleus  was  reconstructed,  to  2.53  CBs  per 
nucleus.  These findings demonstrate that to gain a complete understanding of 
the neuronal nucleus, a number of different techniques must be used.
When the localisation of the same CB proteins were analysed in  R6/2 mice 
striatal nuclei, a number of differences were seen.  The first difference observed 
was  a  decrease  in  the  average  number of CBs  containing  p80  coilin.  At 4 
weeks of age, the average number of p80 coilin-positive CBs per nucleus in the 
R6/2 striatal nuclei was similar to that seen in the wild-type nuclei.  However, at 
10 weeks of age, the average number of CBs had decreased significantly in the 
R6/2  nuclei.  Surprisingly,  the  average  number of CBs  seen  to  contain  the 
other CB  proteins (SMN,  Gemin2,  Gemin4 and  U2” snRNP) did  not show any 
significant  differences from  the  wild~type  values  over the  same  time  period 
studied.  Even  though  the  p80  coilin-positive  CBs  decreased  in  number 
compared  to  the  average  numbers  of the  wild-type  nuclei,  there  was  still  a 
difference between the average numbers of p80 coilin and SMN containing CBs 
in the R6/2 nuclei.  There was a greater average number of p80 coilin-positive 
CBs compared to SMN-positive CBs.
No  immunoreactive  CBs  were  seen  in  the  R6/2  striatal  nuclei  when 
antibodies against PAP  and  EWS were used.  Both  of these  nuclear proteins 
were seen to localise occasionally in CBs in wild-type striatal nuclei.  EWS is an 
RNA binding protein and it interacts with SMN  (Young et al., 2003) and  PAP is
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EWS  from  CBs  in  R6/2  nuclei  could  reflect  alterations  in  protein-protein 
interactions  as  a  result of the  increased  CAG  repeat  in  huntingtin  (htt).  For 
example,  PAP  is  required  for  both  cleavage  of  mRNA  and  polyadenylation 
(Schul  et al.,  1996).  14-3-3 is a protein that has been shown to bind to the C- 
terminal of PAP and this interaction is dependent upon phosphorylation (Kim et 
al.,  2003).  The  binding  of  the  two  proteins  affects  the  localisation  and 
polyadenylation activity of PAP.  This interaction is suggested to play a role in 
the regulation of gene expression (Kim et al., 2003).
14-3-3 has also been shown to interact with ataxin-1, the protein involved in 
SCA1  (chapter  1.7.1)  (Chen  et al.,  2003)  and  this  interaction  increases with 
increased CAG repeat size in ataxin-1.  It could therefore be suggested that 14- 
3-3 might interact with mutant htt in a similar way and this could,  in turn, affect 
the interaction of 14-3-3 and PAP, altering the localisation of this protein.
When a Z-series scan and a complete nuclear reconstruction was performed 
on the  R6/2 striatal  nuclei  using the confocal  microscope,  similar results were 
obtained  to  those  of the  light  microscopy  study  for  SMN,  with  the  average 
number of CBs  seen  with  anti-SMN  did  not greatly  differ from  the wild-type 
nuclei (graph 4.3).  However,  anti-p80 coilin revealed a significant decrease in 
the average number of CBs in the R6/2 nuclei compared to that seen in the wild- 
type nuclei (graph 4.3).  The number of p80 coilin-positive CBs seen in the R6/2 
nuclei, like the wild type nuclei, varied from one CB to four CBs and the size of 
CBs also varied.
However,  a higher percentage of nuclei contained just one CB in the  R6/2 
striatal nuclei (60%) compared to the wild-type nuclei (35%) and the frequency 
of two, three or four CBs in the R6/2 nuclei was also seen to decrease.  When 
the number of SMN-positive CBs was analysed,  no significant difference was 
seen from the wild4ype results with the majority of R6/2 nuclei containing only 
one large SMN-positive CB.
On analysing the distribution of either the p80 coilin or SMN-containing CBs, 
with  regard  to their spatial  relationship with the  nucleolus,  it was seen  that a 
greater percentage of CBs,  immunoreactive for either p80 coilin or SMN, were 
nucleoplasmic CB and  not associated with the nucleolus (graph 4.4A-B).  This 
result was most striking for SMN-containing CBs.  In the wild-type striatal nuclei,
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nuclei,  only  47%  of SMN-positive  CBs were  seen  to  be  associated  with  the 
nucleolus.  There  was  also  a  decrease  in  the  percentage  of  nucleolar- 
associated  p80 coilin-positive CBs in the  R6/2  nuclei.  In the wild-type nuclei, 
approximately  89%  of  p80  coilin-containing  CBs  were  nucleolar-associated 
whereas, in the R6/2 nuclei, only approximately 56% of p80 coilin-positive CBs 
were associated with the nucleolus.
A decrease in the number of p80 coilin-positive CBs has been reported in rat 
SON  neurons  during  the  initial  phase of osmotic stress when transcription  is 
inhibited  (Lafarga  et al.,  1998).  However,  even  though  Lafarga  etal.  (1998) 
demonstrated  a  decrease  in  the  overall  number  of  CBs  per  nucleus  when 
transcription is arrested, the CBs that were still seen were associated with the 
nucleolus.  These nucleolar CBs were also shown to contain  U2” snRNP and 
when analysed via EM, were described as precursors to CBs.  It is suggested 
that  new  CBs  are  constantly  forming  at  the  nucleolar  periphery  and  if 
transcription  is  inhibited,  the  pathway  of CB  maturation  is  slowed  down  and 
consequently more nucleolar-CBs are seen.
The results seen  in this study are therefore not consistent with those seen 
when transcription is inhibited despite there being a decrease in the number of 
p80  coilin-positive  CBs.  This  is  because  there  was  also  a  decrease  in  the 
number of nucleolar-associated  CBs  in the  R6/2  nuclei.  The variation  in the 
number of CBs may possibly be related to a change in the requirements of pre- 
mRNA splicing factors (as snRNP biogenesis is related to the function of CBs) 
and ribosome synthesis in the R6/2 striatal neurons.  Changes in cell size have 
been reported to influence the number of CBs per nucleus (Pena et al.,  2001) 
and it is reported that there is cell body shrinkage in the R6/2 striatum (A.Raza, 
personal communications).  This decrease in cell size could therefore result in a 
decrease in the number of CBs.
In R6/2 nuclei, Gemin3 was seen to localise to nuclear foci that resemble the 
small CBs seen to contain p80 coilin and associate with the nucleolus.  When 
double labelling confocal microscopy was carried out using an antibody against 
Gemin3 and pyronin Y,  it was seen that the small foci were indeed associated 
with the nucleolus and not free in the nucleoplasm.  This finding is surprising as 
Gemin3 forms part of the SMN complex that is involved in the assembly and re­
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colocalise in the Nil-associated CB in the R6/2 nuclei together with U2” snRNP. 
It has been shown that Gemin4 interacts indirectly with SMN to form part of the 
macromolecular complex via  Gemin3.  It  is therefore  intriguing  that  Gemin4 
localises with the other components of the SMN complex without Gemin3.
It  has  been  shown  that  increased  expression  of snRNPs  is  sufficient  to 
cause the formation of CBs in cells that usually lack CBs (Sleeman et al., 2001) 
and,  in  SMA,  a  possible defect  in  U  snRNP  assembly and  re-assembly  may 
lead to the reduction in the number of gems (Lefebvre et al.,  1997 and chapter
1.2.6).  The decrease in the number of CBs in the R6/2 nuclei might therefore 
be related to an impairment or decrease in the biogenesis or expression level of 
snRNPs.  This  could  be  due  to  the  mislocalisation  of  Gemin3  and  the 
incomplete assembly of a functioning SMN complex, affecting the biogenesis of 
snRNPs and causing a decrease in the number of CBs.  However, even though 
a  decrease  in  SMN-containing  gems  was  seen  in  SMA,  a  decrease  in  p80 
coilin-positive  CBs  was  neb reported.  The  results  of  this  study  show  no 
significant difference in the average number of SMN-positive CBs per nucleus 
for the wild-type neurons and the R6/2 neurons.  This suggests that whatever 
the altered cellular pathway is that contributes to SMA,  a different pathway is 
disrupted in HD.
It has been suggested that an increase in CBs associated with the nucleolus 
could  facilitate  the  targeting  to  the  nucleolus  of  components  involved  in 
processing of pre-rRNA e.g. fibrillarin, Nopp140 or GAR1,  in neurons that have 
high demands for ribosomes.  Therefore, if the inverse is true, the consequence 
of the decrease in  nucleolar CBs seen  in the  R6/2  nuclei  could  represent an 
incorrect targeting of nucleolar proteins away from the nucleolus.  The results of 
this could lead to a disruption of pre-rRNA processing and ribosome biogenesis 
in the R6/2 nuclei.
From the light microscopy experiments using a number of antibodies against 
nucleolar proteins, it was possible to see that several nucleolar proteins are also 
found  in CBs in  R6/2 striatal nuclei.  Fibrillarin,  Nopp140 and topoisomerase II 
were all seen to localise in nucleolar-associated CBs as well as the nucleolus. 
Fibrillarin and  Nopp140 were also seen  in nucleoplasmic CBs as well as C23. 
Double  labelling  confocal  microscopy  experiments  revealed  that  fibrillarin
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they were nucleolar-associated or nucleoplasmic.
When the ultrastructural localisation of anti-p80 coilin immunoreactivity was 
investigated  in the  R6/2  striatal  nuclei,  p80  coilin-positive  CBs were  not only 
seen at the nucleolar periphery or free  in the nucleoplasm  but also in a  novel 
localisation:  associated  with  the  neuronal  intranuclear  inclusion  (Nil)  (figure 
3.21 A).  Immunoreactive  CBs  were  seen  juxtaposed  to  the  pale,  granular 
inclusion  in  R6/2  nuclei.  The  Nil-associated  CBs  were  also  seen  to  be 
immunoreactive for U2” snRNP antibodies (figure 3.21 B).  When triple labelling 
immunofluorescence was carried out to ascertain  if any of the free CBs,  seen 
with either p80 coilin or SMN immunoreactivity, were in fact Nil-associated CBs, 
this study discovered that 7 out of 10  R6/2  striatal  nuclei  contained  CBs that 
were associated with Nil.
The  results from  this  study  can  therefore  suggest that  in  the  R6/2  nuclei 
there are two subsets of CBs (figure 4.3).  The first subset is a large, prominent 
nucleoplasmic CB that is the Nil-associated CB that contains p80 coilin,  SMN, 
Gemin2, Gemin4, U2” snRNP, fibrillarin, Nopp140 and C23.  The second subset 
is  nucleolar-associated  and  containing  p80  coilin,  fibrillarin,  Nopp140, 
topoisomerase  II,  Gemin3  and  occasionally  SMN.  The  nucleolar-associated 
CBs are also seen to vary in size and number per nucleus.
It has been shown that the maturation of snRNPs occurs specifically inside 
CBs that contain SMN complex (Sleeman et al.,  2003) and therefore CBs that 
lack SMN  but contain p80 coilin must be carrying out a different function.  It is 
also proposed that CBs that contain fibrillarin are involved in the biogenesis of 
nucleolar snoRNPs (Jady et al., 2003).  As the Nil-associated CB contains both 
of these proteins it could be suggested that both the biogenesis of snRNPs and 
snoRNPs  could  occur  in  these  CBs.  Platani  et al.  (2000)  also  showed  that 
different subsets of CBs exist on a motility level.  With small CBs moving faster 
and over greater distances when compared to larger CBs that appeared to have 
a more restricted area of movement.  It is suggested the latter subset of CBs 
contains the  CBs  that  have  been  shown  to  associate with  specific gene  loci 
(snRNA genes and histone genes) (Platani et al., 2000 and chapter 1.4.2).  This 
raises the possibility that the NII-CB could be associated with specific genes.
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Figure 4.2
A diagram showing the different compositions of different CBs within wild-type (Blue) and  R6/2 
striatal nuclei (pink).
The association of the Nil with the CB could suggest that the CB has moved 
from  its  original  site,  possibly  adjacent  to  the  nucleolus,  to  a  new  location, 
juxtaposed  to the  Nil.  How this  occurred  is  important,  as these two  nuclear 
domains  have  both  been  shown  to  be  associated  with  specific  gene  loci 
(chapter 1.1.2 and chapter 1.2.12).  There are four models that can explain the 
new location of the CB in the R6/2 nuclei.  The first sees the CB moving from its 
original  site  at the  periphery of the  nucleolus to the  Nil.  The  result of which 
could  be  loss of association between the CB and the  nucleolus.  The  second 
model  proposes  that  the  Nil  forms  adjacent  to  the  CB  and  excludes  the 
nucleolus.  The  consequence  of this  could  be  that the  nucleolus  is  then  no 
longer over its normal gene loci.  The third and fourth models propose de  novo 
synthesis of a CB adjacent to the  Nil or synthesis of the  Nil  adjacent to a free
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In summary of the findings of this study a number of alterations to CBs can 
be seen the striatal nuclei of R6/2 transgenic mice:
1.  From  4  weeks  of age to  10 weeks  of age there  is  a  decrease  in  the 
average number of p80 coilin-positive CBs.
2.  A greater number of R6/2  nuclei contained just one p80 coilin-positive 
CB.
3.  A higher percentage of both  p80 coilin-positive and  SMN-positive CBs 
are seen to be not associated with the nucleolus.
4.  CBs in the R6/2 nuclei have a novel localisation: associated with the NIL
5.,  Nil-associated  CBs  contain  p80  coilin,  U2”snRNPl  SMN,  Gemin2,
Gemin4 and fibrillarin.
When  antibodies  to  the  same  CB  proteins  were  used  to  analyse  the 
molecular composition of p80 coilin  KO neuronal CBs,  a very different staining 
pattern was seen to that in the wild-type  neuronal  CBs.  An  antibody against 
p80 coilin showed no staining in the neuronal nuclei of the p80 KO mice which 
was possibly to be expected as these mice lack 85% of the p80 coilin gene and 
have been shown to not express no p80 coilin protein (Tucker et al.,  2001  and 
chapter 1.4.3).  Antibodies against SMN,  Gemin2 and Gemin4 revealed diffuse 
staining of the nucleoplasm and cytoplasm  but did  not localise to CBs.  In the 
p80 coilin KO nuclei,  U2” snRNP demonstrated a speckled staining pattern and 
did  not obviously  localise to any CBs (figure 3.28D).  The only nuclear protein 
seen to localise to the nucleolar-associated CBs in the p80 coilin KO nuclei was 
fibrillarin.  These results are similar to those seen by Tucker et al. (2001).
A more recent study on p80 coilin KO mouse embryonic fibroblasts (MEFs) 
has shown that two types of residual CBs can be identified in these cells (Jady 
et al., 2003).  The first residual CBs seen in the p80 coilin KO nuclei contained 
fibrillarin, Nopp140 and U3 snoRNA and lacked SMN and snRNPs.  The second 
type of residual CB was shown to accumulate small-Cajal-body-specific RNAs 
(scaRNAs)  and  Sm  RNAs  (snRNAs with  a  Sm  protein  binding  motif)  but  not 
fibrillarin, U3 snoRNA or SMN (Jady et al., 2003).  It is suggested that these two 
types  of CBs  are  either  involved  in  the  biogenesis  of nucleolar snoRNPs  or 
spliceosomal snRNPs.  It is also proposed that p80 coilin plays a role in uniting
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snoRNA,  U2” snRNA,  Nopp140 and SMN are all found to colocalise with each 
other (Tucker et al., 2001; Jady et al.,  2003).  It also demonstrates that without 
p80 coilin SMN does not colocalise to either type of residual CB.
Although  two  types  of  residual  CBs  were  not  seen  in  the  p80  coilin  KO 
nuclei,  nucleolar-associated  residual  CBs  were  identified  that  contained 
fibrillarin  and,  from  the  ultrastructural  study,  these  CBs  have  a  similar 
morphology to  that seen  in  the  wild-type  striatal  nuclei  (figure  3.29A).  This 
shows that p80 coilin  is  not needed to target fibrillarin to  nucleolar-associated 
CBs and that  CBs  can form  at the  nucleolar periphery  in the absence of the 
marker protein.  This suggests that p80 coilin does not play a structural role in 
the assembly of CBs or the ultrastructural organisation.
p80 coilin may play a role in the recruiting of SMN and other SMN complex 
proteins to CBs as without p80 coilin none of the proteins in the SMN complex 
are seen  in the residual CBs.  However, the fact that SMN and  its associated 
proteins do  not localise together in  CBs  in the  p80 coilin  KO  nuclei does  not 
appear to affect splicing.  This can be seen when the ultrastructure of speckles 
is analysed in the p80 coilin KO nuclei.  It has been shown that when splicing is 
inhibited  in  HeLa  cells  (O’Keefe  et  al.,  1994),  speckles,  or  interchromatin 
granule clusters  (IGCs)  become enlarged  and  more  rounded when examined 
using the electron microscope.  The morphology of IGCs in the p80 coilin  KO 
nuclei are similar to that seen in the wilchtype nuclei with  IGCs not revealing a 
rounded  and  enlarged  ultrastructure  (figure  3.29B).  The function  of the  SMN 
complex  localising  with  other  proteins  in  CBs  may  lead  to  more  efficient 
processing  jbut is not vital for splicing to occur.
4.2.3 The Molecular Composition of the Speckles
Many pre-mRNA splicing factors  have been shown to  localise to speckles 
and, as with the nucleolus and Cajal body, attempts have been made to identify 
the  complete  protein  composition  of speckles  using  proteomic analysis of an 
enriched IGC fraction purified from mouse liver cells (Saitoh et al., 2004).  136 
proteins  have  been  identified  so far and  the functions  of which  are  not only 
related to splicing (chapter 1.3.4).
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localise to speckles and be involved in pre-mRNA splicing have been examined. 
Antibodies  against  SC35,  HYPA,  HYPC  and  2,2,7-trimethylguanosine 
(m3G/TMG) all revealed a punctate nuclear localisation excluding the nucleolus 
that resembles the characteristic speckled staining pattern (figure 3*13).
In HeLa cells, an antibody to Paraspeckle Protein 1   (PSP1) has been shown 
to  localise  to  a  novel  domain  termed  the  paraspeckle  that  has  a  close 
relationship to speckles (Fox  et al, 2002).  In murine striatal nuclei this antibody 
revealed  a  nucleoplasmic  staining  pattern.  When  double  labelling 
immunofluorescence  was  performed  using  an  antibody  to  PSP1  and  an 
antibody against a  protein that is localised to speckles,  TMG,  both antibodies 
showed a nuclear distribution^ but when the images were overlaid only a small 
area of co-localisation was seen (figure 3.14).  This finding demonstrates that 
murine striatal neuronal nuclei,  PSP1  is not localised to speckles. The staining 
pattern seen for PSP1  did not resemble the punctate pattern seen by Fox et al. 
(2002) in HeLa cells but does suggest that paraspeckles are a separate nuclear 
domain  from  speckles.  Other  proteins  have  been  shown  to  localise  in 
paraspeckles  and  they  include  PSP2  and  p54/nrb.  PSP1  has  no  known 
function  whereas  p54/nrb  is  a  multifunctional  protein  that  is  implicated  in 
transcriptional regulation, splicing,and apoptosis.  PSP2 has been identified as 
a  “co-activator  activator”  (Fox  et al.,  2002).  Therefore, the  paraspeckle  is 
implicated in transcriptional control.
The distribution of the same proteins was examined  in  R6/2 striatal  nuclei 
and for some proteins a difference was seen.  Immunocytochemistry using the 
monoclonal  antibody  against  splicing  factor  SC35  did  not  show  the  usual 
‘speckled’ pattern of staining, instead, a diffuse nucleoplasmic pattern was seen 
and antibodies against HYPA and  HYPC  revealed  infrequent speckle staining 
with many nuclei only exhibiting a nucleoplasmic staining pattern (figure 3.27).
Immunoreactivity  for  TMG,  however,  did  reveal  the  characteristic  speckled 
staining pattern that excludes  the nucleolus.
It has been shown that huntingtin (htt) interacts with HYPA and HYPC, both 
of which are WW domain proteins, and, these interactions are increased as the 
polyglutamine  repeat  increases  (Faber et al.  1998).  HYPA  and  HYPC  are 
known to be involved in pre-mRNA splicing (Passani et al.  2000). The findings
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localised  to  speckles, but  are  in  fact  found  to  have  a  mostly  nucleoplasmic 
distribution could suggest that mutant htt not only affects the interactions of the 
HYP  proteins,  but the  increase  in  polyglutamine  length  may  also  affect the 
subnuclear  distribution  of  these  proteins.  A  study  by  Kegel  et  al.  (2001) 
revealed  that full  length  wild-type  htt  localised  to  speckles  in  a  transcription 
independent manner and therefore, the redistribution of htt to the Nil may result 
in the incorrect targeting of other proteins away from speckles.  The change in 
distribution  of the  HYP  proteins  and  SC35 could  suggest that altered  mRNA 
processing and processing may play a role in HD pathogenesis.
Alternatively,  the  redistribution  of  SC35  and  the  HYP  proteins  may  be 
caused by a disruption to a different cellular pathway.  It has been shown that 
the overexpression of specific kinases,  Clk/STY and  DYRK1A,  both cause the 
disassembly of speckles and  interchromatin granule clusters (IGCs) (Colwill et 
al.,  1996;  Sacco-Bubulya  and  Spector,  2002;  Alvarez  et al.,  2003).  These 
results support the idea that the phosphorylation of SR protein splicing factors 
leads to their release from speckles and their recruitment to transcription sites 
(chapter 1.3.8).  However, the study by Sacco-Bubulya and Spector (2002) also 
revealed that all  speckle  proteins examined  redistributed  to the  nucleoplasm 
after  the  overexpression  of  Clk/STY  and  electron  microscopy  showed  that 
speckles/IGCs  were  no  longer  found  in  treated  cells  and  the  IGCs  had 
completely disassembled.  This is not conclusive with the results of this study 
for two  reasons.  Firstly,  not  all  speckle  proteins  redistributed  as  TMG  still 
revealed a speckled staining pattern, and secondly,  at the ultrastructural level, 
IGCs could still be distinguished in the R6/2 nuclei.
Okadaic  acid  treatment,  which  inhibits  serine-threonine  protein 
phosphatases,  also  causes  a  redistribution  of splicing  factors.  Misteli  et al. 
(1997)  revealed  that  splicing  factor,  ASF/SF2,  shows  a  more  diffuse, 
nucleoplasmic  staining  pattern  after treatment with  okadaic  acid.  A  similar 
staining  pattern  is  also  seen  when  HeLa  cells  are  treated  by  heat  shock, 
causing  most  of  RNA  polymerase  II  transcription  to  be  inhibited  and  an 
induction  of  ‘heat  shock’  genes  (Carmo-Fonseca  et  al.,  1992).  A  similar 
distribution  of  splicing  factors  was  seen  during  the  late  recovery  phase  of 
neuronal stress response in rat SON neurons (Lafarga et al.,  1998) when there
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were seen to be very small.  These findings have led  to the theory that actively 
transcribing  cells  are  seen  to  have  predominantly  dispersed  splicing  factors 
throughout the nucleoplasm.
When  all  RNA  polymerase  transcription  is  inhibited  in  HeLa  cells  using 
Actinomycin  D  or a-amanitin,  speckles are seen  to  decrease  in  number and 
become  larger  in  size  (Misteli  et al.,  1997).  A similar distribution  of splicing 
factors  is  seen  when  cells  are  treated  with  the  protein  and  rRNA  synthesis 
inhibitor,  cycloheximide.  Therefore the nucleoplasmic redistribution of splicing 
factors seen  in the  R6/2 striatal  nuclei in this work,  could  suggests that these 
nuclei are transcriptionally very active and protein synthesis is not affected.
When  the  localisation  of the  paraspeckle  protein,  Paraspeckle  Protein  1  
(PSP1)  was  examined  in  R6/2  striatal  nuclei  using  double  labelling 
immunofluorescence  a  similar staining  pattern  was  seen  to  that  in  wild-type 
nuclei  (figure  3.28).  It was  possible  to  see  that the  R6/2  nuclei  did  contain 
paraspeckles as a separate domain from speckles as the immunofluorescence 
for PSP1  only colocalised  in small areas at the  periphery of speckles.  PSP1 
has been shown to  relocalise to nucleolar cap structures after transcription  is 
arrested in HeLa cells (Fox et al., 2002) and as this relocalisation of PSP1  is not 
seen  in  the  R6/2  nuclei,  this  supports  the  idea  that  the  transcription  is  not 
inhibited in these nuclei.
4.3 Conclusions
The  findings  of  this  study  have  demonstrated  that  by  analysing  the 
ultrastructure  of  nuclei  in  murine  striatal  neurons  in  conjunction  with  the 
distribution  of  specific  nuclear  proteins,  an  understanding  of the  metabolic 
activity of a given neuron can be ascertained.  The ultrastructure and molecular 
composition of the three subdomains examined have previously been shown to 
alter  in  response  to  changes  in  metabolic  activity  (chapter  1.4)  and  these 
changes have been well documented.
The findings of this study show that subdomains within neuronal nuclei have 
specific spatial and molecular relationships with each other that despite the fact
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that reveal an organisation that is specific for striatal nuclei.
This  detailed  analysis  of  murine  striatal  nuclei  has  created  a  three 
dimensional guide.  This has then  been  used to directly compare the nuclear 
organisation  within  the  same  type  of  neuron  but  in  a  mouse  model  of 
Huntington’s disease: a disease that already has documented nuclear changes 
(chapter 1.6.5).  In comparing the wild-type organisation to the organisation of 
the R6/2 nuclei, a number of differences, ultrastructurally and molecularly, have 
been seen.  This has given some insights into the mechanisms underlying the 
pathology of HD.
A  suggested  mechanism  of  pathology  in  HD  involves  the  regulation  of 
transcription (chapter 1.6.7).  This is because research has shown that htt may 
play  a  role  in  transcription:  it  has  been  shown  that  htt,  both  wild-type  and 
mutant,  interacts  with  a  number  of factors  involved  in  transcription  (chapter
1.6.3)  and that microarray analysis  has shown  some transcriptional pathways 
are altered in HD (Luthi-Carter et al., 2000 and chapter 1.6.8).  The current view 
of  transcriptional  dysregulation  in  HD,  more  often  than  not,  proposes  a 
downregulation  of  transcription  due  to  either  sequestration  of transcription 
factors  into  Nils  or  gene  chip  analysis  that  shows  a  downregulation  in  the 
expression  of some genes  but an  increase  in  other genes.  Altered  protein- 
protein interactions are also implicated in transcriptional dysregulation as it has 
been shown that mutant htt disrupts normal binding between some transcription 
factors.
Actinomycin D has been widely used to inhibit transcription in cultured cells 
and  many  of these  studies  have described  the  altered  localisations  of many 
nuclear  proteins.  I  have  produced  a  diagrammatic  representation  of these 
changes (figure 4.3) and have used this as a guide to show the relocalisation of 
nuclear  proteins  when  transcription  is  inhibited.  The  belief  being  that  if 
transcription  is  inhibited  or  downregulated  in  HD,  a  similar  redistribution  of 
nuclear proteins would  be seen.  However,  the  results from this  study do  not 
support the  idea  of transcriptional  downregulation  in  HD  due  to  a  number of 
findings that have also been summarised in a diagram (figure 4.4).
2°3  DISCUSSION & CONCLUSIONS4.3.1 The Nucleolus
The  changes  seen  in  R6/2  nucleoli  did  not  resemble  the  alterations 
documented  in  cells  were  transcription  had  been  inhibited  (Reynolds  et al., 
1964).  Ultrastructurally only 21% of nucleoli showed a different morphology to 
those seen in the wilckype nuclei and this ultrastructure bared a resemblance to 
that reported in cells that had been treated with a protein synthesis inhibitor and 
not an  inhibitor of transcription  (Lafarga et al.,  1994).  This finding  was  also 
supported  by the  molecular study  of the  R6/2  nucleoli  as  nucleolar  proteins 
were seen to localise to the nucleolus in a similar pattern seen in the wild-type 
neurons.  It has been shown that in cells treated with transcriptional inhibitors, 
nucleolar proteins showed altered distribution patterns (chapter 1.4.1  and figure
4.3).
4.3.2 The Cajal Body
A more dramatic difference was seen when the Cajal body was investigated 
in  the  R6/2  nuclei.  Ultrastructurally  there  was  no  difference  between  the 
morphology  of  CBs  in  the  wild-type  nuclei  and  those  in  the  R6/2  nuclei, 
regardless of their localisation.  However, CBs were seen in a novel localisation 
juxtaposed  to  the  Nil.  When  the  molecular  composition  of  the  CBs  was 
examined, the results showed that there was a decrease in the average number 
of p80 coilin-positive CBs in the R6/2 nuclei but not a decrease in the average 
number of CBs that contain other CB proteins e.g. SMN and U2” snRNP.  When 
transcription is inhibited in cultured cells, it has been demonstrated that there is 
a decrease in the overall number of CBs and p80 coilin is seen to redistribute to 
small  nucleolar-associated  CBs  and  snRNPs  are  localised  only  to  speckles 
(chapter 1.4.2).
The decrease in number of p80 coilin-positive CBs could reflect a decrease 
in cell size.  The relocation of the CB to the periphery of the Nil could affect the 
targeting of nucleolar proteins and in turn affect rRNA processing.  In R6/2 there 
are 2 subsets of CBs  (figure 4.2) -
1.  Nucleolar-associated  CB  containing  p80  coilin,  fibrillarin,  Nopp140, 
topoisomerase II, Gemin3 and infrequently SMN that vary in number and size.
2°4  DISCUSSION & CONCLUSIONS2.  Nil-associated  CB that contains p80 coilin,  SMN,  Gemin2,  Gemin4,  U2”  
snRNP, fibrillarin,  Nopp140 and C23, and, that only one is present per nucleus 
and all have similar size.
4.3.3  Speckles
The ultrastructural and molecular analysis of speckles in the R6/2 nuclei also 
produced  results that did  not resemble those seen  in cells treated with drugs 
that inhibited transcription (Misteli et al.,  1997).  The loss of splicing factors from 
speckles  in  the  R6/2  nuclei  has  previously  been  reported  in  transcriptionally 
very active cells.
The  results  of this  study do  suggest that  in  HD  there  is  a  more dramatic 
nuclear rearrangement than was  first reported  (Davies et al.,  1997)  and  that 
this affects three important subdomains: the nucleolus, the Cajal body and the 
speckles.  How the reorganisation of the architecture of the striatal  nucleus in 
this model of HD is caused is yet to be understood but future studies may help 
us gain a better insight.
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A  schematic diagram  showing the  distribution  of nuclear  proteins  in  a  cultured  cell  nucleus  (A)  and  the 
redistribution  of the  same  nuclear proteins after treatment with  the transcription  inhibitor,  Actinomycin  D 
(B).  A Quicktime movie of this relocalisation is included in Appendix I.
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A  schematic  diagram  showing  the  distribution  of  nuclear  proteins  in  a  striatal  nucleus  (A)  and  the 
redistribution of the same nuclear proteins in a  10 week old  R6/2 transgenic mouse (B) that is a model  of 
HD. A Quicktime movie of this relocalisation is included in Appendix I
2°7  DISCUSSION & CONCLUSIONS4.4 Future Studies
This  study  has  demonstrated  that  there  are  major  changes  in  the 
ultrastructure and  molecular organisation  of the nucleus  in a  mouse model  of 
HD.  As the structure and  molecular properties of different subdomains  have 
been  shown  to  determine  their  function,  the  examination  of the  functional 
properties  of the  nucleolus,  Cajal  body  and  speckles  in  the  R6/2  transgenic 
mouse would reveal if the structural changes seen do reflect changes in activity.
The  nucleolus  is  knovwto  function  in  the  biogenesis  of  ribosomes  and, 
therefore, analysing this process in the R6/2 transgenic mouse would establish 
if the ultrastructural and  molecular changes seen in this study, do represent a 
disruption in the production of ribosomes.
Speckles  are  implicated  in  the  recycling  of splicing  factors  and  therefore 
splicing.  An investigation to see if splicing is affected in the R6/2 mouse would 
verify  if  speckles  are  functioning  correctly.  However,  preliminary  studies 
analysing the splicing of tau,  a highly, alternatively spliced protein in the brain, 
has shown no differences between the wild-type and  R6/2 brains (Slavik-Smith 
and Godert,  unpublished).  It cannot be concluded, from this result alone, that 
splicing is unaffected  in the R6/2 brain as the splicing of only one protein  has 
been analysed so far.  More proteins must be investigated to draw any further 
conclusions.
The most dramatic changes were seen  in the CBs of the  R6/2  nuclei,  but 
little is known about the exact function of this domain,  making it very difficult to 
study any possible functional changes.
These studies could also be continued emphasising the movement of the 
CB from  its  original  site  adjacent to the  nucleolus to  a  new  location.  This  is 
important because these two  nuclear domains  have  been  shown  to found  at 
specific DNA loci.  To try and  understand what is happening to these  nuclear 
domains and  their associations with  specific  DNA  loci,  chromosome  painting 
could be carried out on wild-type and R6/2 striatal nuclei.  This technique would 
permit the identification of different gene loci or individual chromosomes using 
biotinylated DNA probes.  After hybridisation, the loci can then be detected with 
fluorescent avidin conjugates and the relationship between the domain and the 
loci can be examined (Cremer et al.,  1988).
208  DISCUSSION & CONCLUSIONSIn  addition  to  these  experiments  it will  be  important to  continue with  the 
molecular characterisation  of the  nucleolus,  Cajal  body  and  speckles  in  the 
R6/2 striatal nuclei.  In 2002, a proteomic analysis of the nucleolus was carried 
out (Andersen et al., 2002) and since then the isolation and proteomic analysis 
of CBs and speckles have also been achieved.  It would be interesting to try and 
repeat these proteomic experiments for striatal nuclei from wild-type mice and 
compare the molecular composition of each domain with the same domain from 
the R6/2 striatal nuclei and the Nil.
Analysing  transcription  in  wild-type  and  R6/2  neurons  would  be  another 
process  to  examine.  Actual  sites  of transcription  can  be  visualised  using 
Bromo-UTP uptake experiments (Cmarko et al.,  1999) or by the distribution of 
different transcription factors in the nucleus (Grande et al.,  1997).  It would also 
be interesting to see what happens when transcription  is inhibited  in a mouse 
neuron by treatment with either Actinomycin D, a-amanitin or DRB.
Hopefully these lines of investigation will help explain part of the pathogenic 
mechanism in  Huntington’s disease.  It will also give valuable insights into the 
dynamic nature of the neuronal nucleus.
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